Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S    O
-    O
adenosyl    O
methionine    O
and    O
jasmonate    B-Alkene114713120
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
adenosylhomocysteine    O
and    O
methyl    B-Alkene114713120
jasmonate    I-Alkene114713120
.    O

Methyl    B-Alkene114713120
jasmonate    I-Alkene114713120

"N"-Octyl    B-Alkene114713120
bicycloheptene    I-Alkene114713120
dicarboximide    I-Alkene114713120
(    O
MGK    O
264    O
)    O
–    O
an    O
optional    O
additive    O
to    O
improve    O
the    O
effectiveness    O
of    O
a    O
pyrethroid    O
.    O

Fusidic    B-Alkene114713120
acid    I-Alkene114713120
is    O
a    O
steroid    O
antibiotic    O
that    O
is    O
often    O
used    O
topically    O
in    O
creams    O
and    O
eyedrops    O
but    O
may    O
also    O
be    O
given    O
systemically    O
as    O
tablets    O
or    O
injections    O
.    O

The    O
company    O
launched    O
Fucidin    B-Alkene114713120
to    O
be    O
used    O
to    O
treat    O
staphylococcus    O
infections    O

After    O
her    O
successful    O
publications    O
,    O
Barber    O
was    O
hired    O
by    O
the    O
Medical    O
Research    O
Council    O
to    O
study    O
semisynthetic    O
penicillin    O
,    O
cephalosporin    O
,    O
fucidin    B-Alkene114713120
,    O
lincomycin    O
,    O
and    O
pristinamycin    O
.    O

Methicillin    O
-    O
resistant    O
Staphylococcus    O
aureus    O
infections    O
may    O
be    O
treated    O
with    O
a    O
combination    O
therapy    O
of    O
fusidic    B-Alkene114713120
acid    I-Alkene114713120
and    O
rifampicin    O
.    O

Alphenal    B-Alkene114713120
(    O
Alphenal    B-Alkene114713120
,    O
Efrodal    B-Alkene114713120
,    O
Prophenal    B-Alkene114713120
,    O
Sanudorm    B-Alkene114713120
)    O
,    O
also    O
known    O
as    O
5-allyl-5-phenylbarbituric    B-Alkene114713120
acid    I-Alkene114713120
,    O
is    O
a    O
barbiturate    O
derivative    O
developed    O
in    O
the    O
1920s    O
.    O

The    O
most    O
potent    O
of    O
these    O
receptor    O
agonists    O
for    O
binding    O
to    O
and    O
activating    O
IP    O
are    O
iloprost    B-Alkene114713120
,    O
taprostene    O
,    O
and    O
esuberaprost    O
which    O
have    O
Kd    O
values    O
(    O
i.e.    O
concentrations    O
which    O
bind    O
to    O
half    O
of    O
available    O
IP    O
receptors    O
)    O
in    O
the    O
low    O
nanamole    O
/    O
liter    O
range    O
(    O
http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345/    O
)    O
.    O

Major    O
drugs    O
in    O
this    O
category    O
include    O
PGI2    O
itself    O
(    O
i.e.    O
epoprostenol    O
)    O
,    O
iloprost    B-Alkene114713120
,    O
treprostinil    O
,    O
and    O
beraprost    B-Alkene114713120
with    O
epoprostenol    O
being    O
favored    O
in    O
some    O
studies    O
.    O

Iloprost    B-Alkene114713120
(    O
Prostacyclin    O
)    O

5,6-dehydrokawain    B-Alkene114713120

Talipexole    B-Alkene114713120
–    O
selective    O
for    O
D2    O
over    O
other    O
dopamine    O
receptors    O
,    O
but    O
also    O
acts    O
as    O
α2–adrenoceptor    O
agonist    O
and    O
5-HT3    O
antagonist    O
.    O

Thioketenes    B-Alkene114713120
are    O
organosulfur    O
compounds    O
analogous    O
to    O
ketene    B-Alkene114713120
with    O
the    O
general    O
formula    O
R2C    O
=    O
C    O
=    O
S    O
,    O
where    O
R    O
is    O
alkyl    O
or    O
aryl    O
.    O

Penicillium    O
paneum    O
"    O
produces    O
1-Octen-3-ol    B-Alkene114713120
and    O
penipanoid    O
A    O
,    O
penipanoid    O
B    O
,    O
penipanoid    O
C    O
,    O
patulin    O
and    O
roquefortine    O
C    O

At    O
least    O
18    O
Microbial    O
VOCs    O
(    O
MVOCs    O
)    O
have    O
been    O
characterised    O
including    O
1-octen-3-ol    B-Alkene114713120
,    O
3-methylfuran    O
,    O
2-pentanol    O
,    O
2-hexanone    O
,    O
2-heptanone    O
,    O
3-octanone    O
,    O
3-octanol    O
,    O
2-octen-1-ol    O
,    O
1-octene    B-Alkene114713120
,    O
2-pentanone    O
,    O
2-nonanone    O
,    O
borneol    O
,    O
geosmin    O
,    O
1-butanol    O
,    O
3-methyl-1-butanol    O
,    O
3-methyl-2-butanol    O
,    O
and    O
thujopsene    O
.    O

However    O
,    O
there    O
are    O
now    O
bug    O
zappers    O
that    O
emit    O
carbon    O
dioxide    O
or    O
use    O
an    O
external    O
bait    O
,    O
such    O
as    O
octenol    B-Alkene114713120
,    O
to    O
better    O
attract    O
biting    O
insects    O
into    O
the    O
light    O
.    O

Big    O
Sagebrush    O
(    O
"    O
Artemisia    O
tridentata    O
"    O
)    O
contains    O
sesquiterpene    B-Alkene114713120
lactones    I-Alkene114713120
which    O
are    O
sesquiterpenoids    O
(    O
built    O
from    O
three    O
isoprene    B-Alkene114713120
units    O
)    O
and    O
contain    O
a    O
lactone    O
ring    O
,    O
hence    O
the    O
name    O
.    O

Monoterpenes    O
are    O
a    O
class    O
of    O
terpenes    O
that    O
consist    O
of    O
two    O
isoprene    B-Alkene114713120
units    O
and    O
have    O
the    O
molecular    O
formula    O
C10H16    O

Frederick    O
W.    O
Stavely    O
(    O
1894    O
-    O
1976    O
)    O
was    O
a    O
researcher    O
at    O
the    O
Firestone    O
Tire    O
&    O
Rubber    O
Company    O
who    O
in    O
1953    O
,    O
while    O
investigating    O
the    O
reaction    O
of    O
butyl    O
lithium    O
on    O
butadiene    O
discovered    O
that    O
polymerization    O
of    O
isoprene    B-Alkene114713120
with    O
metallic    O
lithium    O
produced    O
polyisoprene    O
(    O
dubbed    O
"    O
coral    O
rubber    O
"    O
because    O
of    O
its    O
appearance    O
)    O
with    O
a    O
high    O
"    O
cis    O
"    O
content    O
.    O

The    O
Molecular    O
Kink    O
Paradigm    O
proceeds    O
from    O
the    O
intuitive    O
notion    O
that    O
the    O
chains    O
that    O
make    O
up    O
a    O
natural    O
rubber    O
(    O
polyisoprene    B-Alkene114713120
)    O
network    O
are    O
constrained    O
by    O
surrounding    O
chains    O
to    O
remain    O
within    O
a    O
‘    O

He    O
published    O
his    O
hypothesis    O
,    O
the    O
"    O
Biogenetic    O
Isoprene    O
Rule    O
"    O
(    O
that    O
the    O
carbon    O
skeleton    O
of    O
terpenes    O
is    O
composed    O
variously    O
of    O
regularly    O
or    O
irregularly    O
linked    O
isoprene    B-Alkene114713120
units    O
)    O
,    O
which    O
was    O
the    O
peak    O
of    O
his    O
scientific    O
career    O
.    O

Isoprene    B-Alkene114713120

Nevcin    O
synthesises    O
hydrocarbon    O
resins    O
,    O
using    O
distillates    O
from    O
cracking    O
of    O
the    O
naphtha    O
fraction    O
,    O
with    O
polymerisation    O
feedstock    O
including    O
isoprene    B-Alkene114713120
,    O
piperylene    B-Alkene114713120
and    O
cyclopentadiene    O
(    O
or    O
dicyclopentadiene    B-Alkene114713120
dimer    O
)    O
as    O
well    O
as    O
styrene    O
and    O
styrene    O
-    O
type    O
products    O
including    O
vinyltoluene    O
,    O
indene    O
,    O
methylindene    O
and    O
alpha-methylstyrene    B-Alkene114713120
.    O

Absinthin    O
's    O
(    O
1    O
)    O
complex    O
structure    O
is    O
classified    O
as    O
a    O
sesquiterpene    O
lactone    O
,    O
meaning    O
it    O
belongs    O
to    O
a    O
large    O
category    O
of    O
natural    O
products    O
chemically    O
derived    O
from    O
5-carbon    O
"    O
building    O
blocks    O
"    O
(    O
3    O
)    O
derived    O
from    O
isoprene    B-Alkene114713120
(    O
4    O
)    O
.    O

While    O
terpenoids    O
like    O
Absinthin    O
can    O
be    O
said    O
to    O
consist    O
of    O
isoprene    B-Alkene114713120
"    O
units    O
,    O
"    O
isoprene    B-Alkene114713120
by    O
itself    O
is    O
unstable    O
and    O
does    O
not    O
react    O
directly    O
.    O

A    O
series    O
of    O
ATP    O
-    O
dependent    O
transformations    O
lead    O
to    O
a    O
key    O
isoprene    B-Alkene114713120
unit    O
,    O
isopentenyl    O
diphosphate    O
(    O
IPP    O
)    O
which    O
can    O
be    O
isomerized    O
to    O
dimethylallyl    O
diphosphate    O
(    O
DMAPP    O
)    O
.    O

The    O
terpenoids    O
,    O
sometimes    O
called    O
isoprenoids    O
,    O
are    O
a    O
large    O
and    O
diverse    O
class    O
of    O
naturally    O
occurring    O
organic    O
chemicals    O
similar    O
to    O
terpenes    O
,    O
derived    O
from    O
five    O
-    O
carbon    O
isoprene    B-Alkene114713120
units    O
assembled    O
and    O
modified    O
in    O
thousands    O
of    O
ways    O
.    O

Terpenes    O
are    O
hydrocarbons    O
resulting    O
from    O
the    O
condensation    O
of    O
several    O
5-carbon    O
isoprene    B-Alkene114713120
units    O
.    O

IPP    O
and    O
DMAPP    O
are    O
the    O
end    O
-    O
products    O
in    O
either    O
pathway    O
,    O
and    O
are    O
the    O
precursors    O
of    O
isoprene    B-Alkene114713120
,    O
monoterpenoids    O
(    O
10-carbon    O
)    O
,    O
diterpenoids    O
(    O
20-carbon    O
)    O
,    O
carotenoids    O
(    O
40-carbon    O
)    O
,    O
chlorophylls    O
,    O
and    O
plastoquinone-9    O
(    O
45-carbon    O
)    O
.    O

Terpenes    O
are    O
derived    O
biosynthetically    O
from    O
units    O
of    O
isoprene    B-Alkene114713120
,    O
which    O
has    O
the    O
molecular    O
formula    O
C5H8    O
.    O

In    O
1860    O
,    O
Williams    O
analyzed    O
rubber    O
by    O
destructive    O
distillation    O
and    O
obtained    O
a    O
large    O
quantity    O
of    O
a    O
light    O
oil    O
which    O
he    O
termed    O
isoprene    B-Alkene114713120
(    O
polymer    O
of    O
the    O
monomer    O
isoprene—    O

Terpenoids    O
,    O
produced    O
by    O
conifers    O
and    O
angiosperms    O
,    O
consist    O
of    O
ring    O
structures    O
formed    O
of    O
isoprene    B-Alkene114713120
(    O
C5H8    O
)    O
units    O
.    O

The    O
volatile    O
oils    O
have    O
a    O
reputed    O
component    O
of    O
isoprene    B-Alkene114713120
.    O

oxprenolol    B-Alkene114713120

Oxprenolol    B-Alkene114713120

Ethyl    B-Alkene114713120
cyanoacrylate    I-Alkene114713120
,    O
a    O
type    O
of    O
glue    O

The    O
largest    O
scale    O
reaction    O
is    O
its    O
esterification    O
to    O
give    O
the    O
corresponding    O
ester    O
ethyl    O
cyanoacetate    O
,    O
which    O
is    O
then    O
transformed    O
to    O
ethyl    B-Alkene114713120
cyanoacrylate    I-Alkene114713120
used    O
as    O
superglue    O
,    O
via    O
reaction    O
with    O
formaldehyde    O
.    O

Acrivastine    B-Alkene114713120
is    O
a    O
medication    O
used    O
for    O
the    O
treatment    O
of    O
allergies    O
and    O
hay    O
fever    O
.    O

"    O
beni    O
"    O
(    O
紅    O
)    O
,    O
a    O
Japanese    O
color    O
commonly    O
called    O
"    O
safflower    O
red    O
"    O
or    O
"    O
carthamin    B-Alkene114713120
"    O
in    O
English    O

Naloxegol    B-Alkene114713120

Naloxegol    B-Alkene114713120
(    O
Movantik    O
)    O
–    O
PEGylated    O
naloxol    O
for    O
the    O
treatment    O
of    O
opioid    O
-    O
induced    O
constipation    O
in    O
adults    O
patients    O
with    O
chronic    O
non    O
-    O
cancer    O
pain    O
(    O
un    O
-    O
pegylated    O
methadone    O
can    O
cause    O
adverse    O
gastrointestinal    O
reactions    O
)    O
.    O

Oleamide    B-Alkene114713120
-    O
the    O
corresponding    O
amide    O

Oleamide    B-Alkene114713120

Monocrotophos    B-Alkene114713120

Monocrotophos    B-Alkene114713120
is    O
an    O
organophosphate    O
insecticide    O
.    O

For    O
example    O
,    O
the    O
sunscreen    O
octocrylene    B-Alkene114713120
contains    O
a    O
2-ethylhexyl    O
ester    O
for    O
this    O
purpose    O
.    O

Examples    O
of    O
chemesthetic    O
sensations    O
include    O
the    O
burn    O
-    O
like    O
irritation    O
from    O
capsaicin    O
and    O
related    O
compounds    O
in    O
foods    O
like    O
chili    O
peppers    O
;    O
the    O
coolness    O
of    O
menthol    O
in    O
mouthwashes    O
and    O
topical    O
analgesic    O
creams    O
;    O
the    O
stinging    O
or    O
tingling    O
of    O
carbonated    O
beverages    O
in    O
the    O
nose    O
and    O
mouth    O
;    O
the    O
tear    O
-    O
induction    O
of    O
cut    O
onions    O
;    O
and    O
the    O
pungent    O
,    O
cough    O
-    O
inducing    O
sensation    O
in    O
the    O
back    O
of    O
the    O
throat    O
elicited    O
by    O
the    O
oleocanthal    B-Alkene114713120
in    O
high    O
-    O
quality    O
extra    O
virgin    O
olive    O
oil    O
.    O

The    O
cytokinin    O
zeatin    B-Alkene114713120
is    O
named    O
after    O
the    O
genus    O
of    O
corn    O
,    O
"    O
Zea    O
"    O
,    O
in    O
which    O
it    O
was    O
discovered    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
O    O
-    O
acetyl    O
-    O
L    O
-    O
serine    O
and    O
zeatin    B-Alkene114713120
,    O
whereas    O
its    O
two    O
products    O
are    O
lupinate    O
and    O
acetate    O
.    O

Gyrinal    B-Alkene114713120
,    O
a    O
powerful    O
antiseptic    O
and    O
fish    O
and    O
mammal    O
toxin    O

Spironolactone    O
is    O
also    O
formulated    O
in    O
combination    O
with    O
a    O
variety    O
of    O
other    O
drugs    O
,    O
including    O
with    O
hydrochlorothiazide    O
as    O
Aldactazide    O
,    O
with    O
hydroflumethiazide    O
as    O
Aldactide    O
,    O
Lasilacton    O
,    O
Lasilactone    O
,    O
and    O
Spiromide    O
,    O
with    O
altizide    B-Alkene114713120
as    O
Aldactacine    O
and    O
Aldactazine    O
,    O
with    O
furosemide    O
as    O
Fruselac    O
,    O
with    O
benazepril    O
as    O
Cardalis    O
(    O
veterinary    O
)    O
,    O
with    O
metolazone    O
as    O
Metolactone    O
,    O
with    O
bendroflumethiazide    O
as    O
Sali    O
-    O
Aldopur    O
,    O
and    O
with    O
torasemide    O
as    O
Dytor    O
Plus    O
,    O
Torlactone    O
,    O
and    O
Zator    O
Plus    O
.    O

The    O
active    O
ingredients    O
are    O
extracted    O
with    O
organic    O
solvents    O
to    O
give    O
a    O
concentrate    O
containing    O
the    O
six    O
types    O
of    O
pyrethrins    O
:    O
pyrethrin    B-Alkene114713120
I    I-Alkene114713120
,    O
pyrethrin    B-Alkene114713120
II    I-Alkene114713120
,    O
cinerin    O
I    O
,    O
cinerin    O
II    O
,    O
jasmolin    O
I    O
,    O
and    O
jasmolin    O
II    O
.    O

The    O
chemical    O
structure    O
of    O
rubber    O
from    O
the    O
mushroom    O
consists    O
of    O
a    O
high    O
molecular    O
mass    O
homologue    O
of    O
polyprenol    B-Alkene114713120
,    O
arranged    O
as    O
a    O
dimethylallyl    O
group    O
,    O
two    O
"    O
trans    O
"    O
isoprene    B-Alkene114713120
units    O
,    O
a    O
long    O
sequence    O
of    O
"    O
cis    O
"    O
isoprenes    O
(    O
between    O
260–300    O
units    O
)    O
,    O
terminated    O
by    O
a    O
hydroxyl    O
or    O
fatty    O
acid    O
ester    O
.    O

The    O
enzyme    O
is    O
involved    O
in    O
biosynthesis    O
of    O
dolichol    B-Alkene114713120
(    O
a    O
long    O
-    O
chain    O
polyprenol    B-Alkene114713120
)    O
with    O
a    O
saturated    O
alpha    O
-    O
isoprene    O
unit    O
.    O

Examples    O
include    O
longifolene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
and    O
the    O
alcohol    O
patchoulol    O
.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    B-Alkene114713120
50%    O
,    O
thujene    B-Alkene114713120
,    O
and    O
carene    B-Alkene114713120
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
,    O
α-    O
and    O
β-cubebene    O
,    O
cadinene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
1,8-cineole    O
and    O
the    O
alcohol    O
cubebol    O
.    O

Beraprost    B-Alkene114713120
is    O
a    O
pharmaceutical    O
drug    O
used    O
in    O
several    O
Asian    O
countries    O
,    O
including    O
Japan    O
and    O
South    O
Korea    O
,    O
as    O
a    O
vasodilator    O
and    O
antiplatelet    O
agent    O
.    O

Chemical    O
constituents    O
of    O
the    O
seeds    O
include    O
oleanolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
nuzhenide    O
,    O
and    O
ligustroside    O
.    O

"    O
U.    O
guianensis    O
"    O
contains    O
many    O
phytochemicals    O
(    O
(    O
-)-epicatechin    O
,    O
alkaloid    O
,    O
beta    O
-    O
Sitosterol    B-Alkene114713120
,    O
campesterol    O
,    O
campherol    O
,    O
catechol    O
,    O
catechutannic    O
acid    O
,    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
ellagic    O
acid    O
,    O
gallic    O
acid    O
,    O
hyperin    O
,    O
oleanolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
rutin    O
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
)    O
and    O
proanthocyanidin    O
B1    O
and    O
proanthocyanidin    O
B2    O
,    O
B    O
type    O
proanthocyanidins    O
,    O
in    O
the    O
root    O
.    O

Analysis    O
of    O
the    O
methanolic    O
extract    O
of    O
the    O
aerial    O
parts    O
yields    O
sitosterol    B-Alkene114713120
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
,    O
oleanolic    B-Alkene114713120
acid    I-Alkene114713120
and    O
brassicasterol    O
.    O

"    O
Swertia    O
"    O
contains    O
the    O
chemicals    O
sawertiamarine    O
,    O
mangeferin    O
and    O
amarogenitine    O
1,5,8-trihydroxy-3-methoxyxanthone    O
,    O
1-hydroxy-2,3,5,7-tetramethoxyxanthone    O
,    O
1-hydroxy-3,5,8-trimethoxyxanthone    O
,    O
1-hydroxyl-2,3,4,6-tetramethoxyxanthone    O
,    O
1-hydroxy-2,3,4,7-tetramethoxyxanthone    O
,    O
1,8-dihydroxy-3,5-dimethoxyxanthone    O
,    O
1,7-dihydroxy-3,8-dimethoxyxanthone    O
,    O
1,3,5,8-tetrahydroxyxanthone    O
,    O
balanophonin    O
,    O
oleanolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
maslinic    O
acid    O
,    O
and    O
sumaresinolic    O
acid    O

isosafrole    B-Alkene114713120
(    O
cis    O
+    O
trans    O
)    O

safrole    B-Alkene114713120
,    O
isosafrole    B-Alkene114713120
and    O
3,4-methylenedioxyphenylpropan-2-one    O

It    O
is    O
usually    O
produced    O
by    O
hydroformylation    O
of    O
heptene    B-Alkene114713120
and    O
the    O
dehydrogenation    O
of    O
1-octanol    O
.    O

The    O
purity    O
of    O
manufactured    O
phthalate    O
esters    O
is    O
reportedly    O
between    O
99.70%    O
and    O
99.97%    O
with    O
the    O
main    O
impurities    O
being    O
isophthalic    O
acid    O
,    O
terephthalic    O
acid    O
,    O
and    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120
.    O

Alder    O
reaction    O
of    O
2    O
equivalents    O
of    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120
with    O
a    O
1,1-diarylethylene    O
.    O

Tropone    O
is    O
a    O
diene    O
in    O
a    O
Diels    O
-    O
Alder    O
reaction    O
for    O
instance    O
with    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120

This    O
compound    O
reacts    O
with    O
two    O
equivalents    O
of    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120
in    O
a    O
tandem    O
DA    O
reaction    O
:    O

Maleimide    O
and    O
its    O
derivatives    O
are    O
prepared    O
from    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120
by    O
treatment    O
with    O
amines    O
followed    O
by    O
dehydration    O
.    O

The    O
PEO    O
-    O
PET    O
block    O
copolymers    O
can    O
be    O
crosslinked    O
by    O
using    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120
,    O
glycerin    O
or    O
dimethyl    O
5-isophthalates    O
as    O
a    O
crosslinking    O
agent    O
.    O

Alder    O
reaction    O
of    O
furan    O
and    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120
.    O

Formed    O
by    O
the    O
condensation    O
reaction    O
of    O
a    O
diamine    O
with    O
maleic    B-Alkene114713120
anhydride    I-Alkene114713120
,    O
and    O
processed    O
basically    O
like    O
epoxy    O
resins    O
(    O
cure    O
)    O
.    O

Other    O
:    O
Other    O
prescription    O
and    O
over    O
-    O
the    O
-    O
counter    O
medications    O
,    O
such    O
as    O
theophylline    O
,    O
cromolyn    O
,    O
and    O
montelukast    B-Alkene114713120
are    O
indicated    O
for    O
specific    O
diseases    O
and    O
may    O
only    O
provide    O
bronchoconstriction    O
relief    O
to    O
these    O
studied    O
populations    O
.    O

Non    O
-    O
surgical    O
methods    O
of    O
treating    O
capsules    O
include    O
massage    O
,    O
external    O
ultrasound    O
,    O
treatment    O
with    O
leukotriene    O
pathway    O
inhibitors    O
(    O
e.g.    O
Accolate    O
,    O
Singulair    B-Alkene114713120
)    O
,    O
and    O
pulsed    O
electromagnetic    O
field    O
therapy    O
.    O

Furthermore    O
,    O
the    O
allergic    O
and    O
hypersensitivity    O
responses    O
of    O
humans    O
and    O
animal    O
models    O
are    O
significantly    O
reduced    O
by    O
chronic    O
treatment    O
with    O
Montelukast    B-Alkene114713120
,    O
Zafirlukast    O
,    O
and    O
Pranlukast    O
,    O
drugs    O
which    O
are    O
selective    O
receptor    O
antagonists    O
of    O
CysLTR1    O
but    O
not    O
CysLTR2    O
.    O

Another    O
leukotriene    O
receptor    O
antagonist    O
is    O
montelukast    B-Alkene114713120
(    O
Singulair    O
)    O
,    O
taken    O
once    O
daily    O
.    O

Related    O
compounds    O
include    O
montelukast    B-Alkene114713120
(    O
Singulair    O
)    O
and    O
zafirlukast    O
(    O
Accolate    O
)    O
.    O

The    O
first    O
has    O
long    O
been    O
identified    O
with    O
the    O
Mayo    O
Clinic    O
,    O
and    O
it    O
recommended    O
treatment    O
with    O
beta    O
agonists    O
such    O
as    O
terbutaline    O
,    O
phosphodiesterase    O
-    O
inhibitor    O
theophylline    O
,    O
and    O
leukotriene    O
-    O
receptor    O
antagonists    O
montelukast    B-Alkene114713120
sodium    I-Alkene114713120
.    O

Nalmexone    B-Alkene114713120
(    O
INN    O
)    O
(    O
code    O
names    O
EN-1620A    B-Alkene114713120
,    O
UM-592    B-Alkene114713120
)    O
,    O
or    O
nalmexone    B-Alkene114713120
hydrochloride    I-Alkene114713120
(    O
USAN    O
)    O
,    O
is    O
a    O
semisynthetic    O
,    O
opioid    O
partial    O
agonist    O
or    O
mixed    O
agonist    O
-    O
antagonist    O
with    O
both    O
analgesic    O
and    O
narcotic    O
antagonist    O
properties    O
that    O
was    O
never    O
marketed    O
.    O

The    O
YEATS    O
domain    O
has    O
shown    O
to    O
be    O
a    O
reader    O
domain    O
for    O
the    O
protein    O
modification    O
of    O
lysine    O
crotonylation    B-Alkene114713120
.    O

Crotonic    B-Alkene114713120
acid    I-Alkene114713120
,    O
trans-2-butenoic    O
acid    O
,    O

Crotonic    B-Alkene114713120
acid    I-Alkene114713120

Although    O
not    O
usually    O
prepared    O
from    O
tropone    B-Alkene114713120
,    O
it    O
can    O
be    O
viewed    O
as    O
its    O
derivative    O
with    O
a    O
hydroxyl    O
group    O
in    O
the    O
2-position    O
.    O

Cyclopropatriene    O
is    O
a    O
hypothetical    O
allotrope    O
of    O
carbon    O
that    O
was    O
once    O
proposed    O
as    O
a    O
candidate    O
for    O
a    O
spectroscopically    O
observed    O
tricarbon    B-Alkene114713120
species    O
.    O

Polymethines    B-Alkene114713120
are    O
compounds    O
made    O
up    O
from    O
an    O
"    O
odd    O
"    O
number    O
of    O
methine    O
groups    O
(    O
CH    O
)    O
bound    O
together    O
by    O
alternating    O
single    O
and    O
double    O
bonds    O

Normally    O
aluminium    O
is    O
protected    O
by    O
a    O
passivating    O
oxide    O
layer    O
,    O
but    O
when    O
these    O
layers    O
are    O
disturbed    O
,    O
the    O
metallic    O
aluminium    O
reacts    O
with    O
trichloroethane    O
to    O
give    O
aluminium    O
trichloride    O
,    O
which    O
in    O
turn    O
catalyses    O
the    O
dehydrohalogenation    O
of    O
the    O
remaining    O
trichloroethane    O
to    O
vinylidene    B-Alkene114713120
chloride    I-Alkene114713120
and    O
hydrogen    O
chloride    O
.    O
Dioxane    O
"    O
poisons    O
"    O
this    O
catalysis    O
reaction    O
by    O
forming    O
an    O
adduct    O
with    O
aluminum    O
trichloride    O
.    O

Polyvinylidene    O
chloride    O
(    O
PVDC    O
)    O
is    O
a    O
homopolymer    O
of    O
vinylidene    B-Alkene114713120
chloride    I-Alkene114713120
.    O

Industrially    O
,    O
it    O
is    O
produced    O
by    O
the    O
carbonylation    O
of    O
methylene    O
chloride    O
,    O
oxidation    O
of    O
vinylidene    B-Alkene114713120
chloride    I-Alkene114713120
,    O
or    O
the    O
addition    O
of    O
chlorine    O
to    O
ketene    B-Alkene114713120
.    O

Allylcyclopentane    B-Alkene114713120
is    O
a    O
hydrocarbon    O
that    O
has    O
the    O
formula    O
C8H14    O
.    O

Indalpine    O
(    O
Upstene    O
)    O
and    O
zimelidine    B-Alkene114713120
(    O
Normud    O
,    O
Zelmid    O
)    O
were    O
also    O
formerly    O
used    O
as    O
antidepressants    O
,    O
but    O
were    O
withdrawn    O
from    O
the    O
market    O
.    O

:    O
N06AB02    O
Zimelidine    B-Alkene114713120

In    O
1983    O
Astra    O
withdrew    O
its    O
neuropharmacological    O
drug    O
Zelmid    B-Alkene114713120
,    O
which    O
had    O
only    O
introduced    O
the    O
year    O
before    O
,    O
because    O
of    O
concerns    O
over    O
side    O
effects    O
.    O

Lactucin    B-Alkene114713120
,    O
desoxylactucin    O
,    O
lactucopicrin    B-Alkene114713120
,    O
lactucin-15-oxalate    O
,    O
lactucopicrin-15-oxalate    O
are    O
some    O
of    O
the    O
most    O
prominent    O
found    O
in    O
lettuce    O
and    O
spinach    O
,    O
giving    O
most    O
of    O
the    O
bitter    O
taste    O
to    O
these    O
crops    O
.    O

A    O
2004    O
study    O
of    O
toxaphene    B-Alkene114713120
concentrations    O
found    O
that    O
concentrations    O
were    O
lower    O
in    O
Siskiwit    O
Lake    O
trout    O
than    O
in    O
Lake    O
Superior    O
trout    O
,    O
possibly    O
due    O
to    O
shorter    O
food    O
chains    O
and    O
greater    O
reliance    O
on    O
zooplankton    O
or    O
other    O
pelagic    O
invertebrates    O
.    O

Of    O
these    O
chemicals    O
,    O
the    O
most    O
dangerous    O
were    O
toxaphene    B-Alkene114713120
and    O
phenylmercury    O
acetate    O
,    O
both    O
banned    O
in    O
the    O
European    O
Union    O
since    O
1983    O
.    O

The    O
control    O
measures    O
used    O
have    O
included    O
a    O
wide    O
range    O
of    O
pesticides    O
,    O
including    O
calcium    O
arsenate    O
,    O
DDT    O
,    O
toxaphene    B-Alkene114713120
,    O
aldrin    O
,    O
dieldrin    O
,    O
endrin    B-Alkene114713120
,    O
heptachlor    O
,    O
malathion    O
,    O
and    O
parathion    O
.    O

Protochlorophyllide    O
,    O
or    O
monovinyl    O
protochlorophyllide    O
,    O
is    O
an    O
immediate    O
precursor    O
of    O
chlorophyll    O
"    O
a    O
"    O
that    O
lacks    O
the    O
phytol    B-Alkene114713120
side    O
-    O
chain    O
of    O
chlorophyll    O
.    O

phytol    B-Alkene114713120
:    O
-360    O
±    O
50‰    O
(    O
more    O
depleted    O
than    O
the    O
other    O
two    O
categories    O
)    O

Diterpenes    O
also    O
form    O
the    O
basis    O
for    O
biologically    O
important    O
compounds    O
such    O
as    O
retinol    O
,    O
retinal    O
,    O
and    O
phytol    B-Alkene114713120
.    O

Desloratadine    B-Alkene114713120

Loratadine    B-Alkene114713120
,    O
another    O
non    O
-    O
sedating    O
antihistamine    O
,    O
is    O
the    O
prodrug    O
of    O
desloratadine    B-Alkene114713120
,    O
which    O
is    O
largely    O
responsible    O
for    O
the    O
antihistaminergic    O
effects    O
of    O
the    O
parent    O
compound    O
.    O

desloratadine    B-Alkene114713120

The    O
first    O
to    O
demonstrate    O
the    O
photoinduced    O
free    O
radical    O
chain    O
reaction    O
of    O
vinyl    B-Alkene114713120
bromide    I-Alkene114713120
was    O
Ivan    O
Ostromislensky    O
,    O
a    O
Russian    O
chemist    O
who    O
also    O
studied    O
the    O
polymerization    O
of    O
synthetic    O
rubber    O
.    O

An    O
illustrative    O
application    O
of    O
Trapp    O
solvent    O
is    O
the    O
preparation    O
of    O
vinyllithium    O
by    O
lithium    O
halogen    O
exchange    O
from    O
vinyl    B-Alkene114713120
bromide    I-Alkene114713120
and    O
"    O
tert    O
"-    O
butyllithium    O
.    O

The    O
enzyme    O
is    O
involved    O
in    O
biosynthesis    O
of    O
dolichol    B-Alkene114713120
(    O
a    O
long    O
-    O
chain    O
polyprenol    B-Alkene114713120
)    O
with    O
a    O
saturated    O
alpha    O
-    O
isoprene    O
unit    O
.    O

Cis    O
-    O
prenyltransferases    O
include    O
dehydrodolichol    O
diphosphate    O
synthase    O
(    O
involved    O
in    O
the    O
production    O
of    O
a    O
precursor    O
to    O
dolichol    B-Alkene114713120
)    O
.    O

The    O
apicoplast    O
is    O
also    O
thought    O
to    O
have    O
a    O
role    O
in    O
isoprenoid    O
synthesis    O
,    O
which    O
are    O
prosthetic    O
groups    O
on    O
many    O
enzymes    O
and    O
also    O
act    O
as    O
precursors    O
to    O
ubiquinones    O
(    O
involved    O
in    O
electron    O
transport    O
)    O
and    O
dolichol    B-Alkene114713120
(    O
involved    O
in    O
glycoprotein    O
formation    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
palmitoyl    O
-    O
CoA    O
and    O
dolichol    B-Alkene114713120
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
dolichyl    O
palmitate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
3-sn    O
-    O
phosphatidylcholine    O
and    O
dolichol    B-Alkene114713120
,    O
whereas    O
its    O
two    O
products    O
are    O
1-acyl    O
-    O
sn    O
-    O
glycero-3-phosphocholine    O
and    O
acyldolichol    O
.    O

2-Oleoylglycerol    B-Alkene114713120

Transfluthrin    B-Alkene114713120

Contains    O
ingenol    B-Alkene114713120
mebutate    I-Alkene114713120
(    O
Picato    O
)    O
which    O
is    O
used    O
to    O
treat    O
skin    O
cancer    O

Efficient    O
chemical    O
synthesis    O
of    O
ingenol    B-Alkene114713120
mebutate    I-Alkene114713120
is    O
achieved    O
for    O
the    O
first    O
time    O
.    O

It    O
is    O
an    O
alkene    O
that    O
is    O
classified    O
in    O
industry    O
as    O
higher    O
olefin    O
and    O
an    O
alpha-olefin    B-Alkene114713120
,    O
the    O
latter    O
term    O
meaning    O
that    O
the    O
double    O
bond    O
is    O
located    O
at    O
the    O
alpha    O
(    O
primary    O
)    O
position    O
,    O
endowing    O
the    O
compound    O
with    O
higher    O
reactivity    O
and    O
thus    O
useful    O
chemical    O
properties    O
.    O

Alpha-olefins    B-Alkene114713120
(    O
or    O
α-olefins    B-Alkene114713120
)    O
are    O
a    O
family    O
of    O
organic    O
compounds    O
which    O
are    O
alkenes    O
(    O
also    O
known    O
as    O
olefins    O
)    O
with    O
a    O
chemical    O
formula    O
CxH2x    O
,    O
distinguished    O
by    O
having    O
a    O
double    O
bond    O
at    O
the    O
primary    O
or    O
alpha    O
(    O
α    O
)    O
position    O
.    O

It    O
is    O
classified    O
as    O
an    O
alpha-olefin    B-Alkene114713120
.    O

The    O
simplest    O
isomer    O
is    O
1-octene    B-Alkene114713120
,    O
an    O
alpha-olefin    B-Alkene114713120
used    O
primarily    O
as    O
a    O
co    O
-    O
monomer    O
in    O
production    O
of    O
polyethylene    O
via    O
the    O
solution    O
polymerization    O
process    O
.    O

Perfluoroisobutene    B-Alkene114713120

Sclarene    B-Alkene114713120
,    O
a    O
diterpene    O

Mevinphos    B-Alkene114713120

lafutidine    B-Alkene114713120
(    O
INN    O
)    O

Nitroalkene    B-Alkene114713120

These    O
conversions    O
include    O
subsequent    O
dehydration    O
to    O
yield    O
nitroalkene    B-Alkene114713120
,    O
oxidation    O
of    O
the    O
secondary    O
alcohol    O
to    O
yield    O
α-nitro    O
ketones    O
,    O
or    O
reduction    O
of    O
the    O
nitro    O
group    O
to    O
yield    O
β-amino    O
alcohols    O
.    O

The    O
reduction    O
of    O
the    O
nitroalkene    B-Alkene114713120
may    O
be    O
carried    O
out    O
sequentially    O
.    O

Analysis    O
shows    O
the    O
presence    O
of    O
estragole    B-Alkene114713120
,    O
("E")-anethole    B-Alkene114713120
,    O
methyl    B-Alkene114713120
chavicol    I-Alkene114713120
,    O
(    O
"    O
E")-foeniculin    O
,    O
β-pinene    B-Alkene114713120
,    O
sabinene    B-Alkene114713120
,    O
("Z")-β-ocimene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
B    I-Alkene114713120
,    O
("E")-β-ocimene    B-Alkene114713120
and    O
terpinen-4-ol    B-Alkene114713120
,    O
(    O
"    O
Z")-tagetenone    O
,    O
(    O
"    O
E")-tagetenone    O
,    O
("E")-nerolidol    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
D    I-Alkene114713120
,    O
methyl    B-Alkene114713120
chavicol    I-Alkene114713120
,    O
myrcene    B-Alkene114713120
,    O
limonene    O
,    O
β-caryophyllene    B-Alkene114713120
,    O
3-carene    B-Alkene114713120
,    O
β-humulene    B-Alkene114713120
,    O
coumarins    O
of    O
the    O
furanocoumarin    O
type    O
-    O
imperatorin    O
,    O
isoimperatorin    O
,    O
oxypeucedanine    O
,    O
bergaptene    O
,    O
xanthotoxin    O
,    O
xanthotoxol    O
and    O
chalepin    O
,    O
geranylcoumarin    O
(    O
anisocoumarin    O
A–    O

It    O
is    O
dominated    O
by    O
linalool    O
,    O
benzoates    O
,    O
salicylates    O
,    O
and    O
nerolidol    B-Alkene114713120
.    O

epalrestat    B-Alkene114713120
(    O
INN    O
)    O

In    O
Canada    O
in    O
2004    O
doxycycline    O
was    O
considered    O
a    O
first    O
-    O
line    O
treatment    O
for    O
chlamydia    O
and    O
non    O
-    O
gonococcal    O
urethritis    O
and    O
with    O
cefixime    B-Alkene114713120
for    O
uncomplicated    O
gonorrhea    O
.    O

Ceftriaxone    O
and    O
cefixime    B-Alkene114713120
are    O
third    O
generation    O
cephalosporins    O
and    O
are    O
often    O
used    O
as    O
treatments    O
for    O
"    O
N.    O
gonorrhoeae    O
infections    O
"    O
.    O

These    O
include    O
:    O
cefixime    B-Alkene114713120
(    O
an    O
oral    O
cephalosporin    O
)    O
,    O
ceftriaxone    O
(    O
an    O
injectable    O
cephalosporin    O
)    O
,    O
azithromycin    O
,    O
aminoglycosides    O
,    O
and    O
tetracycline    O
.    O

Lactucin    B-Alkene114713120
,    O
desoxylactucin    O
,    O
lactucopicrin    B-Alkene114713120
,    O
lactucin-15-oxalate    O
,    O
lactucopicrin-15-oxalate    O
are    O
some    O
of    O
the    O
most    O
prominent    O
found    O
in    O
lettuce    O
and    O
spinach    O
,    O
giving    O
most    O
of    O
the    O
bitter    O
taste    O
to    O
these    O
crops    O
.    O

In    O
fact    O
,    O
'    O
radicchio    O
'    O
contains    O
intybin    B-Alkene114713120
,    O
a    O
sedative    O
/    O
analgesic    O
,    O
as    O
well    O
as    O
a    O
type    O
of    O
flavonoid    O
called    O
anthocyanin    O
which    O
is    O
used    O
for    O
making    O
dye    O
-    O
sensitized    O
solar    O
cells    O
.    O

The    O
term    O
allyl    O
applies    O
to    O
many    O
compounds    O
related    O
to    O
H2C    O
=    O
CH−CH2    O
,    O
some    O
of    O
which    O
are    O
of    O
practical    O
or    O
of    O
everyday    O
importance    O
,    O
for    O
example    O
,    O
allyl    B-Alkene114713120
chloride    I-Alkene114713120
.    O

Allyl    B-Alkene114713120
chloride    I-Alkene114713120
(    O
H2C    O
=    O
CH−CH2Cl    O
)    O

Allyl    B-Alkene114713120
chloride    I-Alkene114713120

In    O
the    O
dried    O
crude    O
root    O
,    O
their    O
phenolic    O
aglycones    O
are    O
responsible    O
for    O
the    O
typical    O
odor    O
reminiscent    O
of    O
methyl    O
salicylate    O
or    O
anethole    B-Alkene114713120
.    O

It    O
can    O
also    O
be    O
produced    O
by    O
oxidation    O
of    O
anethole    B-Alkene114713120
,    O
a    O
related    O
fragrance    O
that    O
is    O
found    O
in    O
some    O
alcoholic    O
beverages    O
.    O

It    O
is    O
generally    O
obtained    O
by    O
the    O
oxidation    O
of    O
anethole    B-Alkene114713120
or    O
p    O
-    O
methoxyacetophenone    O
.    O

"    O
Nigella    O
sativa    O
"    O
oil    O
contains    O
linoleic    O
acid    O
,    O
oleic    O
acid    O
,    O
palmitic    O
acid    O
,    O
and    O
trans    O
-    O
anethole    B-Alkene114713120
,    O
among    O
other    O
minor    O
constituents    O
.    O

The    O
ouzo    O
effect    O
occurs    O
when    O
a    O
strongly    O
hydrophobic    O
essential    O
oil    O
such    O
as    O
"trans"-anethole    B-Alkene114713120
is    O
dissolved    O
in    O
a    O
water    O
-    O
miscible    O
solvent    O
,    O
such    O
as    O
ethanol    O
,    O
and    O
the    O
concentration    O
of    O
ethanol    O
is    O
lowered    O
by    O
addition    O
of    O
small    O
amounts    O
of    O
water    O
.    O

The    O
main    O
components    O
of    O
the    O
needle    O
essential    O
oil    O
include    O
terpineol    B-Alkene114713120
(    O
30.2%    O
)    O
,    O
linalool    O
(    O
24.47%    O
)    O
,    O
limonene    O
(    O
17.01%    O
)    O
,    O
anethole    B-Alkene114713120
(    O
14.57%    O
)    O
,    O
caryophyllene    B-Alkene114713120
(    O
3.14%    O
)    O
and    O
eugenol    B-Alkene114713120
(    O
2.14%    O
)    O
.    O

Calorie    O
restriction    O
has    O
been    O
shown    O
to    O
increase    O
DHEA    B-Alkene114713120
in    O
primates    O
,    O
but    O
it    O
has    O
not    O
been    O
shown    O
to    O
increase    O
DHEA    B-Alkene114713120
in    O
post    O
-    O
pubescent    O
primates    O
.    O

By    O
inhibiting    O
3β-HSD    O
,    O
epostane    O
blocks    O
the    O
biosynthesis    O
of    O
progesterone    O
from    O
pregnenolone    O
(    O
and    O
also    O
the    O
conversion    O
of    O
dehydroepiandrosterone    B-Alkene114713120
to    O
androstenedione    O
)    O
,    O
thereby    O
functioning    O
as    O
an    O
antiprogestogen    O
and    O
terminating    O
pregnancy    O
.    O

A    O
Δ5    O
-    O
3-ketosteroid    O
isomerase    O
-    O
disrupted    O
mutant    O
of    O
strain    O
TA441    O
can    O
grow    O
on    O
dehydroepiandrosterone    B-Alkene114713120
,    O
which    O
has    O
a    O
double    O
bond    O
at    O
Δ5    O
,    O
but    O
can    O
not    O
grow    O
on    O
epiandrosterone    O
,    O
which    O
lacks    O
a    O
double    O
bond    O
at    O
Δ5    O
,    O
indicating    O
that    O
"    O
C.    O
testosteroni    O
"    O
KSI    O
is    O
responsible    O
for    O
transfer    O
of    O
the    O
double    O
bond    O
from    O
Δ5    O
to    O
Δ4    O
and    O
transfer    O
of    O
the    O
double    O
bond    O
by    O
hydrogenation    O
at    O
Δ5    O
and    O
following    O
dehydrogenation    O
at    O
Δ4    O
is    O
not    O
possible    O
.    O

In    O
vitro    O
"    O
cell    O
proliferation    O
assay    O
indicates    O
that    O
G6PD    O
inhibitors    O
,    O
DHEA    B-Alkene114713120
(    O
dehydroepiandrosterone    O
)    O
and    O
ANAD    O
(    O
6-aminonicotinamide    O
)    O
,    O
effectively    O
decrease    O
the    O
growth    O
of    O
AML    O
cell    O
lines    O
.    O

In    O
December    O
2009    O
,    O
a    O
urine    O
test    O
taken    O
at    O
the    O
2009    O
USPRO    O
Time    O
Trial    O
Championships    O
the    O
previous    O
August    O
,    O
in    O
which    O
Zirbel    O
came    O
second    O
,    O
tested    O
positive    O
for    O
DHEA    B-Alkene114713120
.    O

Levels    O
of    O
progesterone    O
,    O
17α-hydroxyprogesterone    O
,    O
androstenedione    O
,    O
testosterone    O
,    O
and    O
dihydrotestosterone    O
(    O
DHT    O
)    O
were    O
elevated    O
in    O
the    O
sisters    O
,    O
while    O
concentrations    O
of    O
adrenal    O
steroids    O
including    O
cortisol    O
,    O
dehydroepiandrosterone    B-Alkene114713120
(    O
DHEA    O
)    O
,    O
11β-hydroxyandrostenedione    O
,    O
11-deoxycortisol    O
,    O
and    O
21-deoxycortisol    O
were    O
within    O
normal    O
ranges    O
.    O

It    O
has    O
been    O
demonstrated    O
that    O
,    O
after    O
controlling    O
for    O
age    O
,    O
sex    O
,    O
and    O
BMI    O
,    O
larger    O
quantities    O
of    O
DHEA    B-Alkene114713120
and    O
DHEA    O
-    O
S    O
tended    O
to    O
be    O
linked    O
to    O
larger    O
pituitary    O
volume    O
.    O

Again    O
controlling    O
for    O
age    O
,    O
sex    O
,    O
and    O
BMI    O
,    O
DHEA    B-Alkene114713120
and    O
DHEA    O
-    O
S    O
have    O
been    O
found    O
to    O
be    O
predictive    O
of    O
larger    O
pituitary    O
gland    O
volume    O
,    O
which    O
was    O
also    O
associated    O
with    O
increased    O
ratings    O
of    O
social    O
anxiety    O
.    O

Dehydroepiandrosterone    B-Alkene114713120
(    O
DHEA    O
)    O
is    O
the    O
most    O
abundant    O
circulating    O
androgen    O
hormone    O
and    O
can    O
be    O
rapidly    O
metabolized    O
within    O
target    O
tissues    O
into    O
potent    O
androgens    O
and    O
estrogens    O
.    O

A    O
small    O
human    O
study    O
in    O
2011    O
found    O
that    O
monitoring    O
blood    O
dehydroepiandrosterone    B-Alkene114713120
(    O
DHEA    O
)    O
variations    O
in    O
response    O
to    O
an    O
oxidative    O
stress    O
could    O
be    O
a    O
useful    O
proxy    O
test    O
:    O
the    O
subjects    O
with    O
MCI    O
did    O
not    O
have    O
a    O
DHEA    O
variation    O
,    O
while    O
the    O
healthy    O
controls    O
did    O
.    O

The    O
17α-hydroxylase    O
activity    O
of    O
CYP17A1    O
is    O
required    O
for    O
the    O
generation    O
of    O
glucocorticoids    O
such    O
as    O
cortisol    O
,    O
but    O
both    O
the    O
hydroxylase    O
and    O
17,20-lyase    O
activities    O
of    O
CYP17A1    O
are    O
required    O
for    O
the    O
production    O
of    O
androgenic    O
and    O
oestrogenic    O
sex    O
steroids    O
by    O
converting    O
17α-hydroxypregnenolone    O
to    O
dehydroepiandrosterone    B-Alkene114713120
(DHEA)    I-Alkene114713120
.    O

Other    O
androgens    O
,    O
however    O
,    O
such    O
as    O
DHEA    B-Alkene114713120
,    O
increase    O
immune    O
response    O
.    O

It    O
produces    O
androgens    O
,    O
mainly    O
dehydroepiandrosterone    B-Alkene114713120
(    O
DHEA    O
)    O
,    O
DHEA    O
sulfate    O
(    O
DHEA    O
-    O
S    O
)    O
,    O
and    O
androstenedione    O
(    O
the    O
precursor    O
to    O
testosterone    O
)    O
in    O
humans    O
.    O

Cells    O
in    O
zona    O
reticularis    O
of    O
the    O
adrenal    O
glands    O
produce    O
male    O
sex    O
hormones    O
,    O
or    O
androgens    O
,    O
the    O
most    O
important    O
of    O
which    O
is    O
DHEA    B-Alkene114713120
.    O

During    O
early    O
childhood    O
androgen    O
synthesis    O
and    O
secretion    O
remain    O
low    O
,    O
but    O
several    O
years    O
before    O
puberty    O
(    O
from    O
6–8    O
years    O
of    O
age    O
)    O
changes    O
occur    O
in    O
both    O
anatomical    O
and    O
functional    O
aspects    O
of    O
cortical    O
androgen    O
production    O
that    O
lead    O
to    O
increased    O
secretion    O
of    O
the    O
steroids    O
DHEA    B-Alkene114713120
and    O
DHEA    O
-    O
S.    O
These    O
changes    O
are    O
part    O
of    O
a    O
process    O
called    O
adrenarche    O
,    O
which    O
has    O
only    O
been    O
described    O
in    O
humans    O
and    O
some    O
other    O
primates    O
.    O

This    O
includes    O
interconversion    O
of    O
DHEA    B-Alkene114713120
and    O
androstenediol    O
,    O
androstenedione    O
and    O
testosterone    O
,    O
and    O
estrone    O
and    O
estradiol    O
.    O

The    O
endogenous    O
steroids    O
dehydroepiandrosterone    B-Alkene114713120
(    O
DHEA    O
)    O
and    O
its    O
sulfate    O
ester    O
,    O
DHEA    O
sulfate    O
(    O
DHEA    O
-    O
S    O
)    O
,    O
have    O
been    O
identified    O
as    O
small    O
-    O
molecule    O
agonists    O
of    O
the    O
TrkA    O
and    O
p75NTR    O
with    O
high    O
affinity    O
(    O
around    O
5    O
nM    O
)    O
,    O
and    O
hence    O
as    O
so    O
-    O
called    O
"    O
microneurotrophins    O
"    O
.    O

3β-Hydroxysteroid    O
dehydrogenase/Δ5    O
-    O
4    O
isomerase    O
(    O
3β-HSD    O
)    O
is    O
an    O
enzyme    O
that    O
catalyzes    O
the    O
biosynthesis    O
of    O
progesterone    O
from    O
pregnenolone    O
,    O
17α-hydroxyprogesterone    O
from    O
17α-hydroxypregnenolone    O
,    O
and    O
androstenedione    O
from    O
dehydroepiandrosterone    B-Alkene114713120
(    O
DHEA    O
)    O
in    O
the    O
adrenal    O
gland    O
.    O

DHEA    B-Alkene114713120
to    O
androstenedione    O

2-Amino-3-carboxymuconic    B-Alkene114713120
semialdehyde    I-Alkene114713120
,    O
a    O
chemical    O
in    O
tryptophan    O
metabolism    O

Nordiclazepam    O
is    O
used    O
as    O
the    O
precursor    O
with    O
which    O
to    O
make    O
Uldazepam    B-Alkene114713120
via    O
the    O
thionamide    O
.    O

(e)-β-ocimene    B-Alkene114713120
0.19%    O

Monoterpenes    O
(    O
~    O
5%    O
)    O
:    O
β-pinene    B-Alkene114713120
,    O
myrcene    B-Alkene114713120
,    O
phellandrene    B-Alkene114713120
,    O
"    O
cis    O
"-    O
ocimene    B-Alkene114713120
,    O
terpinolene    B-Alkene114713120
,    O
and    O
terpineol    B-Alkene114713120
.    O

Elimination    O
of    O
the    O
pyrophosphate    O
group    O
leads    O
to    O
the    O
formation    O
of    O
acyclic    O
monoterpenes    O
such    O
as    O
ocimene    B-Alkene114713120
and    O
the    O
myrcene    B-Alkene114713120
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
2-amino-3-(3-oxoprop-1-en-1-yl)but-2-enedioate    O
,    O
and    O
two    O
products    O
,    O
2-aminomuconate    B-Alkene114713120
semialdehyde    I-Alkene114713120
and    O
CO2    O
.    O

Alternative    O
cocktails    O
with    O
inhibitors    O
of    O
histone    O
deacetylation    O
,    O
glycogen    O
synthase    O
kinase    O
and    O
TGF-β    O
pathways    O
(    O
where    O
:    O
sodium    O
butyrate    O
(    O
NaB    O
)    O
or    O
Trichostatin    O
A    O
(    O
TSA    O
)    O
could    O
replace    O
VPA    O
,    O
Lithium    O
chloride    O
(    O
LiCl    O
)    O
or    O
lithium    O
carbonate    O
(    O
Li2CO3    O
)    O
could    O
substitute    O
CHIR99021    O
,    O
or    O
Repsox    O
may    O
be    O
replaced    O
with    O
SB-431542    O
or    O
Tranilast    B-Alkene114713120
)    O
show    O
similar    O
efficacies    O
for    O
ciNPC    O
induction    O
.    O

"    O
Tricycle    O
:    O
"    O
amitriptyline    O
,    O
melitracen    O
,    O
cyclobenzaprine    O
,    O
tianeptine    O
,    O
amineptine    O
,    O
clopenthixol    O
chlorprothixene    B-Alkene114713120
flupentixol    O
thiothixene    O
zuclopenthixol    B-Alkene114713120

:    O
N05AF03    O
Chlorprothixene    B-Alkene114713120

The    O
calicheamicins    O
are    O
a    O
class    O
of    O
enediyne    B-Alkene114713120
antitumor    O
antibiotics    O
derived    O
from    O
the    O
bacterium    O
"    O
Micromonospora    O
echinospora    O
"    O
,    O
with    O
calicheamicin    O
γ1    O
being    O
the    O
most    O
notable    O
.    O

The    O
core    O
metabolic    O
pathway    O
for    O
biosynthesis    O
of    O
this    O
molecule    O
resembles    O
that    O
of    O
other    O
characterized    O
enediyne    B-Alkene114713120
compounds    O
and    O
occurs    O
via    O
an    O
iterative    O
polyketide    O
synthase    O
(    O
PKS    O
)    O
pathway    O
.    O

Enediyne    B-Alkene114713120

A    O
similarly    O
effective    O
drug    O
,    O
entacapone    B-Alkene114713120
,    O
has    O
not    O
been    O
shown    O
to    O
cause    O
significant    O
alterations    O
of    O
liver    O
function    O
.    O

Some    O
of    O
these    O
medicines    O
include    O
selegiline    O
,    O
amantadine    O
,    O
entacapone    B-Alkene114713120
,    O
dopamine    O
agonists    O
,    O
and    O
anticholinergics    O
(    O
“    O
Movement    O
Disorders    O
”    O
)    O
.    O

entacapone    B-Alkene114713120
(    O
COMT    O
inhibitor    O
,    O
used    O
in    O
Parkinson    O
's    O
disease    O
)    O

Canolol    B-Alkene114713120

Canolol    B-Alkene114713120

SKF-77,434    B-Alkene114713120
is    O
a    O
drug    O
which    O
acts    O
as    O
a    O
selective    O
dopamine    O
D1    O
receptor    O
partial    O
agonist    O
,    O
and    O
has    O
stimulant    O
and    O
anorectic    O
effects    O
.    O

vinylbital    B-Alkene114713120

Designed    O
to    O
regulate    O
amphetamines    O
,    O
barbiturates    O
,    O
and    O
other    O
synthetics    O
,    O
the    O
34th    O
version    O
of    O
the    O
treaty    O
,    O
,    O
regulates    O
secobarbital    O
as    O
schedule    O
II    O
,    O
amobarbital    O
,    O
butalbital    O
,    O
cyclobarbital    O
,    O
and    O
pentobarbital    O
as    O
schedule    O
III    O
,    O
and    O
allobarbital    O
,    O
barbital    O
,    O
butobarbital    O
,    O
mephobarbital    O
,    O
phenobarbital    O
,    O
butabarbital    O
,    O
and    O
vinylbital    B-Alkene114713120
as    O
schedule    O
IV    O
on    O
its    O
"    O
Green    O
List    O
"    O
.    O

Cian    O
O'Connor    O
originally    O
claimed    O
the    O
gold    O
medal    O
in    O
the    O
individual    O
show    O
jumping    O
,    O
but    O
was    O
disqualified    O
after    O
his    O
horse    O
Waterford    O
Crystal    O
failed    O
the    O
horse    O
doping    O
test    O
for    O
fluphenazine    O
and    O
zuclopenthixol    B-Alkene114713120
.    O

Zuclopenthixol    B-Alkene114713120

Since    O
his    O
committal    O
Hunt    O
has    O
been    O
forcibly    O
medicated    O
with    O
a    O
diverse    O
range    O
of    O
psychoactive    O
drugs    O
including    O
the    O
typical    O
antipsychotics    O
zuclopenthixol    B-Alkene114713120
and    O
chlorpromazine    O
,    O
the    O
atypical    O
antipsychotic    O
amisulpride    O
,    O
benzodiazepines    O
and    O
sleeping    O
tablets    O
.    O

The    O
lignan    O
sesamin    O
,    O
the    O
N    O
-    O
isobutylamide    O
sanshool    B-Alkene114713120
,    O
the    O
acridone    O
alkaloids    O
1-hydroxy-3-methoxy    O
-    O
N    O
-    O
methylacridone    O
,    O
arborinine    O
,    O
xanthoxoline    O
and    O
1-hydroxy-3-methoxyacridone    O
can    O
also    O
be    O
extracted    O
from    O
the    O
bark    O
as    O
well    O
as    O
the    O
alkaloids    O
oblongine    O
,    O
tembetarine    O
and    O
magnoflorine    O
and    O
the    O
flavonoid    O
hesperidin    O
.    O

Campese    O
Ma'AFU    O
-    O
Enele    O
MA'AFU    O
-    O
Salesi    O
MA'AFU    O
-    O
Jone    O
MACILAI    O
(    O
rugby    O
league    O
)    O
-    O
Jone    O
MACILAI    O
-    O
TORI    O
-    O
Macuata    O
-    O
Sir    O
Kenneth    O
MADDOCKS    O
-    O
James    O
MADHAVAN    O
-    O
Siromaniam    O
MADHAVAN    O
-    O
Ratu    O
Joni    O
MADRAIWIWI    O
-    O
Ratu    O
Joni    O
MADRAIWIWI    O
I    O
-    O
Magimagi    O
-    O
Mago    O
Island    O
-    O
Maha    O
Sangh    O
-    O
Mahatma    O
Gandhi    O
Memorial    O
High    O
School    O
(    O
Fiji    O
)    O
-    O
Mai    O
TV    O
-    O
Main    O
(    O
ship    O
)    O
-    O
Ratu    O
Kinijoji    O
MAIVALILI    O
-    O
Sir    O
Charles    O
MAJOR    O
-    O
Mak    O
Sa'moa    O
-    O
Mak    O
Sa'moa    O
-    O
Makogai    O
-    O
Malakua    O
River    O
-    O
David    O
MALCOLM    O
-    O
Inoke    O
MALE    O
-    O
Malhaha    O
-    O
Malolo    O
-    O
Malolo    O
Lailai    O
-    O
Malolo    O
Lailai    O
Airport    O
-    O
Malumu    O
NAIVAUKURA    O
-    O
Mamanuca    O
Islands    O
-    O
Mammals    O
of    O
Fiji    O
,    O
list    O
of    O
-    O
Mana    O
Island    O
Airport    O
-    O
Injimo    O
MANAGREVE    O
-    O
Maniltoa    O
floribunda    O
-    O
Maniltoa    O
minor    O
-    O
Maniltoa    O
vestita    O
-    O
Craig    O
K.    O
MANSCILL    O
-    O
A.    O
R.    O
MANU    O
-    O
Deacon    O
MANU    O
-    O
Paul    O
MANUELI    O
-    O
Daniel    O
Urai    O
MANUFOLAU    O
-    O
Adi    O
Litiana    O
MAOPA    O
-    O
Maps    O
of    O
Fiji    O
-    O
Maqewa    O
-    O
Samuela    O
MARAYAWA    O
-    O
Adrian    O
MARIAPPA    O
-    O
Saleem    O
MARSOOF    O
-    O
Marist    O
Brothers    O
High    O
School    O
(    O
Fiji    O
)    O
-    O
Mary    O
Jane    O
's    O
Relaxing    O
Soda    O
-    O
MASEIKULA    O
-    O
Manoa    O
MASI    O
-    O
Asaeli    O
MASILACA    O
-    O
Masked    O
shining    O
parrot    O
-    O
Esala    O
MASI    O
-    O
Benito    O
MASILEVU    O
-    O
Anthony    O
MASON    O
-    O
Keith    O
MASON    O
-    O
Master    O
of    O
the    O
High    O
Court    O
-    O
Petero    O
MATACA    O
-    O
Sakiusa    O
MATADIGO    O
-    O
Matagi    O
-    O
Mataika    O
House    O
-    O
Matailobau    O
District    O
-    O
Irami    O
MATAIRAVULA    O
-    O
Isikeli    O
MATAITOGA    O
-    O
Roger    O
MATAKAMIKAMICA    O
-    O
Samuela    O
MATAKIBAU    O
-    O
Timoci    O
MATANAVOU    O
-    O
Naomi    O
MATANITOBUA    O
-    O
Ratu    O
Suliano    O
MATANITOBUA    O
-    O
Matanivanua    O
-    O
Mataniwai    O
River    O
-    O
Mataqali    O
-    O
Josh    O
MATAVESI    O
-    O
MATAWALU    O
-    O
Nikola    O
MATAWALU    O
-    O
Matei    O
Airport    O
-    O
Josua    O
MATEINANIU    O
-    O
Matuku    O
-    O
Maunatul    O
Islam    O
Association    O
of    O
Fiji    O
-    O
Neil    O
MAXWELL    O
-    O
Maxwell    O
Hendry    O
MAXWELL    O
-    O
ANDERSON    O
-    O
Sir    O
Francis    O
Henry    O
MAY    O
-    O
Mac    O
McCALLION    O
-    O
Thomas    O
McCosker    O
v    O
The    O
State    O
-    O
C.    O
Steven    O
McGANN    O
-    O
John    O
McKEE    O
-    O
Danny    O
McLENNAN    O
-    O
Duncan    O
McMULLIN    O
-    O
Medinilla    O
waterhousei    O
-    O
Kali    O
MEEHAN    O
-    O
Willis    O
MEEHAN    O
-    O
Meke    O
-    O
Melanesian    O
Spearhead    O
Group    O
-    O
Commins    O
MENAPI    O
-    O
Men    O
's    O
football    O
at    O
the    O
2003    O
South    O
Pacific    O
Games    O
-    O
Tauili'ili    O
Uili    O
MEREDITH    O
-    O
Mersey    O
(    O
ship    O
)    O
-    O
Methodist    O
Church    O
of    O
Fiji    O
and    O
Rotuma    O
-    O
Methysticin    B-Alkene114713120
-    O
Metrosideros    O
ochrantha    O
-    O
Metroxylon    O
vitiense    O
-    O
Military    O
of    O
Fiji    O
-    O
Military    O
-    O
church    O
relations    O
in    O
Fiji    O
-    O
Daryl    O
MILLARD    O
-    O
Ryan    O
MILLARD    O
-    O
Albert    O
MILLER    O
-    O
Minerva    O
Reefs    O
-    O
Ministry    O
of    O
Foreign    O
Affairs    O
and    O
International    O
Cooperation    O
(    O
Fiji    O
)    O
-    O
Mirchi    O
FM    O
-    O
Ghananand    O
MISHRA    O
-    O
Sudesh    O
MISHRA    O
-    O
Miss    O
Fiji    O
-    O
Sir    O
Charles    O
MITCHELL    O
-    O
Sir    O
Philip    O
MITCHELL    O
-    O
Robin    O
E.    O
MITCHELL    O
-    O
Mix    O
FM    O
-    O
Moala    O
Airport    O
-    O
Moala    O
Island    O
-    O
Moala    O
Islands    O
-    O
Mocis    O
trifasciata    O
-    O
Mocis    O
vitiensis    O
-    O
Leonid    O
MOISEYEV    O
-    O
Ratu    O
Tevita    O
MOMOEDONU    O
-    O
Monarchy    O
of    O
Fiji    O
-    O
Monasavu    O
Dam    O
-    O
Charlie    O
MOORE    O
-    O
Sean    O
MORRELL    O
-    O
Mary    O
MORRIS    O
-    O
Howard    O
MORRISON    O
-    O
Sir    O
John    O
MORRISON    O
-    O
Monuriki    O
-    O
Julian    O
MOTI    O
-    O
Moturiki    O
-    O
Motusa    O
-    O
Movie    O
Talk    O
Show-    O
FBC    O
Production    O
-    O
Moy    O
(    O
ship    O
)    O
-    O
Muniswamy    O
MUDLIAR    O
-    O
Vashist    O
MUNI    O
-    O
{    O
Municipal    O
elections    O
in    O
Fiji    O
;    O
see    O
also    O
separate    O
articles    O
:    O
2002    O
-    O
2005    O
}    O
-    O
Perumal    O
MUPNAR    O
-    O
Murimuria    O
-    O
Kini    O
MURIMURIVALU    O
-    O
Graham    O
MURRAY    O
-    O
Museums    O
in    O
Fiji    O
,    O
list    O
of    O
-    O
Music    O
of    O
Fiji    O
-    O
Mussidia    O
pectinicornella    O
-    O
MV    O
Suilven    O
-    O
Myristica    O
gillespieana    O
-    O
Myristica    O
grandifolia    O
-    O
Myristica    O
macrantha    O

The    O
molecule    O
on    O
the    O
left    O
is    O
β-sitosterol    B-Alkene114713120
.    O

Miscellaneous    O
others    O
(    O
e.g.    O
pectin    O
,    O
β-sitosterol    B-Alkene114713120
,    O
hexadecane    O
,    O
triacontane    O
,    O
kielcorin    O
,    O
norathyriol    O
)    O

"    O
U.    O
guianensis    O
"    O
contains    O
many    O
phytochemicals    O
(    O
(    O
-)-epicatechin    O
,    O
alkaloid    O
,    O
beta    O
-    O
Sitosterol    B-Alkene114713120
,    O
campesterol    O
,    O
campherol    O
,    O
catechol    O
,    O
catechutannic    O
acid    O
,    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
ellagic    O
acid    O
,    O
gallic    O
acid    O
,    O
hyperin    O
,    O
oleanolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
rutin    O
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
)    O
and    O
proanthocyanidin    O
B1    O
and    O
proanthocyanidin    O
B2    O
,    O
B    O
type    O
proanthocyanidins    O
,    O
in    O
the    O
root    O
.    O

It    O
is    O
the    O
glucoside    O
of    O
β-sitosterol    B-Alkene114713120
.    O

Analysis    O
of    O
the    O
methanolic    O
extract    O
of    O
the    O
aerial    O
parts    O
yields    O
sitosterol    B-Alkene114713120
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
,    O
oleanolic    B-Alkene114713120
acid    I-Alkene114713120
and    O
brassicasterol    O
.    O

Major    O
chemical    O
constituents    O
are    O
hentriacontane    O
,    O
hentriacontanol    O
,    O
β-sitosterol    B-Alkene114713120
,    O
β-sitosterol    O
palmitate    O
,    O
β-sitosterol    O
-    O
D    O
-    O
glucoside    O
and    O
quercetin-3-rutinoside    O

In    O
addition    O
,    O
eight    O
unidentified    O
phospholipids    O
were    O
also    O
found    O
,    O
β-sitosterol    B-Alkene114713120
(    O
72.3%    O
of    O
the    O
total    O
sterols    O
)    O
,    O
campsterol    O
(    O
9.9%    O
)    O
,    O
and    O
stigmasterol    O
(    O
6.07%    O
)    O
being    O
prevalent    O
among    O
the    O
kenaf    O
genotypes    O
.    O

Tatakin    O
(    O
4-methoxyisoscutellargin    O
)    O
,    O
takakin    O
8-O    O
-    O
glucoside    O
,    O
takakin    O
7-O    O
-    O
glucoside    O
,    O
sesamin    O
,    O
chrysophanol    O
,    O
emodin    O
,    O
parietin    O
,    O
bucegin    O
7-O    O
-    O
glucoside    O
,    O
isoscutellarein    O
,    O
isoscutellarein    O
7-O    O
-    O
glucoside    O
,    O
methoxsalen    O
,    O
aesculetin    O
,    O
estrone    O
,    O
scopoletin    O
,    O
phytosterols    O
(    O
a    O
mixture    O
of    O
β-sitosterol    B-Alkene114713120
,    O
stigmasterol    O
and    O
campesterol    O
)    O
and    O
α-amyrin    O
were    O
extracted    O
from    O
"    O
G.    O
bruguieri    O
"    O
.    O

The    O
fruit    O
is    O
also    O
rich    O
in    O
plant    O
sterols    O
(    O
340–520    O
mg    O
/    O
kg    O
)    O
,    O
β-sitosterol    B-Alkene114713120
being    O
the    O
major    O
sterol    O
compound    O
as    O
it    O
constitutes    O
57–83%    O
of    O
total    O
sterols    O
.    O

Bergenin    O
,    O
catechin    O
,    O
gallic    O
acid    O
,    O
gallicin    O
,    O
catechin-7-O    O
-    O
glucoside    O
and    O
sitosterol    B-Alkene114713120
can    O
be    O
found    O
in    O
"    O
B.    O
ciliata    O
"    O
.    O

Dihydroalprenolol    O
(    O
DHA    O
)    O
is    O
a    O
hydrogenated    O
alprenolol    B-Alkene114713120
derivative    O
that    O
acts    O
as    O
a    O
beta    O
-    O
adrenergic    O
blocker    O
.    O

Alprenolol    B-Alkene114713120

#    O
Butalbital    B-Alkene114713120

butalbital    B-Alkene114713120

Among    O
that    O
group    O
of    O
drugs    O
are    O
the    O
barbiturates    O
amobarbital    O
,    O
butalbital    B-Alkene114713120
,    O
cyclobarbital    O
,    O
and    O
pentobarbital    O
.    O

The    O
combination    O
medication    O
Fioricet    O
,    O
consisting    O
of    O
butalbital    O
,    O
caffeine    O
,    O
and    O
paracetamol    O
(    O
acetaminophen    O
)    O
,    O
however    O
,    O
is    O
specifically    O
exempted    O
from    O
controlled    O
substance    O
status    O
,    O
while    O
its    O
sibling    O
Fiorinal    B-Alkene114713120
,    O
which    O
contains    O
aspirin    O
instead    O
of    O
paracetamol    O
and    O
may    O
contain    O
codeine    O
phosphate    O
,    O
remains    O
a    O
schedule    O
III    O
drug    O
.    O

Cryogenine    B-Alkene114713120

Cyprenorphine    B-Alkene114713120

Allylescaline    B-Alkene114713120
,    O
a    O
psychedelic    O
drug    O

During    O
that    O
time    O
,    O
he    O
discovered    O
the    O
thioindigo    B-Alkene114713120
.    O

The    O
aroma    O
and    O
flavor    O
of    O
hops    O
comes    O
,    O
in    O
part    O
,    O
from    O
sesquiterpenes    O
(    O
mainly    O
alpha-humulene    B-Alkene114713120
and    O
beta-caryophyllene    B-Alkene114713120
)    O
,    O
which    O
affect    O
beer    O
quality    O
.    O

Examples    O
of    O
sesquiterpenes    O
and    O
sesquiterpenoids    O
include    O
humulene    B-Alkene114713120
,    O
farnesene    B-Alkene114713120
,    O
farnesol    B-Alkene114713120
.    O

The    O
Tasmanian    O
variety    O
contains    O
less    O
myrcene    B-Alkene114713120
oil    O
and    O
more    O
humulene    B-Alkene114713120
oil    O
as    O
well    O
as    O
other    O
more    O
minor    O
differences    O
.    O

"cis"-3-Hexen-1-ol    B-Alkene114713120
(    O
fresh    O
cut    O
grass    O
)    O

He    O
failed    O
a    O
doping    O
test    O
in    O
May    O
2017    O
,    O
testing    O
positive    O
for    O
isometheptene    B-Alkene114713120
and    O
will    O
be    O
eligible    O
to    O
play    O
again    O
after    O
his    O
6-months    O
ban    O
finishes    O
on    O
26    O
November    O
2017    O
.    O

In    O
2010    O
,    O
he    O
was    O
punished    O
for    O
doping    O
with    O
a    O
two    O
-    O
month    O
ban    O
for    O
the    O
use    O
of    O
isometheptene    B-Alkene114713120
,    O
taken    O
as    O
a    O
medication    O
for    O
a    O
headache    O
.    O

Citronellol    O
can    O
be    O
prepared    O
by    O
hydrogenation    O
of    O
geraniol    B-Alkene114713120
or    O
nerol    B-Alkene114713120
.    O

Nerol    B-Alkene114713120
is    O
a    O
monoterpene    O
found    O
in    O
many    O
essential    O
oils    O
such    O
as    O
lemongrass    O
and    O
hops    O
.    O

The    O
compound    O
responsible    O
for    O
the    O
characteristic    O
aroma    O
was    O
identified    O
as    O
(–)-("S")-citronellal    B-Alkene114713120
,    O
which    O
is    O
contained    O
in    O
the    O
leaf    O
oil    O
up    O
to    O
80%    O
;    O
minor    O
components    O
include    O
citronellol    B-Alkene114713120
(    O
10%    O
)    O
,    O
nerol    B-Alkene114713120
and    O
limonene    O
.    O

Methohexital    B-Alkene114713120
(    O
trade    O
name    O
:    O
Brevital    O
)    O

Methohexital    B-Alkene114713120

The    O
anergy    O
in    O
T    O
cells    O
can    O
be    O
induced    O
by    O
Ionomycin    B-Alkene114713120
,    O
the    O
ionophore    O
capable    O
of    O
raising    O
intracellular    O
concentration    O
of    O
calcium    O
ions    O
artificially    O
.    O

The    O
Ionomycin    B-Alkene114713120
(    O
Ionomycin    O
)    O
Family    O

As    O
an    O
example    O
,    O
cyfluthrin    B-Alkene114713120
,    O
cypermethrin    O
,    O
and    O
cynoff    O
contain    O
cyanide    O
,    O
which    O
is    O
one    O
of    O
the    O
most    O
toxic    O
known    O
substances    O
,    O
but    O
some    O
of    O
the    O
products    O
that    O
contain    O
these    O
chemicals    O
may    O
not    O
be    O
identified    O
as    O
restricted    O
use    O
pesticide    O
.    O

Recommended    O
insecticides    O
for    O
infested    O
crops    O
include    O
:    O
Beta-cyfluthrin    B-Alkene114713120
,    O
Carbaryl    O
,    O
Deltamethrin    B-Alkene114713120
,    O
Esfenvalerate    O
,    O
Gamma-cyhalothrin    B-Alkene114713120
,    O
Lambda-cyhalothrin    B-Alkene114713120
,    O
and    O
Zeta    O
-    O
cypermethrin    O
.    O

SNC-80    B-Alkene114713120

Unrefined    O
palm    O
oil    O
is    O
a    O
significant    O
source    O
of    O
tocotrienol    B-Alkene114713120
,    O
part    O
of    O
the    O
vitamin    O
E    O
family    O
.    O

β-Tocotrienol    O
is    O
a    O
tocotrienol    B-Alkene114713120
,    O
a    O
member    O
of    O
vitamin    O
E    O
family    O
.    O

Tocotrienol    B-Alkene114713120

Humans    O
require    O
thirteen    O
vitamins    O
in    O
their    O
diet    O
,    O
most    O
of    O
which    O
are    O
actually    O
groups    O
of    O
related    O
molecules    O
(    O
e.g.    O
vitamin    O
E    O
includes    O
tocopherols    O
and    O
tocotrienol    B-Alkene114713120
)    O
.    O

:    O
N05CA09    O
Vinbarbital    B-Alkene114713120

Both    O
of    O
these    O
metabolites    O
,    O
depending    O
on    O
the    O
cell    O
type    O
which    O
forms    O
them    O
,    O
may    O
be    O
further    O
metabolized    O
to    O
15-oxo    O
-    O
eicosatetraenoic    O
acid    O
(    O
15-oxo    O
-    O
ETE    O
)    O
,    O
5"S",15"S    O
"-    O
dihydroxy    O
-    O
eicosatetraenoic    O
acid    O
(    O
5("S"),15("S")-diHETE    O
)    O
,    O
5-oxo-15("S")-hydroxyeicosatetraenoic    O
acid    O
(    O
5-oxo-15("S")-HETE    O
,    O
and    O
various    O
lipoxins    O
,    O
resolvins    O
,    O
protectins    B-Alkene114713120
,    O
maresins    O
,    O
and    O
eoxins    O
as    O
well    O
as    O
certain    O
other    O
products    O
.    O

Methallylescaline    B-Alkene114713120
,    O
or    O
4-methallyloxy-3,5-dimethoxyphenethylamine    O
,    O
is    O
a    O
lesser    O
-    O
known    O
psychedelic    O
drug    O
.    O

The    O
method    O
uses    O
a    O
ketone    O
and    O
a    O
methyl    B-Alkene114713120
vinyl    I-Alkene114713120
ketone    I-Alkene114713120
to    O
form    O
an    O
α,β-unsaturated    O
ketone    O
in    O
a    O
cyclohexane    O
ring    O
by    O
a    O
Michael    O
addition    O
followed    O
by    O
an    O
aldol    O
condensation    O
.    O

The    O
Wichterle    O
reaction    O
is    O
a    O
variant    O
of    O
the    O
Robinson    O
annulation    O
that    O
replaces    O
methyl    B-Alkene114713120
vinyl    I-Alkene114713120
ketone    I-Alkene114713120
with    O
1,3-dichloro-"cis"-2-butene    O
.    O

Miescher    O
ketone    O
is    O
the    O
Robinson    O
annulation    O
product    O
of    O
2-methyl-1,3-cyclohexanedione    O
and    O
methyl    B-Alkene114713120
vinyl    I-Alkene114713120
ketone    I-Alkene114713120
.    O

Rosarin    O
is    O
a    O
cinnamyl    B-Alkene114713120
alcohol    I-Alkene114713120
glycoside    O
isolated    O
from    O
"    O
Rhodiola    O
rosea    O
"    O
.    O

Tadimety    O
Aromatics    O
manufactures    O
over    O
100    O
aroma    O
chemicals    O
including    O
cinnamyl    B-Alkene114713120
acetate    O
,    O
cinnamyl    O
nitrile    O
,    O
cuminic    O
nitrile    O
,    O
caryophyllene    B-Alkene114713120
acetate    O
,    O
herbox    O
,    O
hydrotropal    O
,    O
phenoxy    O
ethyl    O
isobutyrate    O
,    O
rhuboxide    O
(    O
rhubafuran    O
)    O
,    O
tremone    O
,    O
and    O
woodol    O
.    O

"    O
Streptomyces    O
bottropensis    O
"    O
can    O
metabolize    O
(    O
+    O
)    O
carvone    B-Alkene114713120
to    O
(    O
+    O
)    O
-bottrospicatol    O
.    O

carvone    B-Alkene114713120

Carvone    B-Alkene114713120
is    O
a    O
member    O
of    O
a    O
family    O
of    O
chemicals    O
called    O
terpenoids    O
.    O

Later    O
the    O
oxidation    O
and    O
reduction    O
reactions    O
of    O
chiral    O
pinene    B-Alkene114713120
lead    O
also    O
to    O
several    O
possible    O
isomers    O
of    O
carvone    B-Alkene114713120
(    O
the    O
corresponding    O
cyclohexyl    O
ketone    O
dehydrated    O
at    O
the    O
isopropyl    O
)    O
and    O
sobrerol    O
,    O
making    O
it    O
possible    O
to    O
determine    O
reaction    O
mechanism    O
and    O
the    O
structural    O
properties    O
of    O
pinene    O
and    O
of    O
other    O
terpenes    O
.    O

Methyl    B-Alkene114713120
acrylate    I-Alkene114713120
is    O
an    O
organic    O
compound    O
,    O
more    O
accurately    O
the    O
methyl    O
ester    O
of    O
acrylic    O
acid    O
.    O

Classical    O
examples    O
of    O
the    O
Michael    O
reaction    O
are    O
the    O
reaction    O
between    O
diethyl    O
malonate    O
(    O
Michael    O
donor    O
)    O
and    O
diethyl    O
fumarate    O
(    O
Michael    O
acceptor    O
)    O
,    O
that    O
of    O
mesityl    B-Alkene114713120
oxide    I-Alkene114713120
and    O
diethyl    O
malonate    O
,    O
that    O
of    O
diethyl    O
malonate    O
and    O
methyl    O
crotonate    O
,    O
that    O
of    O
2-nitropropane    O
and    O
methyl    B-Alkene114713120
acrylate    I-Alkene114713120
,    O
that    O
of    O
"    O
ethyl    O
phenylcyanoacetate    O
"    O
and    O
acrylonitrile    O
and    O
that    O
of    O
nitropropane    O
and    O
methyl    B-Alkene114713120
vinyl    I-Alkene114713120
ketone    I-Alkene114713120
.    O

Actually    O
,    O
Lupeol    B-Alkene114713120
is    O
a    O
triterpenoid    O
,    O
not    O
strictly    O
a    O
sterol    O
;    O
it    O
is    O
not    O
a    O
gonane    O
.    O

The    O
rotenoids    O
abronione    O
and    O
boeravinone    O
C    O
,    O
and    O
the    O
terpenoid    O
lupeol    B-Alkene114713120
can    O
be    O
found    O
in    O
"    O
A.    O
villosa    O
"    O
.    O

Recent    O
clinical    O
studies    O
have    O
verified    O
that    O
red    O
alder    O
contains    O
betulin    B-Alkene114713120
and    O
lupeol    B-Alkene114713120
,    O
compounds    O
shown    O
to    O
be    O
effective    O
against    O
a    O
variety    O
of    O
tumors    O
.    O

Among    O
the    O
class    O
of    O
compounds    O
characterized    O
from    O
"    O
S.    O
visco    O
"    O
leaves    O
,    O
the    O
triterpenoid    O
lupeol    B-Alkene114713120
,    O
α-amyrin    O
and    O
β-amyrin    O
may    O
be    O
mainly    O
responsible    O
for    O
the    O
pharmacological    O
activities    O
.    O

The    O
outer    O
fruit    O
layer    O
,    O
left    O
on    O
black    O
pepper    O
,    O
also    O
contains    O
aroma    O
-    O
contributing    O
terpenes    O
,    O
including    O
germacrene    B-Alkene114713120
(    O
11%    O
)    O
,    O
limonene    O
(    O
10%    O
)    O
,    O
pinene    B-Alkene114713120
(    O
10%    O
)    O
,    O
alpha-phellandrene    B-Alkene114713120
(    O
9%    O
)    O
,    O
and    O
beta-caryophyllene    B-Alkene114713120
(    O
7%    O
)    O
,    O
which    O
give    O
citrusy    O
,    O
woody    O
,    O
and    O
floral    O
notes    O
.    O

Germacrene    B-Alkene114713120
D    I-Alkene114713120
,    O
a    O
natural    O
insecticide    O
,    O
is    O
found    O
in    O
"    O
B.    O
veronicifolia    O
"    O
and    O
probably    O
other    O
species    O
,    O
if    O
not    O
all    O
.    O

"    O
Penicillium    O
roqueforti    O
"    O
's    O
enzyme    O
appears    O
to    O
synthesizes    O
aristolochene    O
by    O
way    O
of    O
(    O
"    O
germacrene    B-Alkene114713120
A    O
,    O
however    O
,    O
the    O
"    O
Nicotiana    O
tabacum    O
"    O
enzyme    O
5-epi    O
-    O
aristolochene    O
synthase    O
produces    O
the    O
diastereoisomeric    O
product    O
by    O
way    O
of    O
(    O
"    O
germacrene    B-Alkene114713120
A.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    B-Alkene114713120
50%    O
,    O
thujene    B-Alkene114713120
,    O
and    O
carene    B-Alkene114713120
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
,    O
α-    O
and    O
β-cubebene    O
,    O
cadinene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
1,8-cineole    O
and    O
the    O
alcohol    O
cubebol    O
.    O

Nalfurafine    B-Alkene114713120
,    O
an    O
orally    O
-    O
administered    O
,    O
centrally    O
-    O
acting    O
κ-opioid    O
receptor    O
agonist    O
approved    O
for    O
uremic    O
pruritus    O
and    O
effective    O
in    O
animal    O
models    O
of    O
other    O
prurituses    O

Nalfurafine    B-Alkene114713120

Dectaflur    B-Alkene114713120
(    O
INN    O
)    O
is    O
a    O
fluoride    O
-    O
containing    O
substance    O
used    O
for    O
the    O
prevention    O
and    O
treatment    O
of    O
dental    O
caries    O
,    O
sensitive    O
teeth    O
,    O
and    O
the    O
refluoridation    O
of    O
damaged    O
tooth    O
enamel    O
,    O
typically    O
in    O
combination    O
with    O
olaflur    O
.    O

Sulfadicramide    B-Alkene114713120
(    O
marketed    O
as    O
Irgamid    B-Alkene114713120
)    O
is    O
an    O
anti    O
-    O
infective    O
.    O

Timepidium    B-Alkene114713120
bromide    I-Alkene114713120

ilepcimide    B-Alkene114713120
(    O
INN    O
)    O

Neurine    B-Alkene114713120

Sagebrush    O
essential    O
oil    O
contains    O
approximately    O
40%    O
"    O
l    O
"-    O
camphor    O
;    O
20%    O
pinene    B-Alkene114713120
;    O
7%    O
cineole    O
;    O
5%    O
methacrolein    B-Alkene114713120
;    O
and    O
12%    O
"a"-terpinene    B-Alkene114713120
,    O
"    O
d    O
"-    O
camphor    O
,    O
and    O
sesqiterpenoids    O
.    O

Palmitoleic    B-Alkene114713120
acid    I-Alkene114713120
,    O
or    O
(    O
9"Z")-hexadec-9-enoic    O
acid    O
,    O
is    O
an    O
omega-7    O
monounsaturated    O
fatty    O
acid    O
with    O
the    O
formula    O
CH3(CH2)5CH    O

It    O
is    O
a    O
precursor    O
of    O
both    O
stearic    O
and    O
palmitoleic    B-Alkene114713120
acid    I-Alkene114713120
.    O

In    O
Knock    O
-    O
out    O
mice    O
studies    O
,    O
DECR1−/−    O
subjects    O
accumulate    O
significant    O
concentrations    O
of    O
mono    O
and    O
polyunsaturated    O
fatty    O
acids    O
in    O
the    O
liver    O
during    O
fasting    O
(    O
such    O
as    O
oleic    O
acid    O
,    O
palmitoleic    B-Alkene114713120
acid    I-Alkene114713120
,    O
linoleic    O
acid    O
,    O
and    O
linolenic    O
acid    O
)    O
.    O

The    O
two    O
most    O
common    O
omega-7    O
fatty    O
acids    O
in    O
nature    O
are    O
palmitoleic    B-Alkene114713120
acid    I-Alkene114713120
and    O
vaccenic    O
acid    O
.    O

Allylamine    B-Alkene114713120
(    O
2-propen-1-amine    O
)    O

Functionalized    O
allylamine    B-Alkene114713120
,    O
which    O
can    O
be    O
produced    O
through    O
hydroamination    O
,    O
have    O
extensive    O
pharmaceutical    O
application    O
,    O
although    O
presently    O
such    O
species    O
are    O
not    O
prepared    O
by    O
hydroamination    O
.    O

Deprotonation    O
of    O
the    O
resultant    O
tertiary    O
cation    O
yields    O
("E")-α-bisabolene    B-Alkene114713120
.    O

In    O
1979    O
,    O
Still    O
reported    O
the    O
first    O
total    O
synthesis    O
of    O
periplanone    B-Alkene114713120
B    I-Alkene114713120
,    O
the    O
potent    O
sex    O
pheromone    O
of    O
the    O
American    O
cockroach    O
.    O

#    O
linoleic    O
acid    O
to    O
9,10-epoxy    O
octadecaenoic    O
acids    O
(    O
also    O
termed    O
vernolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
linoleic    O
acid    O
9:10-oxide    O
,    O
or    O
leukotoxin    O
)    O
and    O
12,13-epoxy    O
-    O
octadecaenoic    O
(    O
also    O
termed    O
coronaric    O
acid    O
,    O
linoleic    O
acid    O
12,13-oxide    O
,    O
or    O
isoleukotoxin    O
)    O
;    O

It    O
metabolizes    O
:    O
1    O
)    O
arachidonic    O
acid    O
to    O
various    O
epoxyeicosatrienoic    O
acids    O
(    O
also    O
termed    O
EETs    O
)    O
;    O
2    O
)    O
linoleic    O
acid    O
to    O
9,10-epoxy    O
octadecaenoic    O
acids    O
(    O
also    O
termed    O
vernolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
linoleic    O
acid    O
9:10-oxide    O
,    O
or    O
leukotoxin    O
)    O
and    O
12,13-epoxy    O
-    O
octadecaenoic    O
(    O
also    O
termed    O
coronaric    O
acid    O
,    O
linoleic    O
acid    O
12,13-oxide    O
,    O
or    O
isoleukotoxin    O
)    O
;    O
3    O
)    O
docosohexaenoic    O
acid    O
to    O
various    O
epoxydocosapentaenoic    O
acids    O
(    O
also    O
termed    O
EDPs    O
)    O
;    O
and    O
4    O
)    O
eicosapentaenoic    O
acid    O
to    O
various    O
epoxyeicosatetraenoic    O
acids    O
(    O
also    O
termed    O
EEQs    O
)    O
.    O

CYP2C9    O
and    O
CYP2S1    O
are    O
known    O
to    O
,    O
and    O
many    O
or    O
all    O
of    O
the    O
other    O
CYPs    O
that    O
act    O
on    O
arachidonic    O
acid    O
are    O
thought    O
to    O
,    O
metabolize    O
the    O
18    O
carbon    O
essential    O
fatty    O
acid    O
,    O
9("Z"),12("Z")-octadecadienoic    O
acid    O
,    O
i.e.    O
linoleic    O
acid    O
,    O
at    O
is    O
12,13    O
carbon    O
-    O
carbon    O
double    O
bout    O
to    O
form    O
(    O
+    O
)    O
and    O
(    O
-    O
)    O
epoxy    O
optical    O
isomers    O
viz    O
.    O
,    O
the    O
9"S",10"R    O
"-    O
epoxy-12("Z")-octadecaenoic    O
and    O
9"R",10"S    O
"-    O
epoxy-12("Z")-octadecaenoic    O
acids    O
;    O
this    O
set    O
of    O
optical    O
isomers    O
is    O
also    O
termed    O
vernolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
linoleic    O
acid    O
9:10-oxide    O
,    O
and    O
leukotoxin    O
.    O

Allylprodine    B-Alkene114713120

Allylprodine    B-Alkene114713120
is    O
an    O
opioid    O
analgesic    O
that    O
is    O
an    O
analog    O
of    O
prodine    O
.    O

Megaphone    B-Alkene114713120
(molecule)    I-Alkene114713120

Other    O
chemotypes    O
are    O
PK    O
(    O
perilla    O
ketone    O
)    O
,    O
EK    O
(    O
eschscholzia    O
ketone    O
)    O
,    O
PL    O
(    O
perillene    O
)    O
,    O
PP    O
(    O
phenylpropanoids    O
:    O
myristicin    B-Alkene114713120
,    O
dillapiole    B-Alkene114713120
,    O
elemicin    B-Alkene114713120
)    O
,    O
C    O
(    O
citral    O
)    O
and    O
a    O
type    O
rich    O
in    O
rosefuran    O
.    O

Myristicin    B-Alkene114713120

Myristicin    B-Alkene114713120

Claritin    B-Alkene114713120
,    O
An    O
anti    O
-    O
histamine    O
marketed    O
in    O
alliance    O
with    O
Schering    O
-    O
Plough    O
.    O

Loratadine    B-Alkene114713120

Unlike    O
loratadine    B-Alkene114713120
or    O
fexofenadine    O
,    O
clemastine    O
is    O
a    O
sedating    O
antihistamine    O
;    O
however    O
,    O
it    O
exhibits    O
fewer    O
other    O
side    O
effects    O
than    O
most    O
of    O
the    O
widely    O
used    O
antihistamines    O
.    O

Their    O
clients    O
included    O
major    O
companies    O
such    O
as    O
Schering    O
-    O
Plough    O
(    O
for    O
a    O
website    O
about    O
the    O
Clarityn    B-Alkene114713120
antihistamine    O
)    O
.    O

Schering    O
-    O
Plough    O
and    O
Merck    O
sought    O
permission    O
to    O
market    O
a    O
combined    O
tablet    O
with    O
loratadine    B-Alkene114713120
(    O
Claritin    O
)    O
and    O
montelukast    O
(    O
Singulair    O
)    O
,    O
as    O
many    O
patients    O
combine    O
the    O
two    O
themselves    O
.    O

In    O
2012    O
,    O
Corwin    O
starred    O
in    O
a    O
Claritin    B-Alkene114713120
commercial    O
as    O
himself    O
.    O

The    O
organization    O
also    O
contacted    O
several    O
of    O
their    O
advertisers    O
over    O
the    O
issue    O
,    O
including    O
Lowe    O
's    O
,    O
Campbell    O
's    O
Soup    O
,    O
Claritin    B-Alkene114713120
,    O
Geico    O
,    O
McDonald    O
's    O
and    O
Taco    O
Bell    O
.    O

The    O
non    O
-    O
sedating    O
antihistamine    O
loratidine    B-Alkene114713120
had    O
no    O
effect    O
on    O
any    O
of    O
the    O
measures    O
studied    O
.    O

"    O
Tetrahydrobenzazepine    O
:    O
"    O
SKF-83959    O
,    O
SKF-82958    B-Alkene114713120
,    O
SKF-81297    O
,    O
SKF    O
38393    O
,    O
fenoldopam    O
,    O
6-Br-APB    B-Alkene114713120
,    O
SCH    O
23390    O

Isocrotonic    B-Alkene114713120
acid    I-Alkene114713120
(    O
or    O
quartenylic    B-Alkene114713120
acid    I-Alkene114713120
)    O
is    O
the    O
cis    O
analogue    O
of    O
crotonic    B-Alkene114713120
acid    I-Alkene114713120
.    O

Antagonists    O
/    O
negative    O
allosteric    O
modulators    O
:    O
bicuculline    O
,    O
cicutoxin    B-Alkene114713120
,    O
flumazenil    O
,    O
furosemide    O
,    O
gabazine    O
,    O
oenanthotoxin    B-Alkene114713120
,    O
picrotoxin    B-Alkene114713120
,    O
Ro15    O
-    O
4513    O
,    O
thujone    O
,    O
amentoflavone    O
.    O

The    O
chief    O
poison    O
is    O
cicutoxin    B-Alkene114713120
,    O
an    O
unsaturated    O
aliphatic    O
alcohol    O
that    O
is    O
most    O
concentrated    O
in    O
the    O
roots    O
.    O

"trans"-2-Methyl-2-butenal    B-Alkene114713120

Chemotherapy    O
drugs    O
associated    O
with    O
CIPN    O
include    O
thalidomide    O
,    O
the    O
epothilone    B-Alkene114713120
such    O
as    O
ixabepilone    O
,    O
the    O
"    O
vinca    O
"    O
alkaloids    O
vincristine    O
and    O
vinblastine    O
,    O
the    O
taxanes    O
paclitaxel    O
and    O
docetaxel    O
,    O
the    O
proteasome    O
inhibitors    O
such    O
as    O
bortezomib    O
,    O
and    O
the    O
platinum    O
-    O
based    O
drugs    O
cisplatin    O
,    O
oxaliplatin    O
and    O
carboplatin    O
.    O
and    O
optic    O
neuropathy    O
,    O
which    O
is    O
most    O
common    O
after    O
several    O
months    O
of    O
treatment    O
and    O
may    O
also    O
be    O
irreversible    O
.    O

Epothilone    B-Alkene114713120
-    O
Compounds    O
that    O
target    O
microtubule    O
function    O
leading    O
to    O
cytotoxicity    O
and    O
apoptosis    O
.    O

Metabolites    O
secreted    O
by    O
Sorangium    O
cellulosum    O
known    O
as    O
epothilone    B-Alkene114713120
have    O
been    O
noted    O
to    O
have    O
antineoplastic    O
activity    O
.    O

Among    O
the    O
molecules    O
synthesized    O
by    O
Danishefsky    O
at    O
Columbia    O
University    O
are    O
epothilone    B-Alkene114713120
and    O
calicheamicin    O
,    O
which    O
are    O
natural    O
products    O
with    O
promise    O
as    O
anti    O
-    O
cancer    O
agents    O
.    O

Notable    O
examples    O
of    O
this    O
strategy    O
are    O
the    O
potential    O
drug    O
ixabepilone    O
which    O
is    O
an    O
analogue    O
of    O
the    O
natural    O
product    O
epothilone    B-Alkene114713120
B    I-Alkene114713120
and    O
carfilzomib    O
which    O
is    O
derived    O
from    O
epoxomicin    O
and    O
eravacycline    O
derived    O
from    O
tetracycline    O
.    O

Pyrethroids    O
such    O
as    O
deltamethrin    B-Alkene114713120
are    O
also    O
more    O
expensive    O
than    O
DDT    O
,    O
but    O
are    O
applied    O
more    O
sparingly    O
(    O
0.02–0.3    O
g    O
/    O
m2    O
vs    O
1–2    O
g    O
/    O
m2    O
)    O
,    O
so    O
the    O
net    O
cost    O
per    O
house    O
is    O
about    O
the    O
same    O
.    O

Pyrethroids    O
or    O
pyrethrins    O
(    O
e.g.    O
Cy    O
-    O
Kick    O
,    O
Deltamethrin    B-Alkene114713120
,    O
and    O
d-Phenothrin    B-Alkene114713120
which    O
is    O
used    O
in    O
'    O
Raid    O
'    O
fly    O
spray    O
)    O
–    O
Synthetic    O
or    O
natural    O
pyrethrins    O
available    O
as    O
aerosol    O
spray    O
or    O
as    O
dusts    O
.    O

Recommended    O
insecticides    O
for    O
infested    O
crops    O
include    O
:    O
Beta-cyfluthrin    B-Alkene114713120
,    O
Carbaryl    O
,    O
Deltamethrin    B-Alkene114713120
,    O
Esfenvalerate    O
,    O
Gamma-cyhalothrin    B-Alkene114713120
,    O
Lambda-cyhalothrin    B-Alkene114713120
,    O
and    O
Zeta    O
-    O
cypermethrin    O
.    O

Products    O
containing    O
active    O
ingredients    O
such    O
as    O
permethrin    B-Alkene114713120
,    O
bifenthrin    O
,    O
deltamethrin    B-Alkene114713120
,    O
tralomethrin    O
are    O
components    O
of    O
the    O
Pyrethroid    O
insecticide    O
.    O

The    O
precursor    O
nonylphenol    O
is    O
derived    O
from    O
phenol    O
and    O
a    O
mixture    O
of    O
nonene    B-Alkene114713120
.    O

3.5    O
g    O
china-blue    B-Alkene114713120
aniline    I-Alkene114713120
dye    O
(    O
water    O
-    O
soluble    O
)    O

Maximum    O
concentrations    O
of    O
CVOCs    O
in    O
the    O
site    O
were    O
9500    O
micro    O
grams    O
/    O
Liter    O
of    O
cis    O
1,2-DCE    B-Alkene114713120
and    O
7900    O
micro    O
grams    O
/    O
Liter    O
of    O
vinyl    O
chloride    O
.    O

An    O
example    O
in    O
organic    O
chemistry    O
of    O
the    O
role    O
of    O
geometry    O
in    O
determining    O
dipole    O
moment    O
is    O
the    O
"    O
cis    O
"    O
and    O
"    O
trans    O
"    O
isomers    O
of    O
1,2-dichloroethene    B-Alkene114713120
.    O

Additional    O
rearrangements    O
and    O
oxidations    O
provide    O
compounds    O
such    O
as    O
citral    O
,    O
citronellal    B-Alkene114713120
,    O
citronellol    B-Alkene114713120
,    O
linalool    O
,    O
and    O
many    O
others    O
.    O

Ultra    O
-    O
fine    O
oil    O
’s    O
effect    O
can    O
be    O
strengthened    O
through    O
the    O
combination    O
with    O
oils    O
such    O
as    O
limonene    O
or    O
citronellal    B-Alkene114713120
.    O

The    O
compound    O
responsible    O
for    O
the    O
characteristic    O
aroma    O
was    O
identified    O
as    O
(–)-("S")-citronellal    B-Alkene114713120
,    O
which    O
is    O
contained    O
in    O
the    O
leaf    O
oil    O
up    O
to    O
80%    O
;    O
minor    O
components    O
include    O
citronellol    B-Alkene114713120
(    O
10%    O
)    O
,    O
nerol    B-Alkene114713120
and    O
limonene    O
.    O

He    O
worked    O
with    O
Philippe    O
Barbier    O
on    O
terpene    O
derivatives    O
used    O
in    O
the    O
manufacture    O
of    O
perfumes    O
like    O
citral    O
,    O
rhodinal    B-Alkene114713120
and    O
geraniol    B-Alkene114713120
.    O

Melatonin    O
has    O
been    O
claimed    O
to    O
be    O
an    O
endogenous    O
ligand    O
for    O
ROR-α    O
while    O
CGP    B-Alkene114713120
52608    I-Alkene114713120
has    O
been    O
identified    O
as    O
a    O
ROR-α    O
selective    O
synthetic    O
ligand    O
.    O

Treatment    O
of    O
2,5-dimethoxy-4-chloroaniline    O
with    O
diketene    B-Alkene114713120
gives    O
an    O
acetoacetylated    O
aniline    O
.    O

Treatment    O
of    O
2,4-dimethylaniline    O
with    O
diketene    O
gives    O
an    O
acetoacetylate    B-Alkene114713120
aniline    O
.    O

Oxantel    B-Alkene114713120
is    O
an    O
anthelmintic    O
.    O

With    O
acetic    O
acid    O
as    O
the    O
solvent    O
and    O
with    O
catalysis    O
by    O
a    O
strong    O
acid    O
,    O
alpha    O
-    O
pinene    O
readily    O
rearranges    O
into    O
camphene    B-Alkene114713120
,    O
which    O
in    O
turn    O
undergoes    O
Wagner    O
-    O
Meerwein    O
rearrangement    O
into    O
the    O
isobornyl    O
cation    O
,    O
which    O
is    O
captured    O
by    O
acetate    O
to    O
give    O
isobornyl    O
acetate    O
.    O

A    O
popular    O
fuel    O
in    O
the    O
U.S.    O
before    O
petroleum    O
was    O
a    O
blend    O
of    O
alcohol    O
and    O
turpentine    O
called    O
"    O
camphene    B-Alkene114713120
"    O
,    O
also    O
known    O
as    O
"    O
burning    O
fluid    O
.    O
"    O

For    O
example    O
,    O
one    O
stage    O
in    O
the    O
commercial    O
manufacture    O
of    O
synthetic    O
camphor    O
involves    O
a    O
Wagner    O
-    O
Meerwein    O
rearrangement    O
of    O
camphene    B-Alkene114713120
to    O
isobornyl    O
acetate    O
;    O
here    O
acetic    O
acid    O
acts    O
both    O
as    O
a    O
solvent    O
and    O
as    O
a    O
nucleophile    O
to    O
trap    O
the    O
rearranged    O
carbocation    O
.    O

Two    O
nearby    O
containers    O
were    O
:    O
"    O
...    O
loaded    O
with    O
barrels    O
of    O
camphene-90    B-Alkene114713120
wax    I-Alkene114713120
,    O
a    O
class    O
4.1    O
dangerous    O
cargo    O
.    O
"    O

Other    O
bicyclic    O
monoterpenes    O
include    O
carene    B-Alkene114713120
,    O
sabinene    B-Alkene114713120
,    O
camphene    B-Alkene114713120
,    O
and    O
thujene    B-Alkene114713120
.    O

Traumatic    B-Alkene114713120
acid    I-Alkene114713120
,    O
a    O
monounsaturated    O
dicarboxylic    O
acid    O
naturally    O
occurring    O
in    O
plants    O

Ectocarpene    B-Alkene114713120

"N"-Vinylpyrrolidone    B-Alkene114713120
(    O
NVP    O
)    O

Examples    O
of    O
monomers    O
include    O
styrene    O
,    O
N-Vinylpyrrolidone    B-Alkene114713120
,    O
and    O
acrylates    O
.    O
Styrene    O
is    O
a    O
low    O
cost    O
monomer    O
and    O
provides    O
a    O
fast    O
cure    O
,    O
N    O
-    O
vinylpyrrolidone    O
results    O
in    O
a    O
material    O
that    O
is    O
highly    O
flexible    O
when    O
cured    O
,    O
has    O
low    O
toxicity    O
,    O
and    O
acrylates    O
are    O
highly    O
reactive    O
,    O
allowing    O
for    O
rapid    O
cure    O
rates    O
,    O
and    O
are    O
highly    O
versatile    O
with    O
monomer    O
functionality    O
ranging    O
from    O
monofunctional    O
to    O
tetrafunctional    O
.    O

:    O
N03AX17    O
Stiripentol    B-Alkene114713120

#    O
Stiripentol    B-Alkene114713120

Ambroxide    O
is    O
synthesized    O
from    O
sclareol    B-Alkene114713120
,    O
a    O
component    O
of    O
the    O
essential    O
oil    O
of    O
clary    O
sage    O
.    O

Octadecene    B-Alkene114713120

Nalorphine    B-Alkene114713120
dinicotinate    I-Alkene114713120

Citronellol    B-Alkene114713120

Additional    O
rearrangements    O
and    O
oxidations    O
provide    O
compounds    O
such    O
as    O
citral    O
,    O
citronellal    B-Alkene114713120
,    O
citronellol    B-Alkene114713120
,    O
linalool    O
,    O
and    O
many    O
others    O
.    O

The    O
compound    O
responsible    O
for    O
the    O
characteristic    O
aroma    O
was    O
identified    O
as    O
(–)-("S")-citronellal    B-Alkene114713120
,    O
which    O
is    O
contained    O
in    O
the    O
leaf    O
oil    O
up    O
to    O
80%    O
;    O
minor    O
components    O
include    O
citronellol    B-Alkene114713120
(    O
10%    O
)    O
,    O
nerol    B-Alkene114713120
and    O
limonene    O
.    O

When    O
tested    O
in    O
mice    O
,    O
denatured    O
venom    O
from    O
"    O
P.    O
occidentalis    O
"    O
inhibited    O
convulsions    O
during    O
seizures    O
induced    O
by    O
bicuculline    O
,    O
picrotoxin    B-Alkene114713120
,    O
and    O
kainic    B-Alkene114713120
acid    I-Alkene114713120
.    O

Kainic    B-Alkene114713120
acid    I-Alkene114713120
(    O
kainate    O
)    O
is    O
a    O
natural    O
marine    O
acid    O
present    O
in    O
some    O
seaweed    O
.    O

Other    O
scientists    O
have    O
also    O
worked    O
on    O
this    O
perplexing    O
disorder    O
and    O
have    O
found    O
that    O
the    O
symptoms    O
can    O
be    O
induced    O
by    O
injecting    O
kainic    B-Alkene114713120
acid    I-Alkene114713120
or    O
ibotenic    O
acid    O
into    O
the    O
subthalamic    O
nucleus    O
.    O

Excitotoxins    O
like    O
NMDA    O
and    O
kainic    B-Alkene114713120
acid    I-Alkene114713120
which    O
bind    O
to    O
these    O
receptors    O
,    O
as    O
well    O
as    O
pathologically    O
high    O
levels    O
of    O
glutamate    O
,    O
can    O
cause    O
excitotoxicity    O
by    O
allowing    O
high    O
levels    O
of    O
calcium    O
ions    O
(    O
Ca2    O
+    O
)    O
to    O
enter    O
the    O
cell    O
.    O

Examples    O
of    O
cross    O
-    O
conjugation    O
can    O
be    O
found    O
in    O
molecules    O
such    O
as    O
benzophenone    O
,    O
divinylketones    O
,    O
"    O
p    O
"-    O
quinones    O
,    O
dendralenes    B-Alkene114713120
,    O
radialene    B-Alkene114713120
,    O
fullerene    O
,    O
and    O
Indigo    B-Alkene114713120
dye    I-Alkene114713120
.    O

It    O
arises    O
via    O
the    O
action    O
of    O
urocanase    O
on    O
urocanic    B-Alkene114713120
acid    I-Alkene114713120
.    O

Urocanate    B-Alkene114713120

(    O
2000    O
)    O
Bexarotene    B-Alkene114713120
(    O
Targretin    O
)    O
a    O
retinoid    O

Some    O
cancer    O
treatments    O
like    O
bexarotene    B-Alkene114713120
,    O
busulfan    O
,    O
chlorambucil    O
,    O
estramustine    O
,    O
etoposide    O
,    O
flutamide    O
,    O
idarubicin    O
,    O
ifosfamide    O
,    O
irinotecan    O
,    O
ixabepilone    O
,    O
letrozole    B-Alkene114713120
,    O
lomustine    O
,    O
megestrol    O
,    O
mitomycin    O
,    O
mitoxantrone    O
,    O
paclitaxel    O
,    O
procarbazine    O
,    O
tamoxifen    O
,    O
topotecan    O

Methyleugenol    B-Alkene114713120

methyl    B-Alkene114713120
eugenol    I-Alkene114713120
5.00%    O

Methyl    B-Alkene114713120
eugenol    I-Alkene114713120

In    O
large    O
quantities    O
,    O
jojoba    O
seed    O
meal    O
is    O
toxic    O
to    O
many    O
mammals    O
,    O
later    O
this    O
effect    O
was    O
found    O
to    O
be    O
due    O
to    O
simmondsin    B-Alkene114713120
,    O
which    O
inhibits    O
hunger    O
.    O

Promising    O
results    O
are    O
achieved    O
with    O
mycophenolate    B-Alkene114713120
and    O
tocilizumab    O
.    O

"    O
Penicillium    O
echinulatum    O
"    O
produces    O
Mycophenolic    B-Alkene114713120
acid    I-Alkene114713120

Sirolimus    O
can    O
also    O
be    O
used    O
alone    O
,    O
or    O
in    O
conjunction    O
with    O
a    O
calcineurin    O
inhibitor    O
(    O
such    O
as    O
tacrolimus    O
)    O
,    O
and/or    O
mycophenolate    B-Alkene114713120
mofetil    I-Alkene114713120
,    O
to    O
provide    O
steroid    O
-    O
free    O
immunosuppression    O
regimens    O
.    O

Mycophenolic    B-Alkene114713120
acid    I-Alkene114713120

Mycophenolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
less    O
accurately    O
called    O
mycophenolate    B-Alkene114713120
,    O
is    O
an    O
immunosuppressant    O
drug    O
used    O
to    O
prevent    O
rejection    O
in    O
organ    O
transplantation    O
.    O

Mycophenolate    O
mofetil    O
is    O
marketed    O
under    O
the    O
trade    O
name    O
CellCept    B-Alkene114713120
and    O
mycophenolate    O
sodium    O
as    O
Myfortic    B-Alkene114713120
.    O

Bone    O
marrow    O
suppression    O
due    O
to    O
azathioprine    O
can    O
be    O
treated    O
by    O
changing    O
to    O
another    O
medication    O
such    O
as    O
mycophenolate    B-Alkene114713120
mofetil    I-Alkene114713120
(    O
for    O
organ    O
transplants    O
)    O
or    O
other    O
disease    O
-    O
modifying    O
drugs    O
in    O
rheumatoid    O
arthritis    O
or    O
Crohn    O
's    O
disease    O
.    O

Mycophenolate    B-Alkene114713120
mofetil    I-Alkene114713120
(    O
tradename    O
CellCept    O
)    O
,    O
an    O
immunosuppressant    O
drug    O
used    O
to    O
prevent    O
rejection    O
in    O
organ    O
transplantation    O

Alternatively    O
systemic    O
immunosuppressants    O
may    O
be    O
tried    O
such    O
as    O
ciclosporin    O
,    O
methotrexate    O
,    O
interferon    O
gamma-1b    O
,    O
mycophenolate    B-Alkene114713120
mofetil    I-Alkene114713120
and    O
azathioprine    O
.    O

Mycophenolate    B-Alkene114713120
mofetil    I-Alkene114713120

aminometradine    B-Alkene114713120
(    O
INN    O
)    O

The    O
oil    O
exact    O
composition    O
is    O
:    O
pinene    B-Alkene114713120
(    O
20.2%    O
)    O
,    O
sabinene    B-Alkene114713120
(    O
12.0%    O
)    O
,    O
p    O
-    O
cymene    O
(    O
7.0%    O
)    O
and    O
terpinen-4-ol    B-Alkene114713120
(    O
29.6%    O
)    O
.    O

Of    O
these    O
linalool    O
and    O
linalyl    O
acetate    O
dominate    O
,    O
with    O
moderate    O
levels    O
of    O
lavandulyl    O
acetate    O
,    O
terpinen-4-ol    B-Alkene114713120
and    O
lavandulol    O
.    O

N    O
,    O
N    O
"-    O
Diallyllysergamide    O
("'DAL    B-Alkene114713120
,    O
as    O
the    O
tartrate    O
salt    O
)    O
is    O
a    O
psychedelic    O
lysergamide    O
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
dimethylallyl    B-Alkene114713120
diphosphate    I-Alkene114713120
,    O
and    O
two    O
products    O
,    O
diphosphate    O
and    O
lavandulyl    O
diphosphate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
dimethylallyl    B-Alkene114713120
diphosphate    I-Alkene114713120
and    O
(    O
-)-(2S)-naringenin    O
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
sophoraflavanone    O
B.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
dimethylallyl    B-Alkene114713120
diphosphate    I-Alkene114713120
and    O
L    O
-    O
tryptophan    O
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
4-(3-methylbut-2-enyl)-L    O
-    O
tryptophan    O
.    O

The    O
biosynthesis    O
of    O
α-terpinene    O
and    O
other    O
terpenoids    O
occurs    O
via    O
the    O
mevalonate    O
pathway    O
because    O
its    O
starting    O
reactant    O
,    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
,    O
is    O
derived    O
from    O
mevalonic    O
acid    O
.    O

Dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
is    O
then    O
obtained    O
from    O
the    O
deoxyxylulose    O
pathway    O
,    O
where    O
prenylation    O
of    O
the    O
benzenoid    O
occurs    O
,    O
yielding    O
humulone    O
.    O

IPP    O
is    O
isomerized    O
to    O
the    O
allylic    O
ester    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
by    O
IPP    O
isomerase    O
.    O

Finally    O
,    O
MEcPP    O
is    O
converted    O
to    O
(    O
"    O
E")-4-hydroxy-3-methyl    O
-    O
but-2-enyl    O
pyrophosphate    O
(    O
HMB    O
-    O
PP    O
)    O
by    O
HMB    O
-    O
PP    O
synthase    O
(    O
GcpE    O
,    O
IspG    O
)    O
,    O
and    O
HMB    O
-    O
PP    O
is    O
converted    O
to    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
and    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
by    O
HMB    O
-    O
PP    O
reductase    O
(    O
LytB    O
,    O
IspH    O
)    O
.    O

Simplified    O
version    O
of    O
the    O
steroid    O
synthesis    O
pathway    O
with    O
the    O
terpenoid    O
intermediates    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
,    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
,    O
geranyl    O
pyrophosphate    O
(    O
GPP    O
)    O
,    O
and    O
squalene    B-Alkene114713120
shown    O
.    O

Isoprene    O
itself    O
does    O
not    O
undergo    O
the    O
building    O
process    O
,    O
but    O
rather    O
activated    O
forms    O
,    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
or    O
also    O
isopentenyl    O
diphosphate    O
)    O
and    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
or    O
also    O
dimethylallyl    O
diphosphate    O
)    O
,    O
are    O
the    O
components    O
in    O
the    O
biosynthetic    O
pathway    O
.    O

Isopentenyl    O
pyrophosphate    O
isomerase    O
(    O
IPP    O
isomerase    O
)    O
,    O
also    O
known    O
as    O
Isopentenyl    O
-    O
diphosphate    O
delta    O
isomerase    O
,    O
is    O
an    O
isomerase    O
that    O
catalyzes    O
the    O
conversion    O
of    O
the    O
relatively    O
un    O
-    O
reactive    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
to    O
the    O
more    O
-    O
reactive    O
electrophile    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
.    O

Trans-1,4-dichlorobutene    B-Alkene114713120

Cross-conjugation    B-Alkene114713120
is    O
a    O
special    O
type    O
of    O
conjugation    O
in    O
a    O
molecule    O
,    O
when    O
in    O
a    O
set    O
of    O
three    O
Pi    O
bonds    O
only    O
two    O
pi    O
-    O
bonds    O
interact    O
with    O
each    O
other    O
by    O
conjugation    O
,    O
the    O
third    O
one    O
is    O
excluded    O
from    O
interaction    O
.    O

1-Dodecene    B-Alkene114713120
is    O
an    O
alkene    O
with    O
the    O
formula    O
C10H21CH    O

There    O
are    O
two    O
types    O
of    O
alpha    O
-    O
olefins    O
,    O
branched    O
and    O
linear    B-Alkene114713120
(    O
or    O
normal    O
)    O
.    O

Onchidal    B-Alkene114713120

cis"-3-Hexenal    O
,    B-Alkene114713120
also    I-Alkene114713120
known    I-Alkene114713120
as    I-Alkene114713120
(    O
"    O
Z")-3-hexenal    O
and    B-Alkene114713120
"'leaf    I-Alkene114713120
aldehyde    I-Alkene114713120
,    O
is    O
colorless    O
liquid    O
and    O
an    O
aroma    O
compound    O
with    O
an    O
intense    O
grassy    O
-    O
green    O
odor    O
of    O
freshly    O
cut    O
green    O
grass    O
and    O
leaves    O
.    O

"cis"-3-Hexenal    B-Alkene114713120
(    O
green    O
tomatoes    O
)    O

Benzvalene    B-Alkene114713120
,    O

Prenol    B-Alkene114713120

Ethenone    B-Alkene114713120
is    O
the    O
formal    O
name    O
for    O
ketene    B-Alkene114713120
,    O
an    O
organic    O
compound    O
with    O
formula    O
C2H2O    O
or    O
H2C    O
=    O
C    O
=    O
O.    O
It    O
is    O
the    O
simplest    O
member    O
of    O
the    O
ketene    B-Alkene114713120
class    O
.    O

To    O
a    O
decreasing    O
extent    O
,    O
acetic    O
anhydride    O
is    O
also    O
prepared    O
by    O
the    O
reaction    O
of    O
ketene    O
(    O
ethenone    B-Alkene114713120
)    O
with    O
acetic    O
acid    O
at    O
45–55    O
°C    O
and    O
low    O
pressure    O
(    O
0.05–0.2    O
bar    O
)    O
.    O

Pepper    O
can    O
also    O
lose    O
flavour    O
when    O
exposed    O
to    O
light    O
,    O
which    O
can    O
transform    O
piperine    O
into    O
nearly    O
tasteless    O
chavicine    B-Alkene114713120
.    O

One    O
of    O
the    O
four    O
stereoisomers    O
,    O
(    O
1"R",3"R")-    O
or    O
(    O
+    O
)    O
-"trans    O
"-    O
chrysanthemic    O
acid    O
(    O
pictured    O
)    O
,    O
is    O
the    O
acid    O
part    O
of    O
the    O
ester    O
pyrethrin    B-Alkene114713120
I    I-Alkene114713120
,    O
which    O
occurs    O
naturally    O
in    O
the    O
seed    O
cases    O
of    O
"    O
Chrysanthemum    O
cinerariaefolium    O
"    O
.    O

There    O
was    O
a    O
pronounced    O
decline    O
in    O
American    O
white    O
pelican    O
numbers    O
in    O
the    O
mid-20th    O
century    O
,    O
attributable    O
to    O
the    O
excessive    O
spraying    O
of    O
DDT    O
,    O
endrin    B-Alkene114713120
and    O
other    O
organochlorides    O
in    O
agriculture    O
as    O
well    O
as    O
widespread    O
draining    O
and    O
pollution    O
of    O
wetlands    O
.    O

endrin    B-Alkene114713120
from    O
acetylene    O
,    O
followed    O
by    O
cyclopentadiene    O
,    O
followed    O
by    O
epoxidation    O

Endrin    B-Alkene114713120
(    O
organochlorine    O
insecticide    O
,    O
used    O
in    O
the    O
past    O
for    O
extermination    O
of    O
voles    O
in    O
fields    O
)    O

The    O
control    O
measures    O
used    O
have    O
included    O
a    O
wide    O
range    O
of    O
pesticides    O
,    O
including    O
calcium    O
arsenate    O
,    O
DDT    O
,    O
toxaphene    B-Alkene114713120
,    O
aldrin    O
,    O
dieldrin    O
,    O
endrin    B-Alkene114713120
,    O
heptachlor    O
,    O
malathion    O
,    O
and    O
parathion    O
.    O

Tetracyanoethylene    B-Alkene114713120
(    O
TCNE    O
)    O
,    O
more    O
correctly    O
ethenetetracarbonitrile    O
,    O
is    O
a    O
clear    O
colored    O
organic    O
compound    O
consisting    O
of    O
ethylene    O
with    O
the    O
four    O
hydrogen    O
atom    O
replaced    O
with    O
cyano    O
groups    O
.    O

Most    O
commonly    O
fullerene    O
ligands    O
behave    O
similarly    O
to    O
electron    O
-    O
deficient    O
alkenes    O
such    O
as    O
tetracyanoethylene    B-Alkene114713120
.    O

The    O
Rhodopsin    O
haloprotein    O
family    O
shares    O
the    O
ligand    O
Retinal    O
,    O
Vitamin    O
A    O
Aldehyde    O
,    O
one    O
of    O
the    O
many    O
types    O
of    O
Vitamin    O
A.    O
Retinal    O
is    O
a    O
conjugated    O
poly    O
-    O
unsaturatedchromophore    O
(    O
polyene    B-Alkene114713120
)    O
,    O
obtained    O
from    O
carnivorous    O
diet    O
or    O
by    O
the    O
carotene    O
pathway    O
(    O
β-carotene    O
15,15'-monoxygenase    O
)    O
.    O

Gertraud    O
Gruber    O
and    O
Wolfgang    O
Steglich    O
were    O
not    O
able    O
to    O
detect    O
these    O
compounds    O
in    O
"    O
C.    O
cinnabarinum    O
"    O
,    O
but    O
isolated    O
a    O
novel    O
polyene    B-Alkene114713120
pigment    O
.    O

A    O
dendralene    B-Alkene114713120
is    O
a    O
discrete    O
acyclic    O
cross-conjugated    B-Alkene114713120
polyene    B-Alkene114713120
.    O

Whereas    O
a    O
normal    O
conjugated    O
system    O
such    O
as    O
a    O
polyene    B-Alkene114713120
typically    O
has    O
alternating    O
single    O
and    O
double    O
bonds    O
along    O
consecutive    O
atoms    O
,    O
a    O
cross    O
-    O
conjugated    O
system    O
has    O
a    O
double    O
-    O
bonded    O
unit    O
single    O
-    O
bonded    O
to    O
one    O
of    O
the    O
middle    O
atoms    O
of    O
another    O
conjugated    O
chain    O
.    O

Examples    O
are    O
conjugated    O
carbonyl    O
compounds    O
,    O
conjugated    O
dienes    O
,    O
and    O
polyene    B-Alkene114713120
.    O

A    O
more    O
recent    O
example    O
is    O
E.J.    O
Corey    O
's    O
carbenium    O
-    O
mediated    O
cyclization    O
of    O
an    O
engineered    O
linear    O
polyene    B-Alkene114713120
to    O
provide    O
a    O
tetracyclic    O
steroid    O
ring    O
system    O
,    O
which    O
built    O
upon    O
studies    O
of    O
cationic    O
cyclizations    O
of    O
linear    O
polyenes    O
by    O
the    O
Albert    O
Eschenmoser    O
and    O
Gilbert    O
Stork    O
,    O
and    O
the    O
extensive    O
studies    O
of    O
the    O
W.S.    O
Johnson    O
to    O
define    O
the    O
requirements    O
to    O
initiate    O
and    O
terminate    O
the    O
cyclization    O
,    O
and    O
to    O
stabilize    O
the    O
cationic    O
carbenium    O
group    O
during    O
the    O
cyclization    O
(    O
as    O
nature    O
accomplishes    O
via    O
enzymes    O
during    O
biosynthesis    O
of    O
steroids    O
such    O
as    O
cholesterol    O
)    O
.    O

It    O
is    O
made    O
from    O
a    O
combination    O
of    O
imipenem    O
and    O
cilastatin    B-Alkene114713120
.    O

It    O
is    O
a    O
broad    O
-    O
spectrum    O
beta    O
-    O
lactam    O
containing    O
equal    O
quantities    O
of    O
imipenem    O
and    O
cilastatin    B-Alkene114713120
.    O

TEX86    O
has    O
been    O
used    O
to    O
reconstruct    O
temperature    O
throughout    O
the    O
Cenozoic    O
era    O
(    O
65    O
-    O
0Ma    O
)    O
and    O
is    O
useful    O
when    O
other    O
SST    O
proxies    O
are    O
diagenetically    O
altered    O
(    O
e.g.    O
planktonic    O
foraminifera    O
)    O
or    O
absent    O
(    O
e.g.    O
alkenones    B-Alkene114713120
)    O

During    O
the    O
early    O
Eocene    O
,    O
TEX86    O
values    O
indicate    O
warm    O
high    O
southern    O
hemisphere    O
latitude    O
SSTs    O
(    O
20    O
-    O
25    O
°C    O
)    O
in    O
agreement    O
with    O
other    O
,    O
independently    O
derived    O
proxies    O
(    O
e.g.    O
alkenones    B-Alkene114713120
,    O
CLAMP    O
,    O
Mg    O
/    O
Ca    O
)    O
.    O

Unlike    O
ordinary    O
barrelene    B-Alkene114713120
,    O
this    O
benzobarrelene    O
is    O
also    O
resistant    O
to    O
ring    O
-    O
opening    O
metathesis    O
polymerisation    O
.    O

It    O
was    O
long    O
considered    O
that    O
the    O
best    O
examples    O
of    O
neutral    O
homoaromatics    O
are    O
bishomoaromatics    O
such    O
as    O
barrelene    B-Alkene114713120
and    O
semibullvalene    O
.    O

The    O
Allioideae    O
produce    O
allyl    B-Alkene114713120
sulfide    I-Alkene114713120
compounds    O
which    O
give    O
them    O
their    O
characteristic    O
smell    O
.    O

Beginning    O
in    O
1944    O
,    O
with    O
his    O
colleagues    O
,    O
he    O
reported    O
on    O
the    O
isolation    O
from    O
crushed    O
garlic    O
,    O
synthesis    O
(    O
from    O
diallyl    B-Alkene114713120
disulfide    I-Alkene114713120
)    O
and    O
antibiotic    O
activity    O
of    O
a    O
compound    O
he    O
named    O
allicin    O
.    O

Elastolefin    B-Alkene114713120
is    O
a    O
fibre    O
composed    O
of    O
at    O
least    O
95%    O
(    O
by    O
weight    O
)    O
of    O
macromolecules    O
partially    O
cross    O
-    O
linked    O
,    O
made    O
of    O
ethylene    O
and    O
at    O
least    O
one    O
other    O
olefin    O
.    O

Pseudocholinesterase    O
deficiency    O
results    O
in    O
delayed    O
metabolism    O
of    O
only    O
a    O
few    O
compounds    O
of    O
clinical    O
significance    O
,    O
including    O
the    O
following    O
:    O
succinylcholine    O
,    O
mivacurium    B-Alkene114713120
,    O
procaine    O
,    O
heroin    O
,    O
and    O
cocaine    O
.    O

People    O
who    O
have    O
this    O
abnormality    O
may    O
be    O
sensitive    O
to    O
certain    O
anesthetic    O
drugs    O
,    O
including    O
the    O
muscle    O
relaxants    O
succinylcholine    O
and    O
mivacurium    B-Alkene114713120
as    O
well    O
as    O
other    O
ester    O
local    O
anesthetics    O
.    O

Drugs    O
containing    O
Mivacurium    B-Alkene114713120
-    O
e.g.    O
Mivacron    B-Alkene114713120

Dufour    O
's    O
gland    O
secretions    O
have    O
been    O
found    O
to    O
include    O
a    O
complex    O
mixture    O
of    O
linear    O
hydrocarbons    O
from    O
C15    O
to    O
C25    O
,    O
with    O
("Z")-9-tricosene    B-Alkene114713120
being    O
the    O
main    O
constituent    O
,    O
along    O
with    O
other    O
minor    O
constituents    O
like    O
tetradecyl    O
propionate    O
and    O
traces    O
of    O
tetradecyl    O
acetate    O
and    O
dodecyl    O
acetate    O
.    O

Nevcin    O
synthesises    O
hydrocarbon    O
resins    O
,    O
using    O
distillates    O
from    O
cracking    O
of    O
the    O
naphtha    O
fraction    O
,    O
with    O
polymerisation    O
feedstock    O
including    O
isoprene    B-Alkene114713120
,    O
piperylene    B-Alkene114713120
and    O
cyclopentadiene    O
(    O
or    O
dicyclopentadiene    B-Alkene114713120
dimer    O
)    O
as    O
well    O
as    O
styrene    O
and    O
styrene    O
-    O
type    O
products    O
including    O
vinyltoluene    O
,    O
indene    O
,    O
methylindene    O
and    O
alpha-methylstyrene    B-Alkene114713120
.    O

Allyl(a-methyl-3,4-methylenedioxyphenethyl)amine    B-Alkene114713120

The    O
addition    O
of    O
this    O
push-pull    B-Alkene114713120
configuration    O
results    O
in    O
a    O
strongly    O
asymmetric    O
electron    O
distribution    O
,    O
which    O
modifies    O
a    O
host    O
of    O
optical    O
properties    O
.    O

Lash    O
adhesives    O
are    O
made    O
from    O
methyl    B-Alkene114713120
which    O
is    O
designed    O
to    O
bond    O
a    O
smooth    O
surface    O
(    O
the    O
eyelash    O
extension    O
)    O
to    O
a    O
porous    O
surface    O
(    O
the    O
natural    O
eyelash    O
)    O
.    O

Nitriles    O
are    O
found    O
in    O
many    O
useful    O
compounds    O
,    O
including    O
methyl    B-Alkene114713120
cyanoacrylate    I-Alkene114713120
,    O
used    O
in    O
super    B-Alkene114713120
glue    I-Alkene114713120
,    O
and    O
nitrile    O
rubber    O
,    O
a    O
nitrile    O
-    O
containing    O
polymer    O
used    O
in    O
latex    O
-    O
free    O
laboratory    O
and    O
medical    O
gloves    O
.    O

Prallethrin    B-Alkene114713120

Allyl    O
cyanide    O
can    O
be    O
prepared    O
by    O
treating    O
allyl    B-Alkene114713120
bromide    I-Alkene114713120
with    O
copper(I    O
)    O
cyanide    O
under    O
rigorous    O
heating    O
.    O

It    O
has    O
been    O
prepared    O
from    O
cyclopentanemagnesium    O
bromide    O
and    O
allyl    B-Alkene114713120
bromide    I-Alkene114713120
.    O

Allyl    B-Alkene114713120
bromide    I-Alkene114713120

The    O
compound    O
has    O
no    O
practical    O
value    O
but    O
is    O
a    O
prototypical    O
complex    O
of    O
cycloheptatriene    B-Alkene114713120
.    O

Cycloheptatriene    B-Alkene114713120
(    O
CHT    O
)    O
is    O
an    O
organic    O
compound    O
with    O
the    O
formula    O
C7H8    O
.    O

Two    O
selected    O
methods    O
for    O
the    O
synthesis    O
of    O
tropone    O
are    O
by    O
selenium    O
dioxide    O
oxidation    O
of    O
cycloheptatriene    B-Alkene114713120
and    O
indirectly    O
from    O
tropinone    O
by    O
a    O
Hofmann    O
elimination    O
and    O
a    O
bromination    O
.    O

Polymethylpentene    O
is    O
a    O
4-methyl-1-pentene    B-Alkene114713120
based    O
linear    O
isotactic    O
polyolefin    O
and    O
is    O
made    O
by    O
Ziegler    O
-    O
Natta    O
type    O
catalysis    O
.    O

Pyrantel    B-Alkene114713120

Mebendazole    O
,    O
Pyrantel    B-Alkene114713120
Pamoate    I-Alkene114713120

Pyrantel    B-Alkene114713120
pamoate    I-Alkene114713120
is    O
also    O
used    O
,    O
and    O
a    O
closely    O
related    O
variant    O
,    O
pyrantel    O
tartrate    O
,    O
can    O
be    O
fed    O
as    O
a    O
daily    O
dose    O
that    O
is    O
effective    O
at    O
killing    O
larvae    O
.    O

Other    O
anthelmintics    O
that    O
can    O
be    O
used    O
include    O
thiabendazole    O
,    O
mebendazole    O
,    O
levamisole    O
and    O
pyrantel    B-Alkene114713120
pamoate    I-Alkene114713120
.    O

Pyrantel    B-Alkene114713120
pamoate    I-Alkene114713120
(    O
for    O
most    O
nematode    O
infections    O
)    O

BW373U86    B-Alkene114713120

Gastrointestinal    O
-    O
protectant    O
drugs    O
,    O
such    O
as    O
misoprostol    B-Alkene114713120
,    O
cimetidine    O
,    O
omeprazole    O
,    O
ranitidine    O
,    O
or    O
sucralfate    O
,    O
are    O
frequently    O
included    O
as    O
a    O
part    O
of    O
treatment    O
with    O
any    O
NSAID    O
.    O

Intravaginal    O
,    O
endocervical    O
or    O
extra    O
-    O
amniotic    O
administration    O
of    O
prostaglandin    O
,    O
such    O
as    O
dinoprostone    O
or    O
misoprostol    B-Alkene114713120
.    O

Misoprostol    B-Alkene114713120
6    O
to    O
12    O
hrs    O
before    O
insertion    O
can    O
help    O
with    O
cervical    O
dilation    O
.    O

Misoprostol    B-Alkene114713120
,    O
an    O
EP3    O
and    O
EP4    O
receptor    O
agonist    O
,    O
to    O
prevent    O
ulcers    O
;    O
to    O
induce    O
labor    O
in    O
pregnancy    O
,    O
medical    O
abortion    O
,    O
and    O
late    O
miscarriage    O
;    O
and    O
to    O
prevent    O
and    O
treat    O
postpartum    O
bleeding    O
.    O

Misoprostol    O
,    O
an    O
EP3    O
and    O
EP4    O
receptor    O
agonist    O
,    O
is    O
in    O
clinical    O
use    O
to    O
prevent    O
ulcers    O
,    O
to    O
induce    O
labor    O
in    O
pregnancy    O
,    O
medical    O
abortion    O
,    O
and    O
late    O
miscarriage    O
,    O
and    O
to    O
prevent    O
and    O
treat    O
postpartum    O
bleeding    O
(    O
see    O
Misoprostol    B-Alkene114713120
)    O
.    O

In    O
recent    O
years    O
,    O
significant    O
reductions    O
in    O
maternal    O
death    O
and    O
injury    O
resulting    O
from    O
self    O
-    O
induced    O
abortions    O
have    O
been    O
attributed    O
to    O
the    O
growing    O
use    O
of    O
misoprostol    B-Alkene114713120
(    O
known    O
commercially    O
at    O
"    O
Cytotec    O
"    O
)    O
,    O
an    O
inexpensive    O
,    O
widely    O
available    O
drug    O
with    O
multiple    O
uses    O
,    O
including    O
the    O
treatment    O
of    O
post    O
-    O
partum    O
hemorrhage    O
,    O
stomach    O
ulcers    O
,    O
and    O
induction    O
of    O
labor    O
.    O

The    O
prescription    O
synthetic    O
prostaglandin    O
drug    O
misoprostol    B-Alkene114713120
–    O
used    O
in    O
the    O
U.S.    O
to    O
treat    O
gastric    O
ulcers    O
–    O
is    O
often    O
used    O
as    O
an    O
abortifacient    O
in    O
self    O
-    O
induced    O
abortion    O
in    O
Latin    O
American    O
countries    O
where    O
legal    O
abortions    O
are    O
unavailable    O
,    O
and    O
its    O
use    O
has    O
also    O
been    O
observed    O
in    O
immigrant    O
populations    O
in    O
New    O
York    O
.    O

She    O
had    O
induced    O
abortion    O
at    O
roughly    O
16    O
weeks    O
by    O
ingesting    O
misoprostol    B-Alkene114713120
under    O
the    O
brand    O
name    O
Cytotec    O
,    O
an    O
ulcer    O
medication    O
with    O
abortifacient    O
potential    O
.    O

The    O
anti    O
-    O
estrogen    O
action    O
of    O
letrozole    O
has    O
been    O
shown    O
to    O
be    O
useful    O
in    O
pretreatment    O
for    O
termination    O
of    O
pregnancy    O
,    O
in    O
combination    O
with    O
misoprostol    B-Alkene114713120
.    O

Eribulin    B-Alkene114713120
was    O
approved    O
in    O
the    O
US    O
in    O
Nov    O
2010    O
.    O

eribulin    B-Alkene114713120
(    O
INN    O
)    O
(    O
"    O
investigational    O
drug    O
"    O
)    O

The    O
precursor    O
to    O
the    O
lachrymatory    O
compound    O
,    O
(    O
RS    O
,    O
RC)-("E")-"S"-(1-butenyl    O
)    O
cysteine    O
"    O
S    O
"-    O
oxide    O
(    O
alliin    B-Alkene114713120
)    O
,    O
was    O
isolated    O
from    O
homogenates    O
of    O
"    O
A.    O
siculum    O
"    O
,    O
and    O
a    O
closely    O
related    O
species    O
,    O
"    O
Allium    O
tripedale    O
"    O
,    O
and    O
fully    O
characterized    O
.    O

Cysteine    O
sulphoxides    O
are    O
also    O
largely    O
responsible    O
for    O
the    O
flavour    O
and    O
spicy    O
taste    O
of    O
these    O
species    O
,    O
predominantly    O
the    O
isomeric    O
cysteine    O
derivatives    O
alliin    B-Alkene114713120
and    O
isoalliin    O
.    O

Until    O
a    O
few    O
decades    O
ago    O
,    O
Ayurvedic    O
physicians    O
in    O
Kerala    O
reared    O
Malabar    O
civets    O
to    O
obtain    O
civetone    B-Alkene114713120
,    O
an    O
extract    O
from    O
the    O
scent    O
gland    O
,    O
which    O
was    O
used    O
in    O
medicine    O
,    O
and    O
as    O
an    O
aromatic    O
.    O

The    O
chemical    O
in    O
civet    O
oil    O
that    O
gives    O
it    O
most    O
of    O
its    O
distinctive    O
odor    O
is    O
civetone    B-Alkene114713120
,    O
at    O
a    O
concentration    O
of    O
between    O
2.5    O
and    O
3.4    O
percent    O
.    O

In    O
addition    O
to    O
common    O
six    O
-    O
membered    O
ring    O
systems    O
such    O
as    O
is    O
found    O
in    O
zingiberene    B-Alkene114713120
(    O
a    O
constituent    O
of    O
the    O
oil    O
from    O
ginger    O
)    O
,    O
cyclization    O
of    O
one    O
end    O
of    O
the    O
chain    O
to    O
the    O
other    O
end    O
can    O
lead    O
to    O
macrocyclic    O
rings    O
such    O
as    O
humulene    B-Alkene114713120
.    O

Isoprenol    B-Alkene114713120

It    O
is    O
a    O
precursor    O
to    O
nootkatone    B-Alkene114713120
,    O
the    O
main    O
contributor    O
to    O
the    O
aroma    O
and    O
flavor    O
of    O
grapefruit    O
.    O

Lotusate    B-Alkene114713120

Where    O
there    O
is    O
no    O
β-hydrogen    O
to    O
be    O
eliminated    O
,    O
cyclic    O
compounds    O
may    O
be    O
formed    O
,    O
as    O
in    O
the    O
preparation    O
of    O
methylenecyclopropane    B-Alkene114713120
below    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S    O
-    O
adenosyl    O
methionine    O
and    O
isoeugenol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
adenosylhomocysteine    O
and    O
isomethyleugenol    B-Alkene114713120
.    O

Dewar    B-Alkene114713120
benzene    I-Alkene114713120
and    O
prismane    O
are    O
different    O
chemicals    O
that    O
have    O
Dewar    O
's    O
and    O
Ladenburg    O
's    O
structures    O
.    O

He    O
is    O
remembered    O
for    O
his    O
early    O
investigations    O
of    O
the    O
benzene    O
structure    O
known    O
as    O
the    O
Dewar    B-Alkene114713120
benzene    I-Alkene114713120
.    O

A    O
reported    O
possible    O
synthesis    O
of    O
it    O
involves    O
an    O
elimination    O
reaction    O
from    O
a    O
Dewar    B-Alkene114713120
benzene    I-Alkene114713120
derivative    O
.    O

Examples    O
of    O
drugs    O
commonly    O
associated    O
with    O
depressogenic    O
effects    O
include    O
some    O
anticonvulsants    O
such    O
as    O
the    O
barbiturates    O
(    O
e.g.    O
phenobarbital    O
)    O
,    O
benzodiazepines    O
(    O
e.g.    O
diazepam    O
)    O
,    O
vigabatrin    B-Alkene114713120
,    O
and    O
topiramate    O
,    O
corticosteroids    O
like    O
dexamethasone    O
and    O
prednisone    O
,    O
cytokines    O
like    O
interferon-α    O
and    O
interleukin-2    O
,    O
certain    O
antihypertensives    O
such    O
as    O
amiodarone    O
,    O
clonidine    O
,    O
methyldopa    O
,    O
reserpine    O
,    O
and    O
tetrabenazine    O
(    O
used    O
as    O
an    O
antipsychotic    O
/    O
antihyperkinetic    O
)    O
,    O
and    O
agents    O
with    O
antiandrogen    O
,    O
antiestrogen    O
,    O
and/or    O
anti    O
-    O
neurosteroid    O
activities    O
such    O
as    O
GnRH    O
agonists    O
(    O
e.g.    O
,    O
leuprolide    O
,    O
goserelin    O
)    O
,    O
anastrozole    O
(    O
an    O
aromatase    O
inhibitor    O
)    O
,    O
finasteride    O
(    O
a    O
5α-reductase    O
inhibitor    O
)    O
,    O
and    O
clomiphene    O
(    O
a    O
SERM    O
)    O
,    O
as    O
well    O
as    O
others    O
including    O
flunarizine    O
,    O
mefloquine    O
,    O
and    O
efavirenz    O
.    O

In    O
addition    O
to    O
tiagabine    O
,    O
the    O
marketed    O
anticonvulsant    O
GABA    O
transaminase    O
(    O
GABA    O
-    O
T    O
)    O
inhibitor    O
(    O
and    O
hence    O
also    O
an    O
indirect    O
and    O
non    O
-    O
selective    O
GABA    O
receptor    O
agonist    O
)    O
vigabatrin    B-Alkene114713120
has    O
also    O
been    O
associated    O
with    O
acute    O
psychotic    O
episodes    O
,    O
hallucinations    O
,    O
and    O
other    O
psychiatric    O
adverse    O
reactions    O
,    O
albeit    O
less    O
commonly    O
.    O

Vigabatrin    B-Alkene114713120

Newer    O
AEDs    O
,    O
including    O
lacosamide    O
,    O
vigabatrin    B-Alkene114713120
,    O
felbamate    O
,    O
gabapentin    O
,    O
tiagabine    B-Alkene114713120
,    O
and    O
rufinamide    O
have    O
been    O
found    O
to    O
be    O
more    O
tolerable    O
and    O
safer    O
than    O
older    O
drugs    O
such    O
as    O
carbamazepine    O
,    O
phenytoin    O
,    O
and    O
valproate    O
.    O

Seven    O
phenolic    O
compounds    O
,    O
including    O
ferulic    B-Alkene114713120
acid    I-Alkene114713120
,    O
vanillic    O
acid    O
,    O
coumaric    O
acid    O
,    O
syringic    O
acid    O
,    O
myricetin    O
,    O
and    O
juglone    O
were    O
identified    O
in    O
walnut    O
husks    O
.    O

Streptomyces    O
olivochromogenes    O
is    O
a    O
bacterium    O
species    O
from    O
the    O
genus    O
of    O
"    O
Streptomyces    O
"    O
which    O
has    O
been    O
isolated    O
from    O
soil."Streptomyces    O
olivochromogenes    O
"    O
produces    O
ferulic    B-Alkene114713120
acid    I-Alkene114713120
.    O

The    O
oil    O
compartments    O
in    O
açaí    O
fruit    O
contain    O
polyphenols    O
such    O
as    O
procyanidin    O
oligomers    O
and    O
vanillic    O
acid    O
,    O
syringic    O
acid    O
,    O
p    O
-    O
hydroxybenzoic    O
acid    O
,    O
protocatechuic    O
acid    O
,    O
and    O
ferulic    B-Alkene114713120
acid    I-Alkene114713120
,    O
which    O
were    O
shown    O
to    O
degrade    O
substantially    O
during    O
storage    O
or    O
exposure    O
to    O
heat    O
.    O

Cinnamic    B-Alkene114713120
acid    I-Alkene114713120
and    O
its    O
derivatives    O
,    O
such    O
as    O
ferulic    B-Alkene114713120
acid    I-Alkene114713120
-    O
found    O
in    O
seeds    O
of    O
plants    O
such    O
as    O
in    O
brown    O
rice    O
,    O
whole    O
wheat    O
and    O
oats    O
,    O
as    O
well    O
as    O
in    O
coffee    O
,    O
apple    O
,    O
artichoke    O
,    O
peanut    O
,    O
orange    O
and    O
pineapple    O
.    O

Phenolic    O
acids    O
(    O
e.g.    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
caffeic    O
acid    O
,    O
p    O
-    O
coumaric    O
acid    O
,    O
ferulic    B-Alkene114713120
acid    I-Alkene114713120
,    O
p    O
-    O
hydroxybenzoic    O
acid    O
,    O
vanillic    O
acid    O
)    O

Ferulic    B-Alkene114713120
acid    I-Alkene114713120

Ferulic    B-Alkene114713120
acid    I-Alkene114713120
(    O
3-methoxy-4-hydroxycinnamic    O
acid    O
)    O
–    O
oats    O
,    O
rice    O
,    O
artichoke    O
,    O
orange    O
,    O
pineapple    O
,    O
apple    O
,    O
peanut    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S    O
-    O
adenosyl    O
methionine    O
and    O
3,4-dihydroxy    O
-    O
trans    O
-    O
cinnamate    O
(    O
caffeic    O
acid    O
)    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
adenosylhomocysteine    O
and    O
3-methoxy-4-hydroxy-trans-cinnamate    B-Alkene114713120
(    O
ferulic    O
acid    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
N    O
-    O
feruloylglycine    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
ferulate    B-Alkene114713120
and    O
glycine    O
.    O

DALT    B-Alkene114713120

Jasmone    O
is    O
produced    O
by    O
some    O
plants    O
by    O
the    O
metabolism    O
of    O
jasmonic    B-Alkene114713120
acid    I-Alkene114713120
,    O
via    O
a    O
decarboxylation    O
.    O

12-oxophytodienoic    O
acid    O
is    O
also    O
used    O
in    O
the    O
production    O
of    O
jasmonic    B-Alkene114713120
acid    I-Alkene114713120
.    O

They    O
induce    O
changes    O
in    O
gene    O
expression    O
;    O
the    O
production    O
of    O
abscisic    O
acid    O
,    O
jasmonic    B-Alkene114713120
acid    I-Alkene114713120
,    O
and    O
ethylene    O
;    O
temporary    O
decreases    O
in    O
photosynthesis    O
;    O
and    O
increases    O
in    O
respiration    O
.    O

Such    O
responses    O
include    O
systemic    O
acquired    O
resistance    O
,    O
largely    O
mediated    O
by    O
salicylic    O
acid    O
-    O
dependent    O
pathways    O
,    O
and    O
induced    O
systemic    O
resistance    O
,    O
largely    O
mediated    O
by    O
jasmonic    B-Alkene114713120
acid    I-Alkene114713120
-    O
dependent    O
pathways    O
.    O

Jasmonic    B-Alkene114713120
acid    I-Alkene114713120

β-Santalol    B-Alkene114713120
comprises    O
20    O
-    O
25%    O
.    O

DPI-3290    B-Alkene114713120

Chlorotrifluoroethylene    B-Alkene114713120
(    O
CTFE    O
)    O

Chemically    O
it    O
is    O
a    O
copolymer    O
of    O
ethylene    O
and    O
chlorotrifluoroethylene    B-Alkene114713120
.    O

His    O
industrial    O
consulting    O
work    O
included    O
efforts    O
in    O
seawater    O
desalination    O
,    O
removal    O
of    O
sulfur    O
dioxide    O
from    O
emissions    O
,    O
freeze    O
-    O
drying    O
blood    O
,    O
and    O
the    O
manufacture    O
of    O
penicillin    O
and    O
vinyl    B-Alkene114713120
acetate    I-Alkene114713120
.    O

The    O
primary    O
use    O
of    O
acetic    O
acid    O
is    O
the    O
production    O
of    O
vinyl    B-Alkene114713120
acetate    I-Alkene114713120
monomer    I-Alkene114713120
(VAM)    I-Alkene114713120
.    O

A    O
former    O
industrial    O
route    O
to    O
vinyl    B-Alkene114713120
acetate    I-Alkene114713120
involved    O
the    O
intermediate    O
ethylidene    O
diacetate    O
,    O
the    O
geminal    O
diacetate    O
obtained    O
from    O
acetaldehyde    O
and    O
acetic    O
anhydride    O
:    O

It    O
is    O
a    O
vinyl    B-Alkene114713120
acetate    I-Alkene114713120
polymer    O
that    O
is    O
partially    O
hydrolyzed    O
and    O
then    O
esterified    O
with    O
phthalic    O
acid    O
.    O

According    O
to    O
the    O
state    O
-    O
run    O
Xinhua    O
News    O
Agency    O
,    O
"    O
the    O
plant    O
mainly    O
produces    O
polyvinyl    O
acetate    O
(    O
PVA    O
)    O
,    O
which    O
is    O
used    O
in    O
adhesives    O
,    O
calcium    O
carbide    O
,    O
and    O
vinyl    B-Alkene114713120
acetate    I-Alkene114713120
monomer    I-Alkene114713120
(    O
VAM    O
)    O
,    O
which    O
is    O
used    O
in    O
paints    O
,    O
adhesives    O
and    O
coatings    O
.    O
"    O

The    O
monomer    O
,    O
vinyl    B-Alkene114713120
acetate    I-Alkene114713120
,    O
was    O
first    O
produced    O
on    O
an    O
industrial    O
scale    O
by    O
the    O
addition    O
of    O
acetic    O
acid    O
to    O
acetylene    O
with    O
a    O
mercury(I    O
)    O
salt    O
but    O
it    O
is    O
now    O
primarily    O
made    O
by    O
palladium    O
catalyzed    O
oxidative    O
addition    O
of    O
acetic    O
acid    O
to    O
ethylene    O
.    O

Polyvinyl    O
acetate    O
is    O
prepared    O
by    O
the    O
polymerization    O
of    O
vinyl    B-Alkene114713120
acetate    I-Alkene114713120
monomer    I-Alkene114713120
(    O
free    O
radical    O
vinyl    O
polymerization    O
of    O
the    O
monomer    O
vinyl    O
acetate    O
)    O
.    O

Vinyl    B-Alkene114713120
acetate    I-Alkene114713120

The    O
phenylpropenes    O
,    O
including    O
eugenol    B-Alkene114713120
,    O
chavicol    B-Alkene114713120
,    O
safrole    B-Alkene114713120
and    O
estragole    B-Alkene114713120
,    O
are    O
derived    O
from    O
the    O
monolignols    O
.    O

It    O
was    O
first    O
synthesised    O
in    O
1951    O
during    O
an    O
attempt    O
to    O
prepare    O
the    O
fulvalene    B-Alkene114713120
(    O
C10H8    O
)    O
by    O
oxidative    O
dimerization    O
of    O
cyclopentadiene    O
;    O
the    O
resultant    O
product    O
was    O
found    O
to    O
have    O
molecular    O
formula    O
C10H10Fe    O
and    O
reported    O
to    O
exhibit    O
"    O
remarkable    O
stability    O
"    O
.    O

Fulvalene    B-Alkene114713120

The    O
cyanohydrin    O
is    O
hydrolyzed    O
in    O
the    O
presence    O
of    O
sulfuric    O
acid    O
to    O
a    O
sulfate    O
ester    O
of    O
the    O
methacrylamide    B-Alkene114713120
,    O
Methanolysis    O
of    O
this    O
ester    O
gives    O
ammonium    O
bisulfate    O
and    O
MMA    O
.    O

Contemporary    O
commercial    O
products    O
for    O
the    O
topical    O
treatment    O
of    O
flea    O
infestations    O
on    O
pets    O
contain    O
pesticides    O
such    O
as    O
imidacloprid    O
,    O
permethrin    B-Alkene114713120
,    O
and    O
(    O
S)-methoprene    O
.    O

A    O
program    O
headed    O
by    O
the    O
director    O
of    O
the    O
Johns    O
Hopkins    O
graduate    O
program    O
,    O
Dr.    O
Soumyadipta    O
Acharya    O
,    O
uses    O
"    O
shorter    O
-    O
lived    O
"    O
compounds    O
that    O
can    O
"    O
comfortably    O
reside    O
in    O
[    O
the    O
]    O
skin    O
,    O
"    O
such    O
as    O
permethrin    B-Alkene114713120
,    O
in    O
its    O
soap    O
.    O

Permethrin    B-Alkene114713120

Permethrin    B-Alkene114713120
,    O
which    O
can    O
only    O
be    O
applied    O
to    O
clothing    O
,    O
is    O
much    O
more    O
effective    O
in    O
preventing    O
tick    O
bites    O
.    O

To    O
prevent    O
tick    O
bites    O
,    O
use    O
insect    O
repellent    O
containing    O
DEET    O
on    O
skin    O
or    O
clothing    O
or    O
permethrin    B-Alkene114713120
on    O
clothing    O
or    O
equipment    O
.    O

Insecticides    O
such    O
as    O
pyrethrin    O
,    O
permethrin    B-Alkene114713120
,    O
and    O
amitraz    O
are    O
dangerous    O
to    O
small    O
mammals    O
and    O
must    O
be    O
avoided    O
.    O

Products    O
containing    O
active    O
ingredients    O
such    O
as    O
permethrin    B-Alkene114713120
,    O
bifenthrin    O
,    O
deltamethrin    B-Alkene114713120
,    O
tralomethrin    O
are    O
components    O
of    O
the    O
Pyrethroid    O
insecticide    O
.    O

Treatment    O
with    O
topic    O
agents    O
such    O
as    O
permethrin    B-Alkene114713120
or    O
pyrethrin    O
with    O
piperonyl    O
butoxide    O
is    O
effective    O
.    O

Recommended    O
treatments    O
include    O
the    O
topical    O
agents    O
permethrin    B-Alkene114713120
or    O
pyrethrins    O
with    O
piperonyl    O
butoxide    O
.    O

Tiglic    B-Alkene114713120
acid    I-Alkene114713120

Based    O
on    O
a    O
proposed    O
biosynthesis    O
pathway    O
of    O
proto    O
-    O
daphniphylline    O
from    O
squalene    B-Alkene114713120
,    O
Clayton    O
Heathcock    O
and    O
co    O
-    O
workers    O
developed    O
a    O
remarkably    O
elegant    O
and    O
short    O
total    O
synthesis    O
of    O
proto    O
-    O
daphniphylline    O
from    O
simple    O
starting    O
materials    O
.    O

Heathcock    O
synthesis    O
of    O
squalene    B-Alkene114713120
-    O
derived    O
daphniphylline    O
-    O
type    O
alkaloids    O
,    O
e.g.    O
,    O
Daphniphyllum    O
,    O
via    O
tetra    O
/    O
pentacyclization    O
cascades    O

In    O
some    O
versions    O
of    O
the    O
vaccine    O
used    O
in    O
Europe    O
and    O
Canada    O
,    O
such    O
as    O
"    O
Arepanrix    O
"    O
and    O
"    O
Fluad    O
"    O
,    O
an    O
adjuvant    O
is    O
also    O
added    O
,    O
this    O
contains    O
a    O
fish    O
oil    O
called    O
squalene    B-Alkene114713120
,    O
vitamin    O
E    O
and    O
an    O
emulsifier    O
called    O
polysorbate    B-Alkene114713120
80    I-Alkene114713120
.    O

For    O
example    O
,    O
"    O
Newsweek    O
"    O
states    O
that    O
some    O
chain    O
e    O
-    O
mails    O
make    O
false    O
claims    O
about    O
squalene    B-Alkene114713120
(    O
shark    O
liver    O
oil    O
)    O
in    O
vaccines    O
.    O
"    O

Simplified    O
version    O
of    O
the    O
steroid    O
synthesis    O
pathway    O
with    O
the    O
terpenoid    O
intermediates    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
,    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
,    O
geranyl    O
pyrophosphate    O
(    O
GPP    O
)    O
,    O
and    O
squalene    B-Alkene114713120
shown    O
.    O

Steroids    O
,    O
for    O
example    O
,    O
are    O
derivatives    O
of    O
the    O
triterpene    O
squalene    B-Alkene114713120
.    O

The    O
linear    O
triterpene    O
squalene    B-Alkene114713120
,    O
the    O
major    O
constituent    O
of    O
shark    O
liver    O
oil    O
,    O
is    O
derived    O
from    O
the    O
reductive    O
coupling    O
of    O
two    O
molecules    O
of    O
farnesyl    O
pyrophosphate    O
.    O

The    O
vaccine    O
contains    O
the    O
MF59C.1    O
adjuvant    O
which    O
is    O
an    O
oil    O
-    O
in    O
-    O
water    O
emulsion    O
of    O
squalene    B-Alkene114713120
oil    O
.    O

Making    O
up    O
about    O
5%    O
of    O
the    O
total    O
fatty    O
acids    O
of    O
amaranth    O
,    O
squalene    B-Alkene114713120
is    O
extracted    O
as    O
a    O
vegetable    O
-    O
based    O
alternative    O
to    O
the    O
more    O
expensive    O
shark    O
oil    O
for    O
use    O
in    O
dietary    O
supplements    O
and    O
cosmetics    O
.    O

The    O
grease    O
is    O
a    O
particularly    O
oily    O
form    O
of    O
sebum    O
,    O
thought    O
to    O
contain    O
more    O
squalene    B-Alkene114713120
(    O
C30H50    O
)    O
than    O
the    O
secretions    O
from    O
other    O
parts    O
of    O
the    O
skin    O
.    O

It    O
is    O
a    O
water    O
-    O
in    O
-    O
oil    O
emulsion    O
and    O
consists    O
of    O
squalene    B-Alkene114713120
,    O
an    O
emulsifier    O
(    O
sorbitan    O
monooleate    O
80    O
)    O
,    O
a    O
patented    O
block    O
copolymer    O
and    O
microparticulate    O
silica    O
(    O
Stills    O
2005    O
)    O
.    O

Bevirimat    B-Alkene114713120
,    O
a    O
derivative    O
of    O
the    O
related    O
triterpenoid    O
betulinic    B-Alkene114713120
acid    I-Alkene114713120
,    O
is    O
under    O
development    O
as    O
an    O
anti    O
-    O
HIV    O
drug    O
;    O
however    O
,    O
moronic    O
acid    O
has    O
shown    O
better    O
antiviral    O
profiles    O
"    O
in    O
vitro    O
"    O
than    O
bevirimat    O
.    O

The    O
three    O
common    O
less    O
-    O
lethal    O
rounds    O
are    O
the    O
M651    B-Alkene114713120
CS    I-Alkene114713120
gas    I-Alkene114713120
,    O
the    O
M1006    O
sponge    O
grenade    O
,    O
and    O
the    O
M1029    O
Crowd    O
Dispersal    O
rounds    O
.    O

In    O
addition    O
,    O
it    O
can    O
make    O
a    O
clicking    O
sound    O
which    O
will    O
attract    O
enemies    O
,    O
and    O
also    O
emit    O
a    O
CS    B-Alkene114713120
gas    I-Alkene114713120
that    O
will    O
render    O
unconscious    O
any    O
enemies    O
in    O
the    O
immediate    O
area    O
.    O

He    O
can    O
switch    O
back    O
to    O
any    O
Sticky    O
Camera    O
that    O
has    O
not    O
been    O
destroyed    O
by    O
using    O
the    O
CS    B-Alkene114713120
gas    I-Alkene114713120
attack    O
or    O
due    O
to    O
enemy    O
fire    O
.    O

There    O
is    O
the    O
Gas    O
Grenade    O
,    O
which    O
emits    O
a    O
cloud    O
of    O
CS    B-Alkene114713120
gas    I-Alkene114713120
that    O
knocks    O
enemies    O
unconscious    O
,    O
the    O
Smoke    O
Grenade    O
,    O
which    O
provides    O
Fisher    O
with    O
a    O
cloud    O
of    O
smoke    O
to    O
hide    O
in    O
,    O
the    O
flashbang    O
,    O
which    O
will    O
temporarily    O
blind    O
and    O
deafen    O
any    O
enemy    O
near    O
it    O
,    O
and    O
the    O
Fragmentation    O
Grenade    O
,    O
which    O
will    O
kill    O
any    O
enemy    O
within    O
its    O
blast    O
radius    O
,    O
and    O
send    O
objects    O
flying    O
in    O
all    O
directions    O
.    O

Several    O
passengers    O
were    O
treated    O
for    O
the    O
inhalation    O
of    O
CS    B-Alkene114713120
gas    I-Alkene114713120
.    O

This    O
allows    O
it    O
to    O
be    O
used    O
in    O
the    O
Knoevenagel    O
condensation    O
,    O
for    O
example    O
in    O
the    O
preparation    O
of    O
CS    B-Alkene114713120
gas    I-Alkene114713120
:    O

The    O
rest    O
of    O
the    O
afternoon    O
became    O
a    O
battle    O
as    O
police    O
using    O
horses    O
and    O
personal    O
incapacitant    O
spray    O
containing    O
CS    B-Alkene114713120
gas    I-Alkene114713120
pushed    O
the    O
protesters    O
down    O
Lower    O
Thames    O
Street    O
and    O
out    O
of    O
the    O
City    O
of    O
London    O
.    O

The    O
police    O
were    O
inadequately    O
trained    O
and    O
equipped    O
for    O
such    O
circumstances    O
,    O
and    O
petrol    O
bombs    O
and    O
other    O
missiles    O
thrown    O
by    O
rioters    O
were    O
met    O
by    O
CS    B-Alkene114713120
gas    I-Alkene114713120
and    O
batons    O
from    O
the    O
police    O
,    O
with    O
innocent    O
residents    O
inevitably    O
suffering    O
.    O

It    O
arms    O
between    O
10    O
and    O
30    O
meters    O
and    O
produces    O
a    O
white    O
cloud    O
of    O
CS    B-Alkene114713120
gas    I-Alkene114713120
on    O
impact    O
.    O

Rioting    O
continued    O
until    O
14    O
August    O
,    O
and    O
in    O
that    O
time    O
1,091    O
canisters    O
,    O
each    O
containing    O
12.5    O
g    O
of    O
CS    B-Alkene114713120
gas    I-Alkene114713120
and    O
14    O
canisters    O
containing    O
50    O
g    O
,    O
were    O
released    O
by    O
the    O
RUC    O
.    O

Some    O
of    O
the    O
samples    O
of    O
"    O
yellow    O
rain    O
"    O
collected    O
from    O
Cambodia    O
in    O
1983    O
tested    O
positive    O
for    O
CS    B-Alkene114713120
,    O
which    O
the    O
United    O
States    O
had    O
used    O
during    O
the    O
Vietnam    O
War    O
.    O

Despite    O
being    O
armed    O
,    O
AFOs    O
carry    O
the    O
standard    O
issue    O
telescopic    O
or    O
rigid    O
baton    O
,    O
CS    B-Alkene114713120
/    O
PAVA    O
incapacitant    O
spray    O
,    O
and    O
Speedcuffs    O
on    O
the    O
duty    O
belt    O
.    O

A    O
Less    O
-    O
lethal    O
launcher    O
,    O
especially    O
when    O
loaded    O
with    O
CS    B-Alkene114713120
gas    I-Alkene114713120
grenades    O
.    O

In    O
the    O
1950s    O
the    O
station    O
,    O
now    O
renamed    O
the    O
Chemical    O
Defence    O
Experimental    O
Establishment    O
(    O
CDEE    O
)    O
,    O
became    O
involved    O
with    O
the    O
development    O
of    O
CS    B-Alkene114713120
,    O
a    O
riot    O
control    O
agent    O
,    O
and    O
took    O
an    O
increasing    O
role    O
in    O
trauma    O
and    O
wound    O
ballistics    O
work    O
.    O

Common    O
lachrymators    O
include    O
pepper    O
spray    O
(    O
OC    O
gas    O
)    O
,    O
PAVA    O
spray    O
(    O
nonivamide    O
)    O
,    O
CS    B-Alkene114713120
gas    I-Alkene114713120
,    O
CR    O
gas    O
,    O
CN    O
gas    O
(    O
phenacyl    O
chloride    O
)    O
,    O
bromoacetone    O
,    O
xylyl    O
bromide    O
,    O
syn    O
-    O
propanethial    O
-    O
S    O
-    O
oxide    O
(    O
from    O
onions    O
)    O
,    O
and    O
Mace    O
(    O
a    O
branded    O
mixture    O
)    O
.    O

With    O
CS    B-Alkene114713120
gas    I-Alkene114713120
,    O
symptoms    O
of    O
irritation    O
typically    O
appear    O
after    O
20–60    O
seconds    O
of    O
exposure    O
and    O
commonly    O
resolve    O
within    O
30    O
minutes    O
of    O
leaving    O
(    O
or    O
being    O
removed    O
from    O
)    O
the    O
area    O
.    O

Skin    O
exposure    O
to    O
CS    B-Alkene114713120
may    O
cause    O
chemical    O
burns    O
or    O
induce    O
allergic    O
contact    O
dermatitis    O
.    O

There    O
are    O
reports    O
that    O
water    O
may    O
increase    O
pain    O
from    O
CS    B-Alkene114713120
gas    I-Alkene114713120
,    O
but    O
the    O
balance    O
of    O
limited    O
evidence    O
currently    O
suggests    O
water    O
or    O
saline    O
are    O
the    O
best    O
options    O
.    O

Belgian    O
driver    O
Bertrand    O
Gachot    O
missed    O
his    O
home    O
Grand    O
Prix    O
due    O
to    O
being    O
imprisoned    O
in    O
Britain    O
following    O
an    O
incident    O
in    O
which    O
he    O
sprayed    O
tear    B-Alkene114713120
gas    I-Alkene114713120
at    O
a    O
London    O
taxi    O
driver    O
.    O

CS    B-Alkene114713120
gas    I-Alkene114713120

Prifinium    B-Alkene114713120
bromide    I-Alkene114713120
is    O
an    O
antimuscarinic    O
.    O

The    O
Q    O
-    O
Chem    O
facility    O
is    O
a    O
world    O
-    O
class    O
integrated    O
petrochemical    O
plant    O
capable    O
of    O
producing    O
high    O
-    O
density    O
polyethylene    O
(    O
HDPE    O
)    O
and    O
medium    O
-    O
density    O
polyethylene    O
(    O
MDPE    O
)    O
,    O
1-hexene    B-Alkene114713120
,    O
and    O
other    O
products    O
.    O

1-Hexene    B-Alkene114713120
(    O
also    O
Hex-1-ene    B-Alkene114713120
)    O
is    O
an    O
organic    O
compound    O
with    O
the    O
formula    O
C6H12    O
.    O

Hex-1-ene    B-Alkene114713120
,    O
a    O
typical    O
alpha    O
-    O
olefin    O
.    O

In    O
this    O
reaction    O
2-pentene    O
forms    O
a    O
rapid    O
(    O
a    O
matter    O
of    O
seconds    O
)    O
chemical    O
equilibrium    O
with    O
2-butene    B-Alkene114713120
and    O
3-hexene    O
.    O

In    O
addition    O
to    O
the    O
C4    O
hydrocarbon    O
isomers    O
isobutane    O
and    O
n    O
-    O
butane    O
(    O
important    O
in    O
aviation    O
fuels    O
)    O
Brattain    O
was    O
able    O
to    O
identify    O
a    O
set    O
of    O
four    O
butenes    O
,    O
1-butene    B-Alkene114713120
,    O
cis-2-butene    B-Alkene114713120
,    O
trans-2-butene    B-Alkene114713120
,    O
and    O
isobutene    O
.    O

On    O
the    O
other    O
hand    O
,    O
the    O
molecular    O
graph    O
normally    O
does    O
not    O
contain    O
any    O
information    O
about    O
the    O
three    O
-    O
dimensional    O
arrangement    O
of    O
the    O
bonds    O
,    O
and    O
therefore    O
can    O
not    O
distinguish    O
between    O
conformational    O
isomers    O
(    O
such    O
as    O
"    O
cis    O
"    O
and    O
"    O
trans    O
"    O
2-butene    B-Alkene114713120
)    O
or    O
stereoisomers    O
(    O
such    O
as    O
D-    O
and    O
L    O
-    O
glyceraldehyde    O
)    O
.    O

Geraniol    B-Alkene114713120

Isomeric    O
with    O
nerol    O
is    O
geraniol    B-Alkene114713120
,    O
wherein    O
the    O
double    O
bond    O
is    O
trans    O
.    O

Geraniol    B-Alkene114713120

Hydrolysis    O
of    O
the    O
phosphate    O
groups    O
leads    O
to    O
the    O
prototypical    O
acyclic    O
monoterpenoid    O
geraniol    B-Alkene114713120
.    O

Several    O
floral    O
scent    O
compounds    O
of    O
"    O
Monotropastrum    O
humile    O
"    O
,    O
linalool    O
,    O
α-terpineol    B-Alkene114713120
,    O
and    O
geraniol    B-Alkene114713120
,    O
have    O
been    O
demonstrated    O
to    O
be    O
bumble    O
bee    O
attractants    O
.    O

Examples    O
of    O
monoterpenes    O
and    O
monoterpenoids    O
include    O
geraniol    B-Alkene114713120
,    O
terpineol    B-Alkene114713120
(    O
present    O
in    O
lilacs    O
)    O
,    O
limonene    O
(    O
present    O
in    O
citrus    O
fruits    O
)    O
,    O
myrcene    B-Alkene114713120
(    O
present    O
in    O
hops    O
)    O
,    O
linalool    O
(    O
present    O
in    O
lavender    O
)    O
or    O
pinene    B-Alkene114713120
(    O
present    O
in    O
pine    O
trees    O
)    O
.    O

While    O
largely    O
indistinguishable    O
in    O
appearance    O
,    O
specimens    O
of    O
"    O
T.    O
vulgaris    O
"    O
may    O
be    O
assigned    O
to    O
one    O
of    O
seven    O
different    O
chemotypes    O
,    O
depending    O
on    O
whether    O
the    O
dominant    O
component    O
of    O
the    O
essential    O
oil    O
is    O
thymol    O
,    O
carvacrol    O
,    O
linalool    O
,    O
geraniol    B-Alkene114713120
,    O
sabinene    O
hydrate    O
(    O
thuyanol    O
)    O
,    O
α-terpineol    B-Alkene114713120
,    O
or    O
eucalyptol    O
.    O

Some    O
geranyl    B-Alkene114713120
can    O
be    O
found    O
in    O
"    O
P.    O
tomentosa    O
"    O
.    O

He    O
worked    O
with    O
Philippe    O
Barbier    O
on    O
terpene    O
derivatives    O
used    O
in    O
the    O
manufacture    O
of    O
perfumes    O
like    O
citral    O
,    O
rhodinal    B-Alkene114713120
and    O
geraniol    B-Alkene114713120
.    O

Chalcone    B-Alkene114713120
is    O
an    O
aromatic    O
ketone    O
and    O
an    O
enone    B-Alkene114713120
that    O
forms    O
the    O
central    O
core    O
for    O
a    O
variety    O
of    O
important    O
biological    O
compounds    O
,    O
which    O
are    O
known    O
collectively    O
as    O
chalcones    O
or    O
chalconoids    O
.    O

A    O
chemical    O
analysis    O
found    O
that    O
it    O
contains    O
rotenoids    O
,    O
isolflavones    O
,    O
flavanones    O
,    O
chalcone    B-Alkene114713120
,    O
and    O
flavones    O
,    O

Kukulkanins    O
are    O
chalcone    B-Alkene114713120
isolated    O
from    O
Mexican    O
"    O
Mimosa    O
"    O
.    O

Ethyl    B-Alkene114713120
cinnamate    I-Alkene114713120

Safrole    B-Alkene114713120

Safrole    B-Alkene114713120
also    O
known    O
as    O
4-Allyl-1,2-methylenedioxybenzene    O

Pepper    O
contains    O
phytochemicals    O
,    O
including    O
amides    O
,    O
piperidines    O
,    O
pyrrolidines    O
and    O
trace    O
amounts    O
of    O
safrole    B-Alkene114713120
,    O
which    O
may    O
be    O
carcinogenic    O
in    O
laboratory    O
rodents    O
.    O

The    O
essential    O
oils    O
within    O
the    O
leaf    O
are    O
rich    O
in    O
safrole    B-Alkene114713120
,    O
a    O
substance    O
also    O
found    O
in    O
sassafras    O
,    O
which    O
has    O
been    O
shown    O
to    O
be    O
carcinogenic    O
in    O
animals    O
.    O

It    O
may    O
contain    O
about    O
2%    O
volatile    O
oils    O
,    O
such    O
as    O
ligustilide    O
,    O
n    O
-    O
butylidenephthalide    O
,    O
folic    O
acid    O
,    O
linoleic    O
acid    O
,    O
safrole    B-Alkene114713120
,    O
and    O
isosafrole    B-Alkene114713120
.    O

safrole    B-Alkene114713120

safrole    B-Alkene114713120
,    O
isosafrole    B-Alkene114713120
and    O
3,4-methylenedioxyphenylpropan-2-one    O

The    O
phenylpropenes    O
,    O
including    O
eugenol    B-Alkene114713120
,    O
chavicol    B-Alkene114713120
,    O
safrole    B-Alkene114713120
and    O
estragole    B-Alkene114713120
,    O
are    O
derived    O
from    O
the    O
monolignols    O
.    O

Drugs    O
of    O
the    O
5-nitro    O
variety    O
include    O
metronidazole    O
,    O
tinidazole    O
,    O
nimorazole    O
,    O
dimetridazole    O
,    O
6-Amino    O
PA824    O
,    O
ornidazole    O
,    O
megazol    O
,    O
and    O
azanidazole    B-Alkene114713120
.    O

Aprobarbital    B-Alkene114713120

Apiol    B-Alkene114713120

Among    O
its    O
main    O
components    O
are    O
muskatone    O
,    O
alpha-Pinene    B-Alkene114713120
,    O
beta-Pinene    B-Alkene114713120
,    O
caryophyllene    B-Alkene114713120
oxide    O
,    O
trans    O
-    O
pinocarveol    O
,    O
myrtenal    O
,    O
myrtenol    O
,    O
ledol    O
,    O
cyperotundone    O
,    O
and    O
alpha    O
-    O
cyperone    O
,    O
though    O
the    O
oil    O
is    O
very    O
complex    O
and    O
no    O
single    O
element    O
plays    O
a    O
dominant    O
role    O
over    O
the    O
others    O
.    O

"    O
Melaleuca    O
ericifolia    O
"    O
leaves    O
have    O
been    O
analysed    O
for    O
their    O
oil    O
content    O
and    O
found    O
to    O
contain    O
mostly    O
1,8-cineole    O
(    O
Eucalyptol    O
)    O
but    O
also    O
significant    O
amounts    O
of    O
α-pinene    B-Alkene114713120
.    O

(    O
α-pinene    B-Alkene114713120

This    O
reagent    O
is    O
generated    O
by    O
treating    O
9-BBN    O
with    O
α-pinene    B-Alkene114713120
.    O

The    O
plant    O
contains    O
an    O
essential    O
oil    O
(    O
0.5%    O
)    O
which    O
consists    O
of    O
monoterpenoids    O
and    O
sesquiterpenoids    O
:    O
α-pinene    B-Alkene114713120
,    O
β-pinene    B-Alkene114713120
,    O
1,4-cineol    O
,    O
fenchone    O
,    O
α-humulene    B-Alkene114713120
,    O
β-caryophyllene    B-Alkene114713120
,    O
trans-β-bergamotene    O
.    O

Myrtol    O
standardized    O
is    O
a    O
phytotherapeutic    O
extract    O
(    O
distillate    O
)    O
consisting    O
mainly    O
of    O
three    O
monoterpenes    O
:    O
(+)-α-pinene    B-Alkene114713120
,    O
d    O
-    O
limonene    O
and    O
1,8-cineole    O
(    O
as    O
known    O
as    O
"    O
Eucalyptol    O
"    O
,    O
but    O
not    O
be    O
confused    O
with    O
Eucalyptus    O
oil    O
)    O
.    O

A    O
forest    O
bathing    O
trip    O
involves    O
visiting    O
a    O
forest    O
for    O
relaxation    O
and    O
recreation    O
while    O
breathing    O
in    O
volatile    O
substances    O
,    O
called    O
phytoncides    O
(    O
wood    O
essential    O
oils    O
)    O
,    O
which    O
are    O
antimicrobial    O
volatile    O
organic    O
compounds    O
derived    O
from    O
trees    O
,    O
such    O
as    O
α-Pinene    B-Alkene114713120
and    O
limonene    O
.    O

Dimedone    O
is    O
prepared    O
from    O
mesityl    B-Alkene114713120
oxide    I-Alkene114713120
and    O
diethyl    O
malonate    O
.    O

It    O
undergoes    O
dehydration    O
to    O
give    O
the    O
α,β-unsaturated    O
ketone    O
,    O
mesityl    B-Alkene114713120
oxide    I-Alkene114713120
:    O
Hydrogenation    O
of    O
mesityl    O
oxide    O
gives    O
the    O
industrial    O
solvent    O
,    O
methyl    O
isobutyl    O
ketone    O
(    O
"    O
MIBK    O
"    O
)    O
.    O

Examples    O
of    O
cross    O
-    O
conjugation    O
can    O
be    O
found    O
in    O
molecules    O
such    O
as    O
benzophenone    O
,    O
divinylketones    O
,    O
"    O
p    O
"-    O
quinones    O
,    O
dendralenes    B-Alkene114713120
,    O
radialene    B-Alkene114713120
,    O
fullerene    O
,    O
and    O
Indigo    B-Alkene114713120
dye    I-Alkene114713120
.    O

Additionally    O
,    O
the    O
bioactive    O
triterpene    O
betulinic    B-Alkene114713120
acid    I-Alkene114713120
is    O
completely    O
absent    O
in    O
cultivated    O
Chaga    O
.    O

Regiolone    O
has    O
been    O
isolated    O
with    O
juglone    O
,    O
betulinic    B-Alkene114713120
acid    I-Alkene114713120
and    O
sitosterol    B-Alkene114713120
from    O
the    O
stem    O
bark    O
of    O
"    O
J.    O
regia    O
"    O
.    O

Bevirimat    B-Alkene114713120
,    O
a    O
derivative    O
of    O
the    O
related    O
triterpenoid    O
betulinic    B-Alkene114713120
acid    I-Alkene114713120
,    O
is    O
under    O
development    O
as    O
an    O
anti    O
-    O
HIV    O
drug    O
;    O
however    O
,    O
moronic    O
acid    O
has    O
shown    O
better    O
antiviral    O
profiles    O
"    O
in    O
vitro    O
"    O
than    O
bevirimat    O
.    O

Istradefylline    B-Alkene114713120
(    O
KW-6002    O
)    O

With    O
secondary    O
amines    O
and    O
not    O
primary    O
amines    O
the    O
Zincke    O
reaction    O
takes    O
on    O
a    O
different    O
shape    O
forming    O
so    O
-    O
called    O
Zincke    B-Alkene114713120
aldehyde    I-Alkene114713120
in    O
which    O
the    O
pyridine    O
ring    O
is    O
ring    O
-    O
opened    O
with    O
the    O
terminal    O
iminium    O
group    O
hydrolyzed    O
to    O
an    O
aldehyde    O
:    O

Glutaconic    B-Alkene114713120
acid    I-Alkene114713120

Out    O
of    O
the    O
cephalosporins    O
,    O
cefoxitin    O
and    O
cefotetan    B-Alkene114713120
can    O
be    O
used    O
to    O
cover    O
gram    O
positive    O
bacteria    O
,    O
gram    O
negative    O
bacteria    O
,    O
and    O
anaerobic    O
bacteria    O
.    O

The    O
risk    O
of    O
bleeding    O
increases    O
with    O
the    O
concurrent    O
medications    O
clopidogrel    O
,    O
cefoperazone    O
,    O
valproic    O
acid    O
,    O
cefotetan    B-Alkene114713120
,    O
eptifibatide    O
,    O
tirofiban    O
,    O
and    O
copidine    O
.    O

Cefotetan    B-Alkene114713120

The    O
"    O
mono"-    O
and    O
"    O
bis    O
"-    O
quaternary    O
azasteroid    O
series    O
of    O
compounds    O
to    O
which    O
candocuronium    O
belongs    O
are    O
based    O
on    O
the    O
same    O
principle    O
that    O
led    O
to    O
aminosteroids    O
such    O
as    O
pancuronium    O
,    O
vecuronium    O
and    O
rocuronium    B-Alkene114713120
:    O
use    O
of    O
the    O
steroid    O
skeleton    O
to    O
provide    O
a    O
somewhat    O
rigid    O
distance    O
between    O
the    O
two    O
quaternary    O
ammonium    O
centers    O
,    O
with    O
appendages    O
incorporating    O
fragments    O
of    O
choline    O
or    O
acetylcholine    O
.    O

The    O
site    O
has    O
a    O
long    O
history    O
of    O
research    O
in    O
the    O
area    O
of    O
neuromuscular    O
blockers    O
,    O
which    O
are    O
commonly    O
used    O
during    O
surgery    O
,    O
and    O
was    O
responsible    O
for    O
the    O
identification    O
of    O
rocuronium    B-Alkene114713120
as    O
well    O
as    O
a    O
number    O
of    O
other    O
drugs    O
.    O

Rocuronium    B-Alkene114713120

Commonly    O
used    O
neuromuscular    O
blocking    O
agents    O
used    O
include    O
succinylcholine    O
and    O
rocuronium    B-Alkene114713120
.    O

Vinylacetylene    B-Alkene114713120
is    O
the    O
organic    O
compound    O
with    O
the    O
formula    O
C4H4    O
.    O

Its    O
most    O
singular    O
hazard    O
is    O
associated    O
with    O
its    O
intrinsic    O
instability    O
,    O
especially    O
when    O
it    O
is    O
pressurized    O
:    O
under    O
certain    O
conditions    O
acetylene    O
can    O
react    O
in    O
an    O
exothermic    O
addition    O
-    O
type    O
reaction    O
to    O
form    O
a    O
number    O
of    O
products    O
,    O
typically    O
benzene    O
and/or    O
vinylacetylene    B-Alkene114713120
,    O
possibly    O
in    O
addition    O
to    O
carbon    O
and    O
hydrogen    O
.    O

Ziziphin    O
reduces    O
perceived    O
sweetness    O
of    O
most    O
of    O
the    O
carbohydrates    O
(    O
e.g.    O
glucose    O
,    O
fructose    O
)    O
,    O
bulk    O
sweeteners    O
,    O
intense    O
sweeteners    O
(    O
natural    O
:    O
steviol    B-Alkene114713120
glycoside    I-Alkene114713120
–    O
artificial    O
:    O
sodium    O
saccharin    O
and    O
aspartame    O
)    O
and    O
sweet    O
amino    O
acids    O
(    O
e.g.    O
glycine    O
)    O
.    O

Trop50    O
,    O
introduced    O
by    O
Tropicana    O
in    O
2009    O
,    O
is    O
orange    O
juice    O
with    O
50    O
percent    O
less    O
sugar    O
and    O
calories    O
,    O
and    O
no    O
artificial    O
sweeteners    O
(    O
Note    O
:    O
Has    O
Reb    B-Alkene114713120
A    I-Alkene114713120
or    O
PureVia    O
which    O
is    O
a    O
form    O
of    O
the    O
plant    O
Stevia    O
–    O
but    O
"    O
is    O
"    O
chemically    O
altered    O
and    O
changed    O
.    O
)    O
Trop50    O
is    O
available    O
in    O
several    O
varieties    O
including    O
Farmstand    O
Apple    O
,    O
Pomegranate    O
Blueberry    O
,    O
Pineapple    O
Mango    O
,    O
Orange    O
,    O
Lemonade    O
and    O
Raspberry    O
Lemonade    O
.    O

At    O
least    O
18    O
Microbial    O
VOCs    O
(    O
MVOCs    O
)    O
have    O
been    O
characterised    O
including    O
1-octen-3-ol    B-Alkene114713120
,    O
3-methylfuran    O
,    O
2-pentanol    O
,    O
2-hexanone    O
,    O
2-heptanone    O
,    O
3-octanone    O
,    O
3-octanol    O
,    O
2-octen-1-ol    O
,    O
1-octene    B-Alkene114713120
,    O
2-pentanone    O
,    O
2-nonanone    O
,    O
borneol    O
,    O
geosmin    O
,    O
1-butanol    O
,    O
3-methyl-1-butanol    O
,    O
3-methyl-2-butanol    O
,    O
and    O
thujopsene    O
.    O

The    O
simplest    O
isomer    O
is    O
1-octene    B-Alkene114713120
,    O
an    O
alpha-olefin    B-Alkene114713120
used    O
primarily    O
as    O
a    O
co    O
-    O
monomer    O
in    O
production    O
of    O
polyethylene    O
via    O
the    O
solution    O
polymerization    O
process    O
.    O

Diphenylhexatriene    B-Alkene114713120
,    O
a    O
fluorescent    O
hydrocarbon    O
used    O
in    O
the    O
study    O
of    O
cell    O
membranes    O
.    O

Naloxonazine    B-Alkene114713120

Alinidine    B-Alkene114713120
(    O
ST567    B-Alkene114713120
)    O
is    O
a    O
negative    O
chronotrope    O
that    O
was    O
developed    O
in    O
the    O
1970s    O
and    O
1980s    O
.    O

enilconazole    B-Alkene114713120
(    O
INN    O
)    O

The    O
fungicide    O
enilconazole    B-Alkene114713120
(    O
commonly    O
known    O
as    O
Imazalil    O
)    O
is    O
a    O
known    O
carcinogen    O
widely    O
used    O
to    O
grow    O
citrus    O
crops    O
.    O

Probiotics    O
have    O
been    O
hypothesized    O
to    O
have    O
therapeutic    O
effects    O
for    O
those    O
affected    O
by    O
acne    O
due    O
to    O
their    O
ability    O
to    O
decrease    O
skin    O
inflammation    O
and    O
improve    O
skin    O
moisture    O
by    O
increasing    O
the    O
skin    O
's    O
ceramide    B-Alkene114713120
content    O
.    O

These    O
include    O
several    O
homologs    O
of    O
oxysterol    O
binding    O
protein    O
(    O
OSBP    O
,    O
both    O
in    O
humans    O
and    O
in    O
baker    O
's    O
yeast    O
,    O
as    O
well    O
as    O
ceramide    B-Alkene114713120
transfer    O
protein    O
(    O
CERT    O
)    O
-    O
previously    O
known    O
as    O
Goodpasture    O
's    O
antigen    O
binding    O
protein    O
(    O
GPBP    O
)    O
or    O
Collagen    O
type    O
IV    O
alpha-3-binding    O
protein    O
(    O
COL4A3BP    O
)    O
,    O
and    O
Nir2/RdgB.    O
The    O
significance    O
of    O
this    O
was    O
enhanced    O
by    O
the    O
linked    O
finding    O
in    O
a    O
proteomics    O
study    O
published    O
in    O
Nature    O
(    O
journal    O
)    O
,    O
where    O
all    O
three    O
of    O
proteins    O
in    O
baker    O
's    O
yeast    O
with    O
FFAT    O
motifs    O
(    O
Osh1/Swh1    O
,    O
Osh2    O
and    O
Opi1    O
)    O
were    O
in    O
protein    O
complexes    O
that    O
contain    O
Scs2    O
,    O
the    O
baker    O
's    O
yeast    O
homolog    O
of    O
VAPA    O
and    O
VAPB    O
.    O

CerS4    O
synthesizes    O
ceramides    B-Alkene114713120
containing    O
C18    O
-    O
22    O
fatty    O
acids    O
in    O
a    O
fumonisin    O
B1-independent    O
manner    O
.    O

CerS5    O
robustly    O
synthesizes    O
ceramide    B-Alkene114713120
,    O
which    O
is    O
often    O
considered    O
to    O
be    O
an    O
important    O
pro    O
-    O
apoptotic    O
ceramide    O
.    O

Instead    O
,    O
IMTG    O
metabolites    O
,    O
such    O
as    O
diacylglycerol    O
and    O
ceramide    B-Alkene114713120
are    O
responsible    O
for    O
the    O
insulin    O
resistance    O
.    O

A    O
ganglioside    O
is    O
a    O
molecule    O
composed    O
of    O
a    O
glycosphingolipid    O
(    O
ceramide    B-Alkene114713120
and    O
oligosaccharide    O
)    O
with    O
one    O
or    O
more    O
sialic    O
acids    O
(    O
e.g.    O
n    O
-    O
acetylneuraminic    O
acid    O
,    O
NANA    O
)    O
linked    O
on    O
the    O
sugar    O
chain    O
.    O

Based    O
on    O
the    O
research    O
of    O
Peter    O
M.    O
Elias    O
it    O
is    O
made    O
up    O
of    O
ceramide    B-Alkene114713120
,    O
free    O
fatty    O
acids    O
and    O
cholesterol    O
,    O
and    O
is    O
designed    O
to    O
treat    O
atopic    O
dermatitis    O
,    O
a    O
type    O
of    O
eczema    O
.    O

The    O
ceramide    B-Alkene114713120
-    O
dominant    O
,    O
physiological    O
-    O
lipid    O
based    O
formulation    O
could    O
represent    O
an    O
effective    O
stand    O
-    O
alone    O
or    O
ancillary    O
therapy    O
for    O
many    O
pediatric    O
patients    O
with    O
atopic    O
dermatitis    O
.    O

The    O
stratum    O
corneum    O
is    O
primarily    O
composed    O
of    O
lipophilic    O
cholesterol    O
,    O
cholesterol    O
esters    O
and    O
ceramide    B-Alkene114713120
.    O

It    O
is    O
unclear    O
if    O
moisturizers    O
that    O
contain    O
ceramide    B-Alkene114713120
are    O
more    O
or    O
less    O
effective    O
than    O
others    O
.    O

For    O
example    O
glycosphingolipids    O
become    O
ceramides    B-Alkene114713120
and    O
phospholipids    O
become    O
free    O
fatty    O
acids    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
ceramide    B-Alkene114713120
and    O
phosphatidylcholine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
sphingomyelin    O
and    O
1,2-diacyl    O
-    O
sn    O
-    O
glycerol    O
.    O

Sphingosine    O
(    O
e.g.    O
sphingomyelin    O
and    O
ceramide    B-Alkene114713120
)    O
.    O

Entecavir    B-Alkene114713120

Entecavir    B-Alkene114713120
,    O
also    O
called    O
ETV    O
,    O
is    O
a    O
guanosine    O
analog    O
used    O
for    O
hepatitis    O
B    O
under    O
the    O
trade    O
name    O
Baraclude    O
.    O

Guanosine    O
analogues    O
:    O
abacavir    O
(    O
ABC    O
)    O
and    O
entecavir    B-Alkene114713120
(    O
ETV    O
)    O

The    O
second    O
-    O
generation    O
H1-antihistamine    O
,    O
rupatadine    B-Alkene114713120
,    O
was    O
found    O
to    O
significantly    O
reduce    O
the    O
development    O
of    O
chronic    O
cold    O
urticaria    O
symptom    O
without    O
an    O
increase    O
in    O
adverse    O
effects    O
using    O
20    O
and    O
40    O
mg    O
.    O

("Z")-4-Amino-2-butenoic    B-Alkene114713120
acid    I-Alkene114713120

Chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
–    O
echinacea    O
,    O
strawberries    O
,    O
pineapple    O
,    O
coffee    O
,    O
sunflower    O
,    O
blueberries    O

"    O
U.    O
guianensis    O
"    O
contains    O
many    O
phytochemicals    O
(    O
(    O
-)-epicatechin    O
,    O
alkaloid    O
,    O
beta    O
-    O
Sitosterol    B-Alkene114713120
,    O
campesterol    O
,    O
campherol    O
,    O
catechol    O
,    O
catechutannic    O
acid    O
,    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
ellagic    O
acid    O
,    O
gallic    O
acid    O
,    O
hyperin    O
,    O
oleanolic    B-Alkene114713120
acid    I-Alkene114713120
,    O
rutin    O
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
)    O
and    O
proanthocyanidin    O
B1    O
and    O
proanthocyanidin    O
B2    O
,    O
B    O
type    O
proanthocyanidins    O
,    O
in    O
the    O
root    O
.    O

Apple    O
juice    O
has    O
a    O
significant    O
concentration    O
of    O
natural    O
phenols    O
of    O
low    O
molecular    O
weight    O
(    O
including    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
flavan-3-ols    O
,    O
and    O
flavonols    O
)    O
and    O
procyanidins    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
chlorogenate    B-Alkene114713120
and    O
glucarate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
quinate    O
and    O
2-O    O
-    O
caffeoylglucarate    O
.    O

Phenolics    O
found    O
in    O
flowering    O
heads    O
of    O
"    O
Scorzoneroides    O
"    O
taxa    O
include    O
luteolin    O
type    O
flavonoids    O
and    O
caffeoyl    O
quinic    O
acid    O
derivatives    O
such    O
as    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
and    O
3,5-dicaffeoylquinic    O
acid    O
.    O

Phenolics    O
found    O
in    O
"    O
Crepis    O
"    O
include    O
luteolin    O
-    O
type    O
flavonoids    O
and    O
caffeoyl    O
quinic    O
acid    O
derivatives    O
such    O
as    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
and    O
3,5-dicaffeoylquinic    O
acid    O
.    O

Some    O
investigators    O
report    O
slimming    O
actions    O
induced    O
by    O
chlorogenic    B-Alkene114713120
acid    I-Alkene114713120
from    O
green    O
coffee    O
,    O
but    O
further    O
investigations    O
need    O
to    O
be    O
performed    O
.    O

In    O
plants    O
,    O
the    O
plant    O
hormone    O
Jasmonate    B-Alkene114713120
allows    O
binding    O
between    O
SCF    O
-    O
COI1    O
to    O
the    O
JAZ    O
transcription    O
factor    O
.    O

One    O
of    O
his    O
academic    O
achievements    O
is    O
the    O
discovery    O
of    O
a    O
new    O
jasmonate    B-Alkene114713120
which    O
enhances    O
resistance    O
against    O
external    O
stress    O
of    O
the    O
crop    O
.    O

Choi    O
researched    O
jasmonate    B-Alkene114713120
,    O
which    O
are    O
believed    O
to    O
participate    O
in    O
signal    O
transduction    O
processes    O
between    O
external    O
stresses    O
,    O
such    O
as    O
wounding    O
,    O
pathogenic    O
attack    O
,    O
or    O
cell    O
response    O
by    O
activating    O
the    O
defense    O
genes    O
.    O

ICI-190,622    B-Alkene114713120

maleonitriledithiolate    B-Alkene114713120
,    O
commonly    O
called    O
MNT    O
-    O
an    O
organosulfur    O
anion    O
and    O
ligand    O
commonly    O
used    O
in    O
coordination    O
chemistry    O

This    O
reaction    O
type    O
is    O
often    O
used    O
with    O
ketones    O
leading    O
to    O
enone    B-Alkene114713120
.    O

Enone    B-Alkene114713120

Alkylations    O
are    O
not    O
limited    O
to    O
alkyl    O
halides    O
:    O
Friedel    O
–    O
Crafts    O
reactions    O
are    O
possible    O
with    O
any    O
carbocationic    O
intermediate    O
such    O
as    O
those    O
derived    O
from    O
alkenes    O
and    O
a    O
protic    O
acid    O
,    O
Lewis    O
acid    O
,    O
enone    B-Alkene114713120
,    O
and    O
epoxides    O
.    O

In    O
the    O
reaction    O
depicted    O
below    O
,    O
the    O
Gilman    O
reagent    O
is    O
a    O
methylating    O
reagent    O
reacting    O
with    O
an    O
alkyne    O
in    O
a    O
conjugate    O
addition    O
,    O
and    O
the    O
negative    O
charge    O
is    O
trapped    O
in    O
a    O
nucleophilic    O
acyl    O
substitution    O
with    O
the    O
ester    O
group    O
forming    O
a    O
cyclic    O
enone    B-Alkene114713120
.    O

Finally    O
the    O
C15    O
hydroxyl    O
group    O
was    O
introduced    O
by    O
oxidation    O
at    O
the    O
allyl    O
position    O
with    O
in    O
two    O
steps    O
PPC    O
and    O
sodium    O
acetate    O
(    O
to    O
the    O
enone    B-Alkene114713120
)    O
and    O
with    O
K    O
-    O
selectride    O
to    O
alcohol    O
43    O
which    O
was    O
protected    O
as    O
a    O
TES    O
ether    O
in    O
44    O
.    O

The    O
Lindlar    O
catalyst    O
then    O
reduced    O
the    O
alkyne    O
to    O
the    O
alkene    O
in    O
1.4    O
and    O
Swern    O
oxidation    O
converted    O
the    O
alcohol    O
group    O
to    O
the    O
enone    B-Alkene114713120
group    O
in    O
1.5    O
.    O

This    O
work    O
foreshadowed    O
extensive    O
studies    O
on    O
the    O
conjugate    O
additions    O
to    O
enone    B-Alkene114713120
with    O
organocuprates    O
.    O

The    O
involvement    O
of    O
the    O
otherwise    O
rare    O
Cu(III    O
)    O
oxidation    O
state    O
has    O
been    O
demonstrated    O
in    O
the    O
conjugate    O
addition    O
of    O
the    O
Gilman    O
reagent    O
to    O
an    O
enone    B-Alkene114713120
:    O
In    O
a    O
so    O
-    O
called    O
rapid    O
-    O
injection    O
NMR    O
experiment    O
at    O
-100    O
°C    O
,    O
the    O
Gilman    O
reagent    O
Me2CuLi    O
(    O
stabilized    O
by    O
lithium    O
iodide    O
)    O
was    O
introduced    O
to    O
cyclohexenone    O
(    O
1    O
)    O
enabling    O
the    O
detection    O
of    O
the    O
copper    O
—    O
alkene    O
pi    O
complex    O
2    O
.    O

dialkylamino)-vinyl    O
ketones    O
reacted    O
with    O
Grignard    O
reagents    O
in    O
a    O
1,4-addition    O
to    O
give    O
α,β-unsaturated    B-Alkene114713120
ketones    I-Alkene114713120
,    O
α,β-unsaturated    O
aldehydes    O
and    O
α,β-unsaturated    O
esters    O
as    O
well    O
as    O
poly    O
-    O
unsaturated    O
ketones    O
and    O
aldehydes    O
after    O
hydrolysis    O
of    O
the    O
reaction    O
intermediate    O
and    O
elimination    O
of    O
a    O
dialkylated    O
amine    O
.    O

Other    O
bicyclic    O
monoterpenes    O
include    O
carene    B-Alkene114713120
,    O
sabinene    B-Alkene114713120
,    O
camphene    B-Alkene114713120
,    O
and    O
thujene    B-Alkene114713120
.    O

β-Terpinene    O
has    O
no    O
known    O
natural    O
source    O
but    O
has    O
been    O
prepared    O
from    O
sabinene    B-Alkene114713120
.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    B-Alkene114713120
50%    O
,    O
thujene    B-Alkene114713120
,    O
and    O
carene    B-Alkene114713120
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
,    O
α-    O
and    O
β-cubebene    O
,    O
cadinene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
1,8-cineole    O
and    O
the    O
alcohol    O
cubebol    O
.    O

Other    O
bicyclic    O
monoterpenes    O
include    O
carene    B-Alkene114713120
,    O
sabinene    B-Alkene114713120
,    O
camphene    B-Alkene114713120
,    O
and    O
thujene    B-Alkene114713120
.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    B-Alkene114713120
50%    O
,    O
thujene    B-Alkene114713120
,    O
and    O
carene    B-Alkene114713120
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
,    O
α-    O
and    O
β-cubebene    O
,    O
cadinene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
1,8-cineole    O
and    O
the    O
alcohol    O
cubebol    O
.    O

Alprenoxime    B-Alkene114713120
is    O
a    O
beta    O
blocker    O
.    O

Nitropentadecene    B-Alkene114713120
is    O
a    O
defense    O
compound    O
found    O
in    O
termites    O
.    O

(    O
β-pinene    B-Alkene114713120

Monoterpenes    O
(    O
~    O
5%    O
)    O
:    O
β-pinene    B-Alkene114713120
,    O
myrcene    B-Alkene114713120
,    O
phellandrene    B-Alkene114713120
,    O
"    O
cis    O
"-    O
ocimene    B-Alkene114713120
,    O
terpinolene    B-Alkene114713120
,    O
and    O
terpineol    B-Alkene114713120
.    O

The    O
plant    O
contains    O
an    O
essential    O
oil    O
(    O
0.5%    O
)    O
which    O
consists    O
of    O
monoterpenoids    O
and    O
sesquiterpenoids    O
:    O
α-pinene    B-Alkene114713120
,    O
β-pinene    B-Alkene114713120
,    O
1,4-cineol    O
,    O
fenchone    O
,    O
α-humulene    B-Alkene114713120
,    O
β-caryophyllene    B-Alkene114713120
,    O
trans-β-bergamotene    O
.    O

Nerol    O
can    O
be    O
synthesized    O
by    O
pyrolysis    O
of    O
beta-pinene    B-Alkene114713120
,    O
which    O
affords    O
myrcene    B-Alkene114713120
.    O

Maleic    O
acid    O
esters    O
are    O
also    O
called    O
maleates    O
,    O
for    O
instance    O
dimethyl    B-Alkene114713120
maleate    I-Alkene114713120
.    O

Mitragynine    B-Alkene114713120

Mitragynine    B-Alkene114713120

GABA    O
reuptake    O
inhibitors    O
:    O
deramciclane    O
,    O
hyperforin    O
,    O
tiagabine    B-Alkene114713120
.    O

In    O
contrast    O
to    O
CI-966    O
,    O
the    O
marketed    O
selective    O
GAT-1    O
blocker    O
(    O
and    O
analogue    O
of    O
CI-966    O
)    O
tiagabine    B-Alkene114713120
has    O
been    O
found    O
at    O
the    O
dosages    O
in    O
which    O
it    O
has    O
been    O
studied    O
and    O
used    O
to    O
have    O
far    O
lower    O
although    O
non    O
-    O
absent    O
potential    O
for    O
the    O
same    O
adverse    O
effects    O
of    O
the    O
former    O
,    O
including    O
psychotic    O
reactions    O
.    O

Newer    O
AEDs    O
,    O
including    O
lacosamide    O
,    O
vigabatrin    B-Alkene114713120
,    O
felbamate    O
,    O
gabapentin    O
,    O
tiagabine    B-Alkene114713120
,    O
and    O
rufinamide    O
have    O
been    O
found    O
to    O
be    O
more    O
tolerable    O
and    O
safer    O
than    O
older    O
drugs    O
such    O
as    O
carbamazepine    O
,    O
phenytoin    O
,    O
and    O
valproate    O
.    O

Probably    O
the    O
most    O
important    O
chemical    O
compound    O
within    O
hops    O
are    O
the    O
alpha    O
acids    O
or    O
humulones.    B-Alkene114713120

Humulone    B-Alkene114713120
(    O
α-lupulic    B-Alkene114713120
acid    I-Alkene114713120
)    O
,    O
a    O
vinylogous    O
type    O
of    O
organic    O
acid    O
,    O
is    O
a    O
bitter    O
-    O
tasting    O
chemical    O
compound    O
found    O
in    O
the    O
resin    O
of    O
mature    O
hops    O
(    O
"    O
Humulus    O
lupulus    O
"    O
)    O
.    O

2-Acrylamido-2-methylpropane    B-Alkene114713120
sulfonic    I-Alkene114713120
acid    I-Alkene114713120
,    O
an    O
acidic    O
monomer    O

Valtrex    O
is    O
offered    O
in    O
250    O
mg    O
,    O
500    O
mg    O
,    O
and    O
1    O
gram    O
tablets    O
,    O
the    O
active    O
ingredient    O
being    O
valacyclovir    O
hydrochloride    O
,    O
with    O
the    O
inactive    O
ingredients    O
carnauba    O
wax    O
,    O
colloidal    O
silicon    O
dioxide    O
,    O
crospovidone    O
,    O
FD&C    O
Blue    O
No    O
.    O
2    O
Lake    O
,    O
hypromellose    O
,    O
magnesium    O
stearate    O
,    O
microcrystalline    O
cellulose    O
,    O
polyethylene    O
glycol    O
,    O
polysorbate    B-Alkene114713120
80    I-Alkene114713120
,    O
povidone    O
,    O
and    O
titanium    O
dioxide    O
.    O

It    O
hydrolyses    O
casein    O
and    O
gelatin    O
but    O
not    O
Tween    B-Alkene114713120
80    I-Alkene114713120
,    O
starch    O
,    O
lecithin    O
,    O
aesculin    O
or    O
tyrosine    O
.    O

In    O
some    O
versions    O
of    O
the    O
vaccine    O
used    O
in    O
Europe    O
and    O
Canada    O
,    O
such    O
as    O
"    O
Arepanrix    O
"    O
and    O
"    O
Fluad    O
"    O
,    O
an    O
adjuvant    O
is    O
also    O
added    O
,    O
this    O
contains    O
a    O
fish    O
oil    O
called    O
squalene    B-Alkene114713120
,    O
vitamin    O
E    O
and    O
an    O
emulsifier    O
called    O
polysorbate    B-Alkene114713120
80    I-Alkene114713120
.    O

Examples    O
synthesized    O
on    O
an    O
industrial    O
scale    O
include    O
octyl    O
phenol    O
ethoxylate    O
,    O
polysorbate    B-Alkene114713120
80    I-Alkene114713120
and    O
poloxamers    O
.    O

Other    O
ketolides    O
in    O
development    O
include    O
cethromycin    B-Alkene114713120
and    O
solithromycin    O
.    O

The    O
authors    O
proposed    O
that    O
chronic    O
exposure    O
to    O
alpha    O
-    O
mangostin    B-Alkene114713120
,    O
a    O
xanthone    O
,    O
could    O
be    O
toxic    O
to    O
mitochondrial    O
function    O
,    O
leading    O
to    O
impairment    O
of    O
cellular    O
respiration    O
and    O
production    O
of    O
lactic    O
acidosis    O
.    O

This    O
demethylation    O
step    O
is    O
regarded    O
as    O
the    O
initial    O
checkpoint    O
in    O
the    O
transformation    O
of    O
lanosterol    B-Alkene114713120
to    O
other    O
sterols    O
that    O
are    O
widely    O
used    O
within    O
the    O
cell    O
(    O
Lepesheva    O
et    O
al    O
.    O
)    O
.    O

In    O
fungi    O
,    O
CYP51    O
catalyzes    O
the    O
demethylation    O
of    O
lanosterol    B-Alkene114713120
to    O
create    O
an    O
important    O
precursor    O
that    O
is    O
eventually    O
converted    O
into    O
ergosterol    O
(    O
Lepesheva    O
et    O
al    O
.    O
)    O
.    O

The    O
enzyme    O
-    O
catalyzed    O
demethylation    O
of    O
lanosterol    B-Alkene114713120
is    O
believed    O
to    O
occur    O
in    O
three    O
steps    O
,    O
each    O
of    O
which    O
requires    O
one    O
molecule    O
of    O
diatomic    O
oxygen    O
and    O
one    O
molecule    O
of    O
NADPH    O
(    O
or    O
some    O
other    O
reducing    O
equivalent    O
)    O
.    O

Lanosterol    O
14α-demethylase    O
(    O
CYP51A1    O
)    O
inhibitors    O
such    O
as    O
clotrimazole    O
,    O
fluconazole    O
,    O
itraconazole    O
,    O
ketoconazole    O
,    O
miconazole    O
,    O
and    O
voriconazole    O
prevent    O
the    O
production    O
of    O
ergosterol    O
from    O
lanosterol    B-Alkene114713120
.    O

Through    O
several    O
more    O
biosynthetic    O
steps    O
,    O
squalene    O
is    O
transformed    O
into    O
lanosterol    B-Alkene114713120
,    O
a    O
direct    O
precursor    O
for    O
cholesterol    O
.    O

Squalene    O
is    O
then    O
processed    O
biosynthetically    O
to    O
generate    O
either    O
lanosterol    B-Alkene114713120
or    O
cycloartenol    O
,    O
the    O
structural    O
precursors    O
to    O
all    O
the    O
steroids    O
.    O

Cerulenin    B-Alkene114713120
,    O
a    O
molecule    O
that    O
appears    O
to    O
inhibit    O
by    O
mimicking    O
the    O
“    O
condensation    O
transition    O
state    O
”    O
can    O
only    O
inhibit    O
B    O
or    O
F    O
,    O
but    O
not    O
H.    O
Another    O
molecule    O
,    O
thiolactomycin    O
,    O
which    O
mimics    O
malonyl    O
ACP    O
in    O
the    O
active    O
site    O
,    O
can    O
ony    O
inhibit    O
FabB.    O

By    O
the    O
1960s    O
it    O
was    O
making    O
dosulepin    B-Alkene114713120
,    O
a    O
tricyclic    O
antidepressant    O
(    O
TCA    O
)    O
,    O
under    O
the    O
brand    O
name    O
"    O
Prothiaden    O
"    O
.    O

Other    O
tertiary    O
amine    O
TCAs    O
include    O
amitriptyline    O
,    O
imipramine    O
,    O
clomipramine    O
,    O
dosulepin    B-Alkene114713120
(    O
dothiepin    O
)    O
,    O
doxepin    O
,    O
and    O
trimipramine    O
.    O

Another    O
study    O
reported    O
95%    O
of    O
deaths    O
from    O
antidepressants    O
in    O
England    O
and    O
Wales    O
between    O
1993    O
and    O
1997    O
were    O
associated    O
with    O
tricyclic    O
antidepressants    O
,    O
particularly    O
dothiepin    B-Alkene114713120
and    O
amitriptyline    O
.    O

4-Hydroxynonenal    B-Alkene114713120
(    O
4HNE)—which    O
ALDH3A1    O
metabolizes    O
with    O
Vmax    O
of    O
27,754    O
moles    O
NADPH    O
/    O
min•mg    O
and    O
an    O
apparent    O
Km    O
of    O
362    O
micromolar    O
—is    O
the    O
most    O
abundant    O
aldehyde    O
produced    O
in    O
the    O
LPO    O
of    O
arachidonic    O
acid    O
and    O
linoleic    O
acid    O
.    O

It    O
is    O
also    O
reported    O
to    O
be    O
involved    O
in    O
the    O
metabolism    O
of    O
4-hydroxynonenal    B-Alkene114713120
and    O
play    O
a    O
role    O
in    O
the    O
resistance    O
to    O
oxidative    O
stress    O
.    O

The    O
bacterial    O
G6PD    O
found    O
in    O
"    O
Leuconostoc    O
mesenteroides    O
"    O
was    O
shown    O
to    O
be    O
reactive    O
toward    O
4-Hydroxynonenal    B-Alkene114713120
,    O
in    O
addition    O
to    O
G6P.    O

Two    O
more    O
examples    O
are    O
shown    O
below    O
,    O
on    O
the    O
left    O
methylenecyclohexane    B-Alkene114713120
and    O
on    O
the    O
right    O
1-methylcyclohexene    O
:    O

Bromoacetylalprenololmenthane    B-Alkene114713120
(    O
BAAM    B-Alkene114713120
or    O
BrAAM    B-Alkene114713120
)    O
is    O
a    O
β    O
adrenergic    O
receptor    O
agonist    O
.    O

These    O
compounds    O
are    O
glycosides    O
of    O
steviol    B-Alkene114713120
,    O
a    O
diterpene    O
compound    O
.    O

Examples    O
of    O
diterpenes    O
and    O
diterpenoids    O
are    O
cafestol    O
,    O
kahweol    O
,    O
cembrene    B-Alkene114713120
and    O
taxadiene    O
(    O
precursor    O
of    O
taxol    O
)    O
.    O

Oudenone    B-Alkene114713120
,    O
a    O
fungal    O
metabolite    O
.    O

Dillapiole    B-Alkene114713120
is    O
an    O
organic    O
chemical    O
compound    O
and    O
essential    O
oil    O
commonly    O
extracted    O
from    O
dill    O
weed    O
,    O
though    O
it    O
can    O
be    O
found    O
in    O
a    O
variety    O
of    O
other    O
plants    O
such    O
as    O
fennel    O
root    O
.    O

Dillapiole    B-Alkene114713120

Geranyl    O
pyrophosphate    O
(    O
GPP    O
)    O
is    O
produced    O
from    O
the    O
reaction    O
of    O
a    O
resonance    O
-    O
stable    O
allylic    O
cation    O
,    O
formed    O
from    O
the    O
loss    O
of    O
the    O
pyrophosphate    O
group    O
from    O
DMAPP    O
,    O
and    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
,    O
and    O
the    O
subsequent    O
loss    O
of    O
a    O
proton    O
.    O

Phosphosphomevalonate    O
decarboxylase    O
through    O
a    O
concerted    O
decarboxylation    O
reaction    O
affords    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
.    O

Finally    O
,    O
MEcPP    O
is    O
converted    O
to    O
(    O
"    O
E")-4-hydroxy-3-methyl    O
-    O
but-2-enyl    O
pyrophosphate    O
(    O
HMB    O
-    O
PP    O
)    O
by    O
HMB    O
-    O
PP    O
synthase    O
(    O
GcpE    O
,    O
IspG    O
)    O
,    O
and    O
HMB    O
-    O
PP    O
is    O
converted    O
to    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
and    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
by    O
HMB    O
-    O
PP    O
reductase    O
(    O
LytB    O
,    O
IspH    O
)    O
.    O

Chemical    O
structure    O
of    O
the    O
terpenoid    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
,    O
an    O
intermediate    O
in    O
the    O
HMG    O
-    O
CoA    O
reductase    O
pathway    O
.    O

Simplified    O
version    O
of    O
the    O
steroid    O
synthesis    O
pathway    O
with    O
the    O
terpenoid    O
intermediates    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
,    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
,    O
geranyl    O
pyrophosphate    O
(    O
GPP    O
)    O
,    O
and    O
squalene    B-Alkene114713120
shown    O
.    O

Isoprene    O
itself    O
does    O
not    O
undergo    O
the    O
building    O
process    O
,    O
but    O
rather    O
activated    O
forms    O
,    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
or    O
also    O
isopentenyl    O
diphosphate    O
)    O
and    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
or    O
also    O
dimethylallyl    O
diphosphate    O
)    O
,    O
are    O
the    O
components    O
in    O
the    O
biosynthetic    O
pathway    O
.    O

Of    O
note    O
,    O
all    O
Vγ9/Vδ2    O
T    O
cells    O
recognize    O
the    O
same    O
small    O
microbial    O
compound    O
(    O
"    O
E")-4-hydroxy-3-methyl    O
-    O
but-2-enyl    O
pyrophosphate    O
(    O
HMB    O
-    O
PP    O
)    O
,    O
a    O
natural    O
intermediate    O
of    O
the    O
non    O
-    O
mevalonate    O
pathway    O
of    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
biosynthesis    O
.    O

IPP    B-Alkene114713120
itself    O
is    O
structurally    O
closely    O
related    O
to    O
HMB    O
-    O
PP    O
and    O
ubiquitously    O
present    O
in    O
all    O
living    O
cells    O
(    O
i.e.    O
also    O
in    O
human    O
cells    O
)    O
,    O
yet    O
its    O
potency    O
"    O
in    O
vitro    O
"    O
is    O
reduced    O
10,000    O
fold    O
;    O
whether    O
IPP    O
represents    O
a    O
physiological    O
'    O
danger    O
'    O
signal    O
of    O
stressed    O
or    O
transformed    O
cells    O
is    O
still    O
unclear    O
.    O

Thus    O
,    O
the    O
presence    O
of    O
a    O
functional    O
Vγ9/Vδ2    O
TCR    O
appears    O
mandatory    O
for    O
a    O
response    O
to    O
non    O
-    O
peptidic    O
antigens    O
although    O
the    O
basis    O
for    O
the    O
huge    O
differences    O
in    O
bioactivity    O
between    O
closely    O
related    O
molecules    O
like    O
HMB    O
-    O
PP    O
and    O
IPP    B-Alkene114713120
can    O
not    O
be    O
explained    O
by    O
conventional    O
epitope    O
presentation    O
/    O
recognition    O
models    O
.    O

Isopentenyl    O
pyrophosphate    O
isomerase    O
(    O
IPP    O
isomerase    O
)    O
,    O
also    O
known    O
as    O
Isopentenyl    O
-    O
diphosphate    O
delta    O
isomerase    O
,    O
is    O
an    O
isomerase    O
that    O
catalyzes    O
the    O
conversion    O
of    O
the    O
relatively    O
un    O
-    O
reactive    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
IPP    O
)    O
to    O
the    O
more    O
-    O
reactive    O
electrophile    O
dimethylallyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
(    O
DMAPP    O
)    O
.    O

Cinnamic    B-Alkene114713120
acid    I-Alkene114713120

Cinnamic    B-Alkene114713120
acid    I-Alkene114713120
–    O
aloe    O

The    O
benzoyl    O
moiety    O
required    O
for    O
the    O
formation    O
of    O
the    O
cocaine    O
diester    O
is    O
synthesized    O
from    O
phenylalanine    O
via    O
cinnamic    B-Alkene114713120
acid    I-Alkene114713120
.    O

The    O
pleasant    O
fragrance    O
of    O
rambutan    O
fruit    O
derives    O
from    O
numerous    O
volatile    O
organic    O
compounds    O
,    O
including    O
beta    O
-    O
damascenone    O
,    O
vanillin    O
,    O
phenylacetic    O
acid    O
,    O
and    O
cinnamic    B-Alkene114713120
acid    I-Alkene114713120
.    O

Together    O
these    O
plants    O
are    O
used    O
to    O
create    O
a    O
drink    O
containing    O
puerarin    O
,    O
daidzein    O
,    O
paenoflorin    O
,    O
cinnamic    B-Alkene114713120
acid    I-Alkene114713120
,    O
glycyrrhizin    O
,    O
ephedrine    O
and    O
gingerol    O
.    O

Carboxylic    O
acids    O
(    O
cinnamic    B-Alkene114713120
,    O
valeric    O
and    O
caproic    O
acid    O
)    O
and    O
their    O
esters    O
were    O
present    O
in    O
traces    O
.    O

3,4-Dimethoxycinnamic    O
acid    O
is    O
a    O
cinnamic    B-Alkene114713120
acid    I-Alkene114713120
derivative    O
isolated    O
from    O
coffee    O
beans    O
.    O

The    O
balsam    O
contains    O
a    O
fairly    O
large    O
amount    O
of    O
benzyl    O
and    O
cinnamyl    O
esters    O
of    O
benzoic    O
and    O
cinnamic    B-Alkene114713120
acid    I-Alkene114713120
(    O
benzyl    O
benzoate    O
,    O
benzyl    O
cinnamate    O
)    O
.    O

Work    O
on    O
alcohol    O
,    O
amber    O
,    O
benzoin    O
resin    O
and    O
cinnamic    B-Alkene114713120
acid    I-Alkene114713120
.    O

Benzyl    O
cinnamate    O
is    O
the    O
chemical    O
compound    O
which    O
is    O
the    O
ester    O
derived    O
from    O
cinnamic    B-Alkene114713120
acid    I-Alkene114713120
and    O
benzyl    O
alcohol    O
.    O

Benzyl    O
cinnamate    O
can    O
be    O
prepared    O
by    O
heating    O
benzyl    O
chloride    O
and    O
excess    O
sodium    B-Alkene114713120
cinnamate    I-Alkene114713120
in    O
water    O
to    O
100–115    O
°C    O
or    O
by    O
heating    O
sodium    O
cinnamate    O
with    O
an    O
excess    O
of    O
benzyl    O
chloride    O
in    O
the    O
presence    O
of    O
diethylamine    O
.    O

Bicyclopropenyl    B-Alkene114713120

Ethylenetetracarboxylic    B-Alkene114713120
acid    I-Alkene114713120
is    O
an    O
organic    O
compound    O
with    O
formula    O
,    O
or    O
(    O
HO(OC)-)2C    O
=    O
C(-(CO)OH)2    O
.    O

1,1-Difluoroethylene    B-Alkene114713120
also    O
known    O
as    O
vinylidene    O
fluoride    O
,    O
is    O
a    O
hydrofluoroolefin    B-Alkene114713120
.    O

A    O
new    O
type    O
of    O
Fluorine    O
refrigerant    O
,    O
that    O
is    O
scoped    O
to    O
replace    O
the    O
high    O
Global    O
Warming    O
Potential    O
HFC    O
compounds    O
,    O
are    O
Hydrofluoroolefins    B-Alkene114713120
(    O
HFO    O
)    O
.    O

teprenone    B-Alkene114713120
(    O
INN    O
)    O

Another    O
theoretical    O
interaction    O
is    O
with    O
drugs    O
with    O
affinity    O
to    O
the    O
transporter    O
protein    O
ABCG2    O
(    O
also    O
known    O
as    O
BCRP    O
)    O
,    O
such    O
as    O
pitavastatin    B-Alkene114713120
,    O
pravastatin    O
,    O
ciprofloxacin    O
,    O
methotrexat    O
,    O
and    O
diclofenac    O
;    O
a    O
study    O
with    O
the    O
latter    O
has    O
shown    O
no    O
clinical    O
relevance    O
.    O

The    O
leaves    O
were    O
a    O
source    O
of    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
.    O

MCA    O
is    O
used    O
in    O
the    O
manufacture    O
of    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
.    O

At    O
that    O
time    O
,    O
Germany    O
was    O
producing    O
10,000    O
tons    O
of    O
glacial    O
acetic    O
acid    O
,    O
around    O
30%    O
of    O
which    O
was    O
used    O
for    O
the    O
manufacture    O
of    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
.    O

One    O
of    O
the    O
dye    O
's    O
main    O
chemical    O
ingredients    O
is    O
dibromo    O
-    O
indigotin    B-Alkene114713120
,    O
and    O
if    O
left    O
in    O
the    O
sun    O
for    O
a    O
few    O
minutes    O
before    O
becoming    O
fast    O
,    O
its    O
color    O
turns    O
to    O
a    O
blue    O
indigo    O
(    O
like    O
the    O
dye    O
used    O
in    O
blue    O
jeans    O
)    O
.    O

In    O
order    O
for    O
this    O
to    O
occur    O
,    O
Oriental    O
goods    O
such    O
as    O
spice    O
,    O
indigo    B-Alkene114713120
and    O
quartz    O
must    O
be    O
produced    O
and    O
shipped    O
from    O
Oriental    O
colonies    O
.    O

It    O
was    O
formerly    O
used    O
with    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
for    O
the    O
production    O
of    O
pencil    O
blue    O
,    O
which    O
allowed    O
dark    O
blue    O
hues    O
to    O
be    O
added    O
to    O
fabric    O
via    O
pencil    O
or    O
brush    O
.    O

Condensation    O
with    O
acenaphthoquinone    O
gives    O
8    O
,    O
a    O
dye    O
of    O
the    O
so    O
-    O
called    O
Ciba    O
-    O
Scarlet    O
type    O
,    O
while    O
condensation    O
of    O
7    O
with    O
isatin    O
results    O
in    O
the    O
thio    O
-    O
Indigo    B-Alkene114713120
dye    I-Alkene114713120
9    O
.    O

The    O
"    O
Periplus    O
Maris    O
Erythraei    O
"    O
describes    O
Greco    O
—    O
Roman    O
merchants    O
selling    O
in    O
Barbaricum    O
"    O
thin    O
clothing    O
,    O
figured    O
linens    O
,    O
topaz    O
,    O
coral    O
,    O
storax    O
,    O
frankincense    O
,    O
vessels    O
of    O
glass    O
,    O
silver    O
and    O
gold    O
plate    O
,    O
and    O
a    O
little    O
wine    O
"    O
in    O
exchange    O
for    O
"    O
costus    O
,    O
bdellium    O
,    O
lycium    O
,    O
nard    O
,    O
turquoise    O
,    O
lapis    O
lazuli    O
,    O
Seric    O
skins    O
,    O
cotton    O
cloth    O
,    O
silk    O
yarn    O
,    O
and    O
indigo    B-Alkene114713120
"    O
.    O

The    O
color    O
indigo    O
is    O
named    O
after    O
the    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
derived    O
from    O
the    O
plant    O
"    O
Indigofera    O
tinctoria    O
"    O
and    O
related    O
species    O
.    O

Like    O
many    O
other    O
colors    O
(    O
orange    O
,    O
rose    O
,    O
and    O
violet    O
are    O
the    O
best    O
-    O
known    O
)    O
,    O
indigo    O
gets    O
its    O
name    O
from    O
an    O
object    O
in    O
the    O
natural    O
world    O
—    O
the    O
plant    O
named    O
indigo    O
once    O
used    O
for    O
dyeing    O
cloth    O
(    O
see    O
also    O
Indigo    B-Alkene114713120
dye    I-Alkene114713120
)    O
.    O

In    O
1806    O
,    O
Napoleon    O
decided    O
to    O
restore    O
the    O
white    O
coats    O
because    O
of    O
shortages    O
of    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
imposed    O
by    O
the    O
British    O
continental    O
blockade    O
.    O

It    O
was    O
laden    O
with    O
many    O
luxury    O
goods    O
,    O
typical    O
for    O
the    O
"    O
rich    O
trade    O
"    O
:    O
spices    O
,    O
among    O
which    O
4    O
million    O
catty    O
of    O
pepper    O
,    O
440,000    O
pounds    O
of    O
clove    O
,    O
314,000    O
pounds    O
of    O
nutmeg    O
,    O
121,600    O
pounds    O
of    O
mace    O
and    O
about    O
half    O
a    O
million    O
pounds    O
of    O
cinnamon    O
;    O
18,000    O
pounds    O
of    O
ebony    O
;    O
8690    O
catty    O
of    O
silk    O
and    O
about    O
200,000    O
other    O
pieces    O
of    O
cloth    O
;    O
22,000    O
pounds    O
of    O
indigo    B-Alkene114713120
;    O
18,151    O
pearls    O
;    O
2,933    O
rubies    O
,    O
3,084    O
raw    O
diamonds    O
and    O
16,580    O
pieces    O
of    O
porcelain    O
,    O
with    O
a    O
total    O
European    O
market    O
value    O
of    O
about    O
eleven    O
million    O
guilders    O
or    O
three    O
million    O
rigsdaler    O
,    O
more    O
than    O
the    O
total    O
annual    O
revenues    O
of    O
the    O
Danish    O
crown    O
.    O

Examples    O
of    O
cross    O
-    O
conjugation    O
can    O
be    O
found    O
in    O
molecules    O
such    O
as    O
benzophenone    O
,    O
divinylketones    O
,    O
"    O
p    O
"-    O
quinones    O
,    O
dendralenes    B-Alkene114713120
,    O
radialene    B-Alkene114713120
,    O
fullerene    O
,    O
and    O
Indigo    B-Alkene114713120
dye    I-Alkene114713120
.    O

Indigofera    O
tinctoria    O
,    O
also    O
called    O
true    O
indigo    O
,    O
is    O
a    O
species    O
of    O
plant    O
from    O
the    O
bean    O
family    O
that    O
was    O
one    O
of    O
the    O
original    O
sources    O
of    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
.    O

They    O
are    O
soaked    O
in    O
water    O
and    O
fermented    O
in    O
order    O
to    O
convert    O
the    O
glycoside    O
indican    O
naturally    O
present    O
in    O
the    O
plant    O
to    O
the    O
blue    O
dye    O
indigotin    B-Alkene114713120
.    O

Indigo    B-Alkene114713120
dye    I-Alkene114713120

Indigo    B-Alkene114713120
dye    I-Alkene114713120
:    O
Indigo    O
,    O
a    O
blue    O
pigment    O
and    O
a    O
dye    O
,    O
was    O
used    O
in    O
India    O
,    O
which    O
was    O
also    O
the    O
earliest    O
major    O
center    O
for    O
its    O
production    O
and    O
processing    O
.    O

The    O
cultivation    O
and    O
use    O
of    O
many    O
agricultural    O
products    O
in    O
the    O
United    O
States    O
,    O
such    O
as    O
yams    O
,    O
peanuts    O
,    O
rice    O
,    O
okra    O
,    O
sorghum    O
,    O
grits    O
,    O
watermelon    O
,    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
,    O
and    O
cotton    O
,    O
can    O
be    O
traced    O
to    O
West    O
African    O
and    O
African    O
-    O
American    O
influences    O
.    O

Indigo    B-Alkene114713120
dye    I-Alkene114713120

"    O
Persian    O
indigo    O
"    O
is    O
named    O
for    O
an    O
association    O
with    O
a    O
product    O
from    O
Persia    O
:    O
Persian    O
cloth    O
dyed    O
with    O
indigo    B-Alkene114713120
.    O

The    O
color    O
"    O
Persian    O
indigo    O
"    O
,    O
which    O
as    O
noted    O
above    O
was    O
originally    O
called    O
"    O
regimental    O
"    O
,    O
was    O
called    O
by    O
that    O
name    O
because    O
it    O
used    O
to    O
be    O
the    O
color    O
of    O
the    O
navy    O
uniforms    O
of    O
a    O
number    O
of    O
different    O
nations    O
in    O
the    O
late    O
19th    O
and    O
early    O
20th    O
centuries    O
due    O
to    O
the    O
fact    O
that    O
it    O
was    O
easy    O
and    O
inexpensive    O
to    O
use    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
to    O
dye    O
navy    O
uniforms    O
.    O

Its    O
prosperity    O
was    O
built    O
on    O
a    O
strong    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
industry    O
.    O

In    O
1826    O
at    O
the    O
age    O
of    O
20    O
,    O
Unverdorben    O
discovered    O
aniline    O
,    O
which    O
he    O
obtained    O
from    O
the    O
distillation    O
of    O
natural    O
vegetable    O
indigo    B-Alkene114713120
.    O

;    O
1865:Adolf    O
von    O
Baeyer    O
begins    O
work    O
on    O
indigo    B-Alkene114713120
dye    I-Alkene114713120
,    O
a    O
milestone    O
in    O
modern    O
industrial    O
organic    O
chemistry    O
which    O
revolutionizes    O
the    O
dye    O
industry    O
.    O

The    O
most    O
common    O
stretch    O
wrap    O
material    O
linear    O
low    O
-    O
density    O
polyethylene    O
or    O
LLDPE    O
,    O
which    O
is    O
produced    O
by    O
copolymerization    O
of    O
ethylene    O
with    O
alpha-olefin    B-Alkene114713120
,    O
the    O
most    O
common    O
of    O
which    O
are    O
butene    O
,    O
hexene    B-Alkene114713120
and    O
octene    B-Alkene114713120
.    O

Aliphatic    O
compounds    O
can    O
be    O
saturated    O
,    O
like    O
hexane    O
,    O
or    O
unsaturated    O
,    O
like    O
hexene    B-Alkene114713120
and    O
hexyne    O
.    O

Brands    O
included    O
in    O
United    O
Industries    O
were    O
Vigoro    O
,    O
Spectracide    O
and    O
Sta    O
-    O
Green    O
lawn    O
products    O
,    O
Cutter    O
,    O
Hot    B-Alkene114713120
Shot    I-Alkene114713120
and    O
Repel    O
insect    O
control    O
products    O
and    O
pet    O
supply    O
products    O
with    O
the    O
Marineland    O
,    O
Perfecto    O
,    O
and    O
Eight    O
in    O
One    O
brands    O
.    O

In    O
2014    O
,    O
Khon    O
Kaen    O
University    O
concluded    O
after    O
a    O
study    O
,    O
that    O
Thailand    O
should    O
ban    O
155    O
types    O
of    O
pesticides    O
,    O
with    O
14    O
listed    O
as    O
urgent    O
:    O
Carbofuran    O
,    O
Methyl    O
Bromide    O
,    O
Dichlorvos    O
,    O
Lambda-cyhalothrin    B-Alkene114713120
,    O
Methidathion    O
-    O
methyl    O
,    O
Omethoate    O
,    O
Zeta    O
Cypermethrin    O
,    O
Endosulfan    O
sulfate    O
,    O
Aldicarb    O
,    O
Azinphos    O
-    O
methyl    O
,    O
Chlorpyrifos    O
-    O
ethyl    O
,    O
Methoxychlor    O
and    O
Paraquat    O
.    O

Early    O
pesticide    O
development    O
included    O
Gramoxone    O
(    O
1962    O
,    O
a    O
herbicide    O
)    O
,    O
the    O
insecticides    O
pirimiphos    O
-    O
methyl    O
in    O
1967    O
and    O
pirimicarb    O
in    O
1970    O
,    O
brodifacoum    O
(    O
a    O
rodenticide    O
)    O
was    O
developed    O
in    O
1974    O
;    O
in    O
the    O
late    O
1970s    O
,    O
ICI    O
was    O
involved    O
in    O
the    O
early    O
development    O
of    O
synthetic    O
pyrethroid    O
insecticides    O
such    O
as    O
lambda-cyhalothrin    B-Alkene114713120
.    O

Antagonists    O
/    O
negative    O
allosteric    O
modulators    O
:    O
bicuculline    O
,    O
cicutoxin    B-Alkene114713120
,    O
flumazenil    O
,    O
furosemide    O
,    O
gabazine    O
,    O
oenanthotoxin    B-Alkene114713120
,    O
picrotoxin    B-Alkene114713120
,    O
Ro15    O
-    O
4513    O
,    O
thujone    O
,    O
amentoflavone    O
.    O

Picrotoxin    B-Alkene114713120

It    O
is    O
related    O
to    O
the    O
picrotoxin    B-Alkene114713120
family    O
of    O
natural    O
products    O
.    O

While    O
structurally    O
related    O
to    O
picrotoxin    B-Alkene114713120
,    O
dendrobine    O
is    O
not    O
an    O
antagonist    O
of    O
GABA    O
.    O

When    O
tested    O
in    O
mice    O
,    O
denatured    O
venom    O
from    O
"    O
P.    O
occidentalis    O
"    O
inhibited    O
convulsions    O
during    O
seizures    O
induced    O
by    O
bicuculline    O
,    O
picrotoxin    B-Alkene114713120
,    O
and    O
kainic    B-Alkene114713120
acid    I-Alkene114713120
.    O

("E")-Stilbene    B-Alkene114713120

The    O
wavelengths    O
at    O
which    O
azobenzene    O
isomerization    O
occurs    O
depends    O
on    O
the    O
particular    O
structure    O
of    O
each    O
azo    O
molecule    O
,    O
but    O
they    O
are    O
typically    O
grouped    O
into    O
three    O
classes    O
:    O
the    O
azobenzene    O
-    O
type    O
molecules    O
,    O
the    O
aminoazobenzenes    O
,    O
and    O
the    O
pseudo    O
-    O
stilbenes    B-Alkene114713120
.    O

Allyl    B-Alkene114713120
iodide    I-Alkene114713120
(    O
3-iodopropene    B-Alkene114713120
)    O
is    O
an    O
organic    O
halide    O
used    O
in    O
synthesis    O
of    O
other    O
organic    O
compounds    O
such    O
as    O
N    O
-    O
alkyl    O
2-pyrrolidones    O
,    O
sorbic    O
acid    O
esters    O
,    O
5,5-disubstituted    O
barbituric    O
acids    O
,    O
and    O
organometallic    O
catalysts    O
.    O

gamolenic    B-Alkene114713120
acid    I-Alkene114713120
(    O
INN    O
)    O

About    O
30–35%    O
of    O
the    O
weight    O
of    O
hempseed    O
is    O
an    O
edible    O
oil    O
that    O
contains    O
about    O
80%    O
as    O
essential    O
fatty    O
acids    O
(    O
EFAs    O
)    O
;    O
i.e.    O
,    O
linoleic    O
acid    O
,    O
omega-6    O
(    O
LA    O
,    O
55%    O
)    O
,    O
alpha    O
-    O
linolenic    O
acid    O
,    O
omega-3    O
(    O
ALA    O
,    O
22%    O
)    O
,    O
in    O
addition    O
to    O
gamma-linolenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
omega-6    O
(    O
GLA    O
,    O
1–4%    O
)    O
and    O
stearidonic    O
acid    O
,    O
omega-3    O
(    O
SDA    O
,    O
0–2%    O
)    O
.    O

Currant    O
root    O
and    O
seeds    O
are    O
high    O
in    O
gamma-linolenic    B-Alkene114713120
acid    I-Alkene114713120
(    O
GLA    O
)    O
.    O

However    O
,    O
the    O
same    O
enzymes    O
that    O
metabolize    O
arachidonic    O
acid    O
to    O
series    O
2    O
prostanoids    O
similarly    O
metabolize    O
two    O
other    O
straight    O
chain    O
PUFAs    O
:    O
they    O
metabolize    O
gamma-Linolenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
which    O
has    O
one    O
less    O
double    O
bond    O
than    O
arachidonic    O
acid    O
,    O
to    O
series    O
1    O
prostanoids    O
(    O
PGD1    O
,    O
PGE1    O
,    O
etc    O
.    O
)    O
,    O
which    O
have    O
one    O
less    O
double    O
bond    O
than    O
the    O
series    O
2    O
prostanoids    O
,    O
and    O
they    O
metabolize    O
eicosapentaenoic    O
acid    O
,    O
which    O
has    O
one    O
more    O
double    O
bond    O
than    O
arachidonic    O
acid    O
,    O
to    O
series    O
3    O
prostanoids    O
(    O
PGD3    O
,    O
PGE3    O
,    O
etc    O
.    O
)    O
,    O
which    O
have    O
one    O
more    O
double    O
bond    O
than    O
the    O
series    O
2    O
prostanoids    O
.    O

γ-Linolenic    B-Alkene114713120
acid    I-Alkene114713120
,    O
an    O
omega-6    O
(    O
n-6    O
)    O
fatty    O
acid    O

The    O
aniseed    O
myrtle    O
selections    O
are    O
also    O
low    O
in    O
methyl    B-Alkene114713120
chavicol    I-Alkene114713120
and    O
cis    O
-    O
anethole    O
(    O
less    O
than    O
0.1%    O
)    O
.    O

The    O
most    O
important    O
are    O
1,8    O
cineol    O
,    O
linalool    O
,    O
citral    O
,    O
methyl    O
chavicol    O
(    O
estragole    B-Alkene114713120
)    O
,    O
eugenol    B-Alkene114713120
and    O
methyl    B-Alkene114713120
cinnamate    I-Alkene114713120
,    O
although    O
hardly    O
any    O
basil    O
contains    O
all    O
of    O
these    O
in    O
any    O
significant    O
amount    O
.    O

The    O
phenylpropenes    O
,    O
including    O
eugenol    B-Alkene114713120
,    O
chavicol    B-Alkene114713120
,    O
safrole    B-Alkene114713120
and    O
estragole    B-Alkene114713120
,    O
are    O
derived    O
from    O
the    O
monolignols    O
.    O

The    O
synthesis    O
recovers    O
1-hexene    O
from    O
the    O
aforementioned    O
fuel    O
streams    O
,    O
where    O
the    O
initial    O
1-hexene    O
concentration    O
cut    O
may    O
be    O
60%    O
in    O
a    O
narrow    O
distillation    O
,    O
with    O
the    O
remainder    O
being    O
vinylidenes    B-Alkene114713120
,    O
linear    O
and    O
branched    O
internal    O
olefins    O
,    O
linear    O
and    O
branched    O
paraffins    O
,    O
alcohols    O
,    O
aldehydes    O
,    O
carboxylic    O
acids    O
,    O
and    O
aromatic    O
compounds    O
.    O

Other    O
bicyclic    O
monoterpenes    O
include    O
carene    B-Alkene114713120
,    O
sabinene    B-Alkene114713120
,    O
camphene    B-Alkene114713120
,    O
and    O
thujene    B-Alkene114713120
.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    B-Alkene114713120
50%    O
,    O
thujene    B-Alkene114713120
,    O
and    O
carene    B-Alkene114713120
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
,    O
α-    O
and    O
β-cubebene    O
,    O
cadinene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
1,8-cineole    O
and    O
the    O
alcohol    O
cubebol    O
.    O

Nealbarbital    B-Alkene114713120

Monoterpenes    O
(    O
~    O
5%    O
)    O
:    O
β-pinene    B-Alkene114713120
,    O
myrcene    B-Alkene114713120
,    O
phellandrene    B-Alkene114713120
,    O
"    O
cis    O
"-    O
ocimene    B-Alkene114713120
,    O
terpinolene    B-Alkene114713120
,    O
and    O
terpineol    B-Alkene114713120
.    O

Several    O
floral    O
scent    O
compounds    O
of    O
"    O
Monotropastrum    O
humile    O
"    O
,    O
linalool    O
,    O
α-terpineol    B-Alkene114713120
,    O
and    O
geraniol    B-Alkene114713120
,    O
have    O
been    O
demonstrated    O
to    O
be    O
bumble    O
bee    O
attractants    O
.    O

Examples    O
of    O
monoterpenes    O
and    O
monoterpenoids    O
include    O
geraniol    B-Alkene114713120
,    O
terpineol    B-Alkene114713120
(    O
present    O
in    O
lilacs    O
)    O
,    O
limonene    O
(    O
present    O
in    O
citrus    O
fruits    O
)    O
,    O
myrcene    B-Alkene114713120
(    O
present    O
in    O
hops    O
)    O
,    O
linalool    O
(    O
present    O
in    O
lavender    O
)    O
or    O
pinene    B-Alkene114713120
(    O
present    O
in    O
pine    O
trees    O
)    O
.    O

While    O
largely    O
indistinguishable    O
in    O
appearance    O
,    O
specimens    O
of    O
"    O
T.    O
vulgaris    O
"    O
may    O
be    O
assigned    O
to    O
one    O
of    O
seven    O
different    O
chemotypes    O
,    O
depending    O
on    O
whether    O
the    O
dominant    O
component    O
of    O
the    O
essential    O
oil    O
is    O
thymol    O
,    O
carvacrol    O
,    O
linalool    O
,    O
geraniol    B-Alkene114713120
,    O
sabinene    O
hydrate    O
(    O
thuyanol    O
)    O
,    O
α-terpineol    B-Alkene114713120
,    O
or    O
eucalyptol    O
.    O

The    O
main    O
components    O
of    O
the    O
needle    O
essential    O
oil    O
include    O
terpineol    B-Alkene114713120
(    O
30.2%    O
)    O
,    O
linalool    O
(    O
24.47%    O
)    O
,    O
limonene    O
(    O
17.01%    O
)    O
,    O
anethole    B-Alkene114713120
(    O
14.57%    O
)    O
,    O
caryophyllene    B-Alkene114713120
(    O
3.14%    O
)    O
and    O
eugenol    B-Alkene114713120
(    O
2.14%    O
)    O
.    O

One    O
product    O
of    O
this    O
enzyme    O
is    O
allyl    B-Alkene114713120
isothiocyanate    I-Alkene114713120
,    O
the    O
pungent    O
ingredient    O
in    O
horseradish    O
sauces    O
.    O

Nitrogen    O
mustards    O
are    O
not    O
related    O
to    O
the    O
mustard    O
plant    O
or    O
its    O
pungent    O
essence    O
,    O
allyl    B-Alkene114713120
isothiocyanate    I-Alkene114713120
;    O
the    O
name    O
comes    O
from    O
the    O
pungent    O
smell    O
of    O
chemical    O
weapons    O
preparations    O
.    O

Some    O
TRP    O
channels    O
are    O
activated    O
by    O
molecules    O
found    O
in    O
spices    O
like    O
garlic    O
(    O
allicin    O
)    O
,    O
chilli    O
pepper    O
(    O
capsaicin    O
)    O
,    O
wasabi    O
(    O
allyl    B-Alkene114713120
isothiocyanate    I-Alkene114713120
)    O
;    O
others    O
are    O
activated    O
by    O
menthol    O
,    O
camphor    O
,    O
peppermint    O
,    O
and    O
cooling    O
agents    O
;    O
yet    O
others    O
are    O
activated    O
by    O
molecules    O
found    O
in    O
cannabis    O
(    O
i.e.    O
,    O
THC    O
,    O
CBD    O
and    O
CBN    O
)    O
or    O
stevia    O
.    O

TRPA1    O
responds    O
to    O
mustard    O
oil    O
(    O
allyl    B-Alkene114713120
isothiocyanate    I-Alkene114713120
)    O
,    O
wasabi    O
,    O
and    O
cinnamon    O
,    O
TRPA1    O
and    O
TRPV    O
responds    O
to    O
garlic    O
(    O
allicin    O
)    O
,    O
TRPV1    O
responds    O
to    O
chilli    O
pepper    O
(    O
capsaicin    O
)    O
,    O
TRPM8    O
is    O
activated    O
by    O
menthol    O
,    O
camphor    O
,    O
peppermint    O
,    O
and    O
cooling    O
agents    O
;    O
TRPV2    O
is    O
activated    O
by    O
molecules    O
(    O
THC    O
,    O
CBD    O
and    O
CBN    O
)    O
found    O
in    O
marijuana    O
;    O
TRPM5    O
is    O
activated    O
by    O
the    O
sweet    O
glycosides    O
found    O
in    O
the    O
stevia    O
plant    O
.    O

Allyl    B-Alkene114713120
isothiocyanate    I-Alkene114713120
(    O
also    O
allyl    O
mercaptan    O
)    O
,    O
the    O
active    O
piquant    O
chemical    O
in    O
mustard    O
,    O
radishes    O
,    O
horseradish    O
,    O
and    O
wasabi    O

Nerol    O
can    O
be    O
synthesized    O
by    O
pyrolysis    O
of    O
beta-pinene    B-Alkene114713120
,    O
which    O
affords    O
myrcene    B-Alkene114713120
.    O

Elimination    O
of    O
the    O
pyrophosphate    O
group    O
leads    O
to    O
the    O
formation    O
of    O
acyclic    O
monoterpenes    O
such    O
as    O
ocimene    B-Alkene114713120
and    O
the    O
myrcene    B-Alkene114713120
.    O

Myrcene    B-Alkene114713120
,    O
a    O
monoterpene    O
.    O

Examples    O
of    O
monoterpenes    O
and    O
monoterpenoids    O
include    O
geraniol    B-Alkene114713120
,    O
terpineol    B-Alkene114713120
(    O
present    O
in    O
lilacs    O
)    O
,    O
limonene    O
(    O
present    O
in    O
citrus    O
fruits    O
)    O
,    O
myrcene    B-Alkene114713120
(    O
present    O
in    O
hops    O
)    O
,    O
linalool    O
(    O
present    O
in    O
lavender    O
)    O
or    O
pinene    B-Alkene114713120
(    O
present    O
in    O
pine    O
trees    O
)    O
.    O

Myrcene    B-Alkene114713120

The    O
secretion    O
from    O
"    O
Tenuirostritemes    O
tenuirostris    O
"    O
consists    O
of    O
a    O
mixture    O
of    O
three    O
terpenes    O
,    O
namely    O
62%    O
pinene    B-Alkene114713120
,    O
27%    O
myrcene    B-Alkene114713120
and    O
11%    O
limonene    O
.    O

The    O
Tasmanian    O
variety    O
contains    O
less    O
myrcene    B-Alkene114713120
oil    O
and    O
more    O
humulene    B-Alkene114713120
oil    O
as    O
well    O
as    O
other    O
more    O
minor    O
differences    O
.    O

Seletracetam    B-Alkene114713120
(    O
UCB    O
44212    O
)    O
is    O
a    O
pyrrolidone    O
-    O
derived    O
drug    O
of    O
the    O
racetam    O
family    O
that    O
is    O
structurally    O
related    O
to    O
levetiracetam    O
(    O
trade    O
name    O
Keppra    O
)    O
.    O

Hydramethylnon    B-Alkene114713120
is    O
an    O
organic    O
chemical    O
compound    O
.    O

Grandisol    B-Alkene114713120

To    O
make    O
any    O
of    O
the    O
phenyltropanes    O
requires    O
either    O
a    O
source    O
of    O
cocaine    O
,    O
or    O
extensive    O
and    O
repeated    O
separation    O
of    O
enantiomers    O
due    O
to    O
the    O
lack    O
of    O
enantioselective    O
routes    O
to    O
the    O
essential    O
intermediate    O
methylecgonidine    B-Alkene114713120
and    O
the    O
large    O
differences    O
in    O
potency    O
between    O
different    O
structural    O
isomers    O
of    O
the    O
final    O
product    O
.    O

Methylecgonidine    B-Alkene114713120
is    O
the    O
direct    O
precursor    O
to    O
this    O
compound    O
.    O

Therefore    O
,    O
they    O
are    O
now    O
being    O
replaced    O
in    O
markets    O
where    O
leaks    O
are    O
likely    O
,    O
by    O
using    O
a    O
third    O
generation    O
of    O
refrigerants    O
,    O
most    O
prominently    O
HFO-1234yf    B-Alkene114713120
,    O
which    O
have    O
global    O
warming    O
potentials    O
much    O
closer    O
to    O
that    O
of    O
CO2    O
.    O

GM    O
announced    O
that    O
it    O
would    O
start    O
using    O
"    O
hydrofluoroolefin    O
"    O
,    O
HFO-1234yf    B-Alkene114713120
,    O
in    O
all    O
of    O
its    O
brands    O
by    O
2013    O
.    O

Thebaine    B-Alkene114713120
(    O
paramorphine    O
)    O

#    O
Thebaine    B-Alkene114713120

The    O
psychoactive    O
compounds    O
found    O
in    O
the    O
opium    O
plant    O
include    O
morphine    O
,    O
codeine    O
,    O
and    O
thebaine    B-Alkene114713120
.    O

The    O
major    O
psychoactive    O
opiates    O
are    O
morphine    O
,    O
codeine    O
,    O
and    O
thebaine    B-Alkene114713120
.    O

Therefore    O
,    O
most    O
of    O
the    O
opiate    O
-    O
type    O
analgesics    O
in    O
use    O
today    O
are    O
either    O
extracted    O
from    O
"    O
Papaver    O
somniferum    O
"    O
or    O
synthesized    O
from    O
those    O
opiates    O
,    O
especially    O
thebaine    B-Alkene114713120
.    O

Synthesis    O
of    O
morphine    O
-    O
like    O
alkaloids    O
in    O
chemistry    O
describes    O
the    O
total    O
synthesis    O
of    O
the    O
natural    O
morphinan    O
class    O
of    O
alkaloids    O
that    O
includes    O
codeine    O
,    O
morphine    O
,    O
oripavine    O
,    O
and    O
thebaine    B-Alkene114713120
and    O
the    O
closely    O
related    O
semisynthetic    O
analogs    O
buprenorphine    O
,    O
hydrocodone    O
,    O
isocodeine    O
,    O
naltrexone    O
,    O
naloxone    O
,    O
nalbuphine    O
,    O
and    O
oxycodone    O
.    O

For    O
example    O
,    O
naloxone    O
,    O
an    O
opioid    O
receptor    O
antagonist    O
,    O
is    O
a    O
derivative    O
of    O
thebaine    B-Alkene114713120
that    O
is    O
present    O
in    O
opium    O
.    O

File    O
:    O
Thebaine    O
Thebaine    B-Alkene114713120

Thebaine    B-Alkene114713120
is    O
used    O
in    O
the    O
synthesis    O
of    O
many    O
painkillers    O
such    O
as    O
oxycodone    O
.    O

Octene    B-Alkene114713120
is    O
an    O
alkene    O
with    O
the    O
formula    O
.    O

"    O
Chloroform    O
"    O
:    O
Chloroform    O
is    O
stabilized    O
with    O
small    O
quantities    O
of    O
amylene    B-Alkene114713120
or    O
ethanol    O
,    O
because    O
exposure    O
of    O
pure    O
chloroform    O
to    O
oxygen    O
and    O
ultraviolet    O
light    O
produces    O
phosgene    O
gas    O
.    O

The    O
olefin    O
feed    O
to    O
an    O
alkylation    O
unit    O
generally    O
originates    O
from    O
a    O
FCCU    O
and    O
contains    O
butene    O
,    O
isobutene    O
,    O
and    O
possibly    O
propene    O
and/or    O
amylene    B-Alkene114713120
.    O

Pentene    B-Alkene114713120

Alkannin    B-Alkene114713120

These    O
are    O
very    O
similar    O
in    O
principle    O
:    O
Leonard    O
and    O
Hauck    O
reacted    O
phorone    B-Alkene114713120
with    O
ammonia    O
,    O
to    O
produce    O
2,2,6,6-tetramethyl-4-piperidone    O
,    O
which    O
was    O
then    O
reduced    O
by    O
means    O
of    O
the    O
Wolff    O
–    O
Kishner    O
reduction    O
to    O
2,2,6,6-tetramethylpiperidine    O
;    O
this    O
secondary    O
amine    O
was    O
then    O
"    O
N    O
"-    O
methylated    O
using    O
methyl    O
iodide    O
and    O
potassium    O
carbonate    O
.    O

Metofluthrin    B-Alkene114713120
is    O
a    O
pyrethroid    O
used    O
as    O
an    O
insect    O
repellent    O
.    O

It    O
is    O
also    O
available    O
by    O
mouth    O
in    O
combination    O
with    O
lumefantrine    B-Alkene114713120
,    O
known    O
as    O
artemether    O
/    O
lumefantrine    O
.    O

Given    O
in    O
combination    O
with    O
lumefantrine    B-Alkene114713120
,    O
it    O
may    O
be    O
followed    O
by    O
a    O
14    O
day    O
regimen    O
of    O
primaquine    O
to    O
prevent    O
relapse    O
of    O
"    O
P.    O
vivax    O
"    O
or    O
"    O
P.    O
ovale    O
"    O
malarial    O
parasites    O
and    O
provide    O
a    O
complete    O
cure    O
.    O

croconazole    B-Alkene114713120
(    O
INN    O
)    O

Allyl    B-Alkene114713120
methyl    I-Alkene114713120
sulfide    I-Alkene114713120
(    O
AMS    O
)    O
can    O
not    O
be    O
digested    O
and    O
is    O
passed    O
into    O
the    O
blood    O
.    O

Cinchonidine    B-Alkene114713120
,    O
one    O
of    O
the    O
cinchona    O
alkaloids    O
.    O

Naloxazone    B-Alkene114713120

For    O
those    O
who    O
are    O
unresponsive    O
to    O
somatostatin    O
analogues    O
,    O
or    O
for    O
whom    O
they    O
are    O
otherwise    O
contraindicated    O
,    O
it    O
is    O
possible    O
to    O
treat    O
using    O
one    O
of    O
the    O
dopamine    O
agonists    O
,    O
bromocriptine    O
or    O
cabergoline    B-Alkene114713120
.    O

Cabergoline    B-Alkene114713120
is    O
derived    O
from    O
a    O
number    O
of    O
ergot    O
alkaloids    O
one    O
of    O
which    O
is    O
lysergic    O
acid    O
and    O
Simvastatin    O
is    O
based    O
on    O
Lovastatin    O
.    O

Dopamine    O
agonists    O
include    O
bromocriptine    O
,    O
pergolide    O
,    O
pramipexole    O
,    O
ropinirole    O
,    O
piribedil    O
,    O
cabergoline    B-Alkene114713120
,    O
apomorphine    O
and    O
lisuride    O
.    O

The    O
D2    O
receptor    O
is    O
involved    O
in    O
the    O
regulation    O
of    O
prolactin    O
secretion    O
,    O
and    O
agonists    O
of    O
the    O
receptor    O
such    O
as    O
bromocriptine    O
and    O
cabergoline    B-Alkene114713120
decrease    O
prolactin    O
levels    O
while    O
antagonists    O
of    O
the    O
receptor    O
such    O
as    O
domperidone    O
,    O
metoclopramide    O
,    O
haloperidol    O
,    O
risperidone    O
,    O
and    O
sulpiride    O
increase    O
prolactin    O
levels    O
.    O

Prolactinomas    O
are    O
most    O
often    O
treated    O
with    O
cabergoline    B-Alkene114713120
or    O
quinagolide    O
(    O
both    O
dopamine    O
agonists    O
)    O
,    O
which    O
decrease    O
tumor    O
size    O
as    O
well    O
as    O
alleviates    O
symptoms    O
,    O
followed    O
by    O
serial    O
imaging    O
to    O
detect    O
any    O
increase    O
in    O
size    O
.    O

Another    O
chemical    O
which    O
is    O
considered    O
to    O
be    O
responsible    O
for    O
the    O
male    O
refractory    O
period    O
is    O
prolactin    O
,    O
which    O
represses    O
dopamine    O
,    O
which    O
is    O
responsible    O
for    O
sexual    O
arousal    O
.    O
Because    O
of    O
this    O
,    O
there    O
is    O
currently    O
an    O
experimental    O
interest    O
in    O
drugs    O
which    O
inhibit    O
prolactin    O
,    O
such    O
as    O
cabergoline    B-Alkene114713120
(    O
also    O
known    O
as    O
Cabeser    O
,    O
or    O
Dostinex    O
)    O
.    O

Cabergoline    B-Alkene114713120

Ferulic    O
acid    O
is    O
converted    O
by    O
certain    O
strains    O
of    O
yeast    O
,    O
notably    O
strains    O
used    O
in    O
brewing    O
of    O
wheat    O
beers    O
,    O
such    O
as    O
"    O
Saccharomyces    O
delbrueckii    O
"    O
(    O
"    O
Torulaspora    O
delbrueckii    O
"    O
)    O
,    O
to    O
4-vinyl    B-Alkene114713120
guaiacol    I-Alkene114713120
(    O
2-methoxy-4-vinylphenol    O
)    O
which    O
gives    O
beers    O
such    O
as    O
Weissbier    O
and    O
Wit    O
their    O
distinctive    O
"    O
clove    O
"    O
flavour    O
.    O

Phenothrin    B-Alkene114713120

Infections    O
of    O
the    O
eyelashes    O
may    O
be    O
treated    O
with    O
either    O
petroleum    O
jelly    O
applied    O
twice    O
daily    O
for    O
10    O
days    O
or    O
malathion    O
,    O
phenothrin    B-Alkene114713120
,    O
and    O
carbaryl    O
.    O

Mild    O
to    O
moderate    O
iron    O
-    O
deficiency    O
anemia    O
is    O
treated    O
by    O
oral    O
iron    O
supplementation    O
with    O
ferrous    O
sulfate    O
,    O
ferrous    B-Alkene114713120
fumarate    I-Alkene114713120
,    O
or    O
ferrous    O
gluconate    O
.    O

Ferrous    O
sulfate    O
can    O
cause    O
considerable    O
GI    O
distress    O
in    O
normal    O
doses    O
;    O
alternatives    O
include    O
ferrous    B-Alkene114713120
fumarate    I-Alkene114713120
,    O
or    O
a    O
chelated    O
form    O
of    O
iron    O
.    O

Levoverbenone    B-Alkene114713120
is    O
an    O
expectorant    O
.    O

The    O
unripened    O
or    O
inedible    O
portions    O
of    O
the    O
fruit    O
contain    O
the    O
toxin    O
hypoglycin    B-Alkene114713120
A    I-Alkene114713120
and    O
hypoglycin    O
B.    O
Hypoglycin    O
A    O
is    O
found    O
in    O
both    O
the    O
seeds    O
and    O
the    O
arils    O
,    O
while    O
hypoglycin    O
B    O
is    O
found    O
only    O
in    O
the    O
seeds    O
.    O

However    O
,    O
it    O
is    O
currently    O
allowed    O
,    O
provided    O
that    O
the    O
amount    O
of    O
hypoglycin    B-Alkene114713120
present    O
meets    O
the    O
standards    O
of    O
the    O
Food    O
and    O
Drug    O
Administration    O
.    O

Alfetamine    B-Alkene114713120
,    O
or    O
alpha    O
-    O
allyl    O
-    O
phenethylamine    O
,    O
is    O
a    O
chemical    O
compound    O
of    O
the    O
phenethylamine    O
family    O
.    O

The    O
ligands    O
for    O
LPL    O
-    O
R    O
group    O
are    O
the    O
lysophospholipid    O
extracellular    O
signaling    O
molecules    O
,    O
lysophosphatidic    O
acid    O
(    O
LPA    O
)    O
and    O
sphingosine    B-Alkene114713120
1-phosphate    I-Alkene114713120
(    O
S1P    O
)    O
.    O

Sphingosine    O
kinase    O
1    O
phosphorylates    O
sphingosine    B-Alkene114713120
to    O
sphingosine-1-phosphate    B-Alkene114713120
(    O
S1P    O
)    O
SK1    O
is    O
normally    O
a    O
cytosolic    O
protein    O
but    O
is    O
recruited    O
to    O
membranes    O
rich    O
in    O
phosphatidate    O
(    O
PA    O
)    O
,    O
a    O
product    O
of    O
Phospholipase    O
D    O
(    O
PLD    O
)    O

Sphingosine-1-phosphate    B-Alkene114713120
(    O
S1P    O
)    O
is    O
a    O
novel    O
lipid    O
messenger    O
with    O
both    O
intracellular    O
and    O
extracellular    O
functions    O
.    O

It    O
has    O
been    O
proposed    O
that    O
sphingosine    B-Alkene114713120
1-phosphate    I-Alkene114713120
(    O
S1P    O
)    O
and    O
sphingosylphosphorylcholine    O
(    O
SPC    O
)    O
are    O
GPR3    O
ligands    O
,    O
however    O
this    O
result    O
was    O
not    O
confirmed    O
in    O
a    O
β-arrestin    O
recruitment    O
assay    O
.    O

Siponimod    O
(    O
INN    O
,    O
code    O
name    O
BAF312    O
)    O
is    O
a    O
selective    O
sphingosine-1-phosphate    B-Alkene114713120
receptor    O
modulator    O
for    O
oral    O
use    O
that    O
is    O
an    O
investigational    O
drug    O
for    O
multiple    O
sclerosis    O
(    O
MS    O
)    O
.    O

Interestingly    O
,    O
however    O
,    O
this    O
catalytic    O
triad    O
is    O
essential    O
for    O
the    O
dephosphorylation    O
of    O
lysophosphatidic    O
acid    O
,    O
phosphatidic    O
acid    O
,    O
and    O
sphingosine-1-phosphate    B-Alkene114713120
,    O
but    O
is    O
not    O
essential    O
in    O
its    O
entirety    O
for    O
the    O
enzyme    O
's    O
native    O
substrate    O
,    O
phosphatidylglycerol    O
phosphate    O
;    O
His-207    O
alone    O
is    O
sufficient    O
to    O
hydrolyze    O
PGP    O
.    O

Azaprocin    B-Alkene114713120

Fursultiamine    O
(    O
INN    O
;    O
Adventan    O
,    O
Alinamin    O
-    O
F    O
,    O
Benlipoid    O
,    O
Bevitol    O
Lipophil    O
,    O
Judolor    O
,    O
Lipothiamine    O
)    O
,    O
chemically    O
thiamine    O
tetrahydrofurfuryl    O
disulfide    O
(    O
TTFD    O
)    O
,    O
is    O
a    O
disulfide    O
derivative    O
of    O
thiamine    O
,    O
or    O
an    O
allithiamine    B-Alkene114713120
.    O

Nizatidine    B-Alkene114713120

H2-receptor    O
antagonists    O
:    O
include    O
cimetidine    O
(    O
Tagamet    O
)    O
,    O
famotidine    O
(    O
Pepcid    O
)    O
,    O
nizatidine    B-Alkene114713120
(    O
Axid    O
)    O
,    O
and    O
ranitidine    O
(    O
Zantac    O
)    O
.    O

Resmethrin    B-Alkene114713120

Brallobarbital    B-Alkene114713120
is    O
a    O
barbiturate    O
developed    O
in    O
the    O
1920s    O
.    O

Creams    O
and    O
Ointments    O
:    O
Ointment    O
containing    O
antibiotic    O
like    O
mupirocin    B-Alkene114713120
2%    O
or    O
a    O
mixture    O
of    O
components    O
like    O
neomycin    O
,    O
nystatin    O
and    O
triamcinolone    O
can    O
be    O
used    O
to    O
control    O
bacterial    O
or    O
mixed    O
bacterial    O
/    O
fungal    O
infections    O
.    O

However    O
,    O
at    O
least    O
in    O
Canadian    O
hospitals    O
,    O
data    O
collected    O
between    O
1999    O
-    O
2005    O
showed    O
rather    O
low    O
rate    O
of    O
resistance    O
of    O
MSSA    O
and    O
MRSA    O
to    O
fusidic    O
acid    O
,    O
and    O
mupirocin    B-Alkene114713120
was    O
found    O
to    O
be    O
the    O
more    O
problematic    O
topical    O
antibiotic    O
for    O
the    O
aforementioned    O
conditions    O
.    O

However    O
,    O
Pseudomonas    O
aeruginosa    O
produces    O
antimicrobial    O
substances    O
such    O
as    O
pseudomonic    O
acid    O
(    O
that    O
are    O
exploited    O
commercially    O
such    O
as    O
Mupirocin    B-Alkene114713120
)    O
.    O

Mupirocin    B-Alkene114713120

The    O
situation    O
for    O
α-methylstyrene    B-Alkene114713120
,    O
PhC(Me)=CH2    O
,    O
is    O
an    O
exception    O
to    O
this    O
trend    O
.    O

Nevcin    O
synthesises    O
hydrocarbon    O
resins    O
,    O
using    O
distillates    O
from    O
cracking    O
of    O
the    O
naphtha    O
fraction    O
,    O
with    O
polymerisation    O
feedstock    O
including    O
isoprene    B-Alkene114713120
,    O
piperylene    B-Alkene114713120
and    O
cyclopentadiene    O
(    O
or    O
dicyclopentadiene    B-Alkene114713120
dimer    O
)    O
as    O
well    O
as    O
styrene    O
and    O
styrene    O
-    O
type    O
products    O
including    O
vinyltoluene    O
,    O
indene    O
,    O
methylindene    O
and    O
alpha-methylstyrene    B-Alkene114713120
.    O

Propallylonal    B-Alkene114713120
(    O
trade    O
names    O
Nostal    B-Alkene114713120
,    O
Quietal    B-Alkene114713120
,    O
Ibomal    B-Alkene114713120
)    O
is    O
a    O
barbiturate    O
derivative    O
invented    O
in    O
the    O
1920s    O
.    O

Fencamfamin    O
may    O
be    O
synthesized    O
in    O
a    O
straightforward    O
fashion    O
via    O
the    O
Diels    O
-    O
Alder    O
reaction    O
between    O
cyclopentadiene    O
and    O
β-nitrostyrene    B-Alkene114713120
(    O
1-nitro-2-phenyl    O
-    O
ethene    O
)    O
.    O

The    O
Diels    O
-    O
Alder    O
reaction    O
of    O
β-nitrostyrene    B-Alkene114713120
and    O
cyclopentadiene    O
is    O
described    O
in    O
a    O
number    O
of    O
early    O
papers    O
.    O

Possible    O
enophiles    O
contain    O
carbon    O
-    O
carbon    O
multiple    O
bonds    O
(    O
olefins    O
,    O
acetylenes    O
,    O
benzynes    O
)    O
,    O
carbon    O
-    O
hetero    O
multiple    O
bonds    O
(    O
C    O
=    O
O    O
in    O
the    O
case    O
of    O
carbonyl    O
-    O
ene    O
reactions    O
,    O
C    O
=    O
N    O
,    O
C    O
=    O
S    O
,    O
C≡P    O
)    O
,    O
hetero    O
-    O
hetero    O
multiple    O
bonds    O
(    O
N    O
=    O
N    O
,    O
O    O
=    O
O    O
,    O
Si    O
=    O
Si    O
,    O
N    O
=    O
O    O
,    O
S    O
=    O
O    O
)    O
,    O
cumulene    B-Alkene114713120
systems    O
(    O
N    O
=    O
S    O
=    O
O    O
,    O
N    O
=    O
S    O
=    O
N    O
,    O
C    O
=    O
C    O
=    O
O    O
,    O
C    O
=    O
C    O
=    O
S    O
,    O
SO2    O
)    O
and    O
charged    O
π    O
systems    O
(    O
C    O
=    O
N+    O
,    O
C    O
=    O
S+    O
,    O
C≡O+    O
,    O
C≡N+    O
)    O
.    O

The    O
most    O
commonly    O
depicted    O
form    O
is    O
the    O
alkyne    O
(    O
1    O
)    O
,    O
but    O
the    O
cumulene    B-Alkene114713120
(    O
1’    O
)    O
form    O
can    O
be    O
helpful    O
in    O
visualizing    O
ring    O
formation    O
by    O
[    O
4    O
+    O
2    O
]    O
cycloaddition    O
.    O

It    O
is    O
a    O
cyclic    O
cumulene    B-Alkene114713120
.    O

As    O
for    O
related    O
organic    O
cumulene    B-Alkene114713120
(    O
e.g.    O
ketene    B-Alkene114713120
)    O
,    O
C3O2    O
obeys    O
the    O
octet    O
rule    O
.    O

An    O
example    O
is    O
the    O
ozonolysis    O
of    O
eugenol    B-Alkene114713120
converting    O
the    O
terminal    O
alkene    O
to    O
an    O
aldehyde    O
:    O

Coniferyl    O
alcohol    O
is    O
an    O
intermediate    O
in    O
biosynthesis    O
of    O
eugenol    B-Alkene114713120
and    O
of    O
stilbenoids    O
and    O
coumarin    O
.    O

In    O
Indonesia    O
,    O
a    O
specific    O
type    O
of    O
cigarette    O
that    O
includes    O
cloves    O
called    O
"    O
kretek    O
"    O
was    O
invented    O
in    O
the    O
early    O
1880s    O
as    O
a    O
way    O
of    O
delivering    O
the    O
therapeutic    O
properties    O
of    O
clove    O
oil    O
,    O
or    O
eugenol    B-Alkene114713120
,    O
to    O
the    O
lungs    O
.    O

It    O
contains    O
the    O
chemical    O
eugenol    B-Alkene114713120
,    O
the    O
chemical    O
responsible    O
for    O
the    O
cinnamon    O
aroma    O
in    O
the    O
cinnamon    O
plant    O
.    O

The    O
phenylpropenes    O
,    O
including    O
eugenol    B-Alkene114713120
,    O
chavicol    B-Alkene114713120
,    O
safrole    B-Alkene114713120
and    O
estragole    B-Alkene114713120
,    O
are    O
derived    O
from    O
the    O
monolignols    O
.    O

Eugenol    B-Alkene114713120

The    O
primary    O
chemical    O
constituents    O
of    O
the    O
seed    O
include    O
cinnamaldehyde    B-Alkene114713120
,    O
gum    O
,    O
tannins    O
,    O
mannitol    O
,    O
coumarins    O
and    O
essential    O
oils    O
(    O
aldehydes    O
,    O
eugenol    B-Alkene114713120
and    O
pinene    B-Alkene114713120
)    O
.    O

Single    O
synthetic    O
compounds    O
are    O
commonly    O
used    O
as    O
bait    O
to    O
attract    O
and    O
collect    O
males    O
for    O
study    O
,    O
and    O
include    O
many    O
familiar    O
flavorings    O
and    O
odors    O
considered    O
appealing    O
to    O
humans    O
(    O
e.g.    O
,    O
methyl    O
salicylate    O
,    O
eugenol    B-Alkene114713120
,    O
cineole    O
,    O
benzyl    O
acetate    O
,    O
methyl    O
benzoate    O
,    O
methyl    B-Alkene114713120
cinnamate    I-Alkene114713120
)    O
,    O
and    O
others    O
which    O
are    O
not    O
(    O
e.g.    O
,    O
skatole    O
)    O
.    O

The    O
salts    O
are    O
dissolved    O
in    O
ethanol    O
and    O
mixed    O
with    O
essential    O
oils    O
high    O
in    O
eugenol    B-Alkene114713120
and    O
thymol    O
(    O
such    O
as    O
thyme    O
and    O
clove    O
oils    O
)    O
.    O

The    O
main    O
components    O
of    O
the    O
needle    O
essential    O
oil    O
include    O
terpineol    B-Alkene114713120
(    O
30.2%    O
)    O
,    O
linalool    O
(    O
24.47%    O
)    O
,    O
limonene    O
(    O
17.01%    O
)    O
,    O
anethole    B-Alkene114713120
(    O
14.57%    O
)    O
,    O
caryophyllene    B-Alkene114713120
(    O
3.14%    O
)    O
and    O
eugenol    B-Alkene114713120
(    O
2.14%    O
)    O
.    O

An    O
enyne    B-Alkene114713120
is    O
a    O
functional    O
group    O
in    O
organic    O
chemistry    O
consisting    O
of    O
a    O
conjugated    O
alkyne    O
and    O
alkene    O
group    O
.    O

Crotyl    B-Alkene114713120
alcohol    I-Alkene114713120
(    O
CH3CH    O
=    O
CH−CH2OH    O
)    O

Exemestane    B-Alkene114713120
,    O
a    O
drug    O
used    O
in    O
the    O
treatment    O
of    O
breast    O
cancer    O
,    O
is    O
an    O
inhibitor    O
of    O
the    O
aromatase    O
enzyme    O
.    O

Certain    O
medications    O
that    O
block    O
the    O
effect    O
of    O
estrogen    O
(    O
i.e.    O
tamoxifen    O
,    O
raloxifen    B-Alkene114713120
,    O
exemestane    B-Alkene114713120
)    O
can    O
reduce    O
the    O
risk    O
by    O
about    O
50%    O
but    O
also    O
have    O
side    O
effects    O
.    O

Breast    O
cancer    O
in    O
post    O
-    O
menopausal    O
women    O
with    O
advanced    O
hormone    O
-    O
receptor    O
positive    O
,    O
HER2-negative    O
type    O
cancer    O
,    O
in    O
conjunction    O
with    O
exemestane    B-Alkene114713120
(    O
US    O
FDA    O
July    O
2012    O
)    O

Interim    O
phase    O
III    O
trial    O
results    O
in    O
2011    O
showed    O
that    O
adding    O
Afinitor    O
(    O
everolimus    O
)    O
to    O
exemestane    B-Alkene114713120
therapy    O
against    O
advanced    O
breast    O
cancer    O
can    O
significantly    O
improve    O
progression    O
-    O
free    O
survival    O
compared    O
with    O
exemestane    O
therapy    O
alone    O
.    O

:    O
A11DA03    O
Benfotiamine    B-Alkene114713120

Gingerol    O
and    O
shogaol    B-Alkene114713120
,    O
the    O
active    O
piquant    O
flavor    O
chemicals    O
in    O
ginger    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
2-trans,6-trans-farnesol    B-Alkene114713120
,    O
and    O
one    O
product    O
,    O
2-cis,6-trans    O
-    O
farnesol    O
.    O

Oxidation    O
of    O
farnesene    O
then    O
provides    O
sesquiterpenoids    O
such    O
as    O
farnesol    B-Alkene114713120
.    O

Farnesol    B-Alkene114713120
is    O
used    O
by    O
the    O
fungus    O
"    O
Candida    O
albicans    O
"    O
as    O
a    O
quorum    O
sensing    O
molecule    O
that    O
inhibits    O
filamentation    O
.    O

Examples    O
of    O
sesquiterpenes    O
and    O
sesquiterpenoids    O
include    O
humulene    B-Alkene114713120
,    O
farnesene    B-Alkene114713120
,    O
farnesol    B-Alkene114713120
.    O

In    O
accordance    O
with    O
this    O
,    O
farnesol    B-Alkene114713120
and    O
geranylgeraniol    O
have    O
been    O
shown    O
to    O
be    O
able    O
to    O
rescue    O
effects    O
caused    O
by    O
statins    O
or    O
nitrogenous    O
bisphosphonates    O
,    O
further    O
supporting    O
that    O
alcohols    O
"    O
can    O
"    O
be    O
involved    O
in    O
prenylation    O
,    O
likely    O
via    O
phosphorylation    O
to    O
the    O
corresponding    O
isoprenoid    O
pyrophosphate    O
.    O

1,2-Dimethylcyclopropane    O
is    O
1    O
of    O
10    O
structural    O
isomers    O
(    O
cycloalkanes    O
and    O
aliphatic    O
alkenes    O
)    O
which    O
share    O
the    O
general    O
formula    O
of    O
C5H10    O
,    O
the    O
others    O
being    O
cyclopentane    O
,    O
methylcyclobutane    O
,    O
1,1-dimethylcyclopropane    O
,    O
ethylcyclopropane    O
,    O
1-pentene    B-Alkene114713120
,    O
2-pentene    B-Alkene114713120
,    O
2-methyl-1-butene    O
,    O
3-methyl-1-butene    O
,    O
and    O
2-methyl-2-butene    B-Alkene114713120
.    O

Ginsenoside    B-Alkene114713120
,    O
unique    O
phytochemicals    O
of    O
the    O
"    O
Panax    O
"    O
species    O
,    O
are    O
being    O
studied    O
for    O
their    O
potential    O
biological    O
properties    O
.    O

"    O
P.    O
notoginseng    O
"    O
contains    O
dammarane    O
-    O
type    O
ginsenosides    B-Alkene114713120
as    O
major    O
constituents    O
.    O

"    O
Panax    O
"    O
species    O
are    O
characterized    O
by    O
the    O
presence    O
of    O
ginsenoside    B-Alkene114713120
and    O
gintonin    O
.    O

Ecgonidine    B-Alkene114713120
(    O
anhydroecgonine    O
)    O
is    O
an    O
alkaloid    O
related    O
to    O
ecgonine    O
and    O
cocaine    O
.    O

Van    O
der    O
Waals    O
molecules    O
formed    O
with    O
organic    O
molecules    O
in    O
gas    O
include    O
aniline    O
,    O
dimethyl    O
ether    O
,    O
1,1-difluoroethylene    B-Alkene114713120
,    O
pyrimidine    O
,    O
chlorobenzene    O
,    O
cyclopentanone    O
,    O
cyanocyclobutane    O
,    O
and    O
cyclopentadienyl    O
.    O

Type    O
1    O
FKMs    O
are    O
composed    O
of    O
vinylidene    B-Alkene114713120
fluoride    I-Alkene114713120
(    O
VDF    O
)    O
and    O
hexafluoropropylene    O
(    O
HFP    O
)    O
.    O

The    O
enzyme    O
cyclizes    O
farnesyl    O
diphosphate    O
to    O
delta    O
-    O
cadinene    B-Alkene114713120
and    O
releases    O
pyrophosphate    O
.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    B-Alkene114713120
50%    O
,    O
thujene    B-Alkene114713120
,    O
and    O
carene    B-Alkene114713120
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
,    O
α-    O
and    O
β-cubebene    O
,    O
cadinene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
1,8-cineole    O
and    O
the    O
alcohol    O
cubebol    O
.    O

These    O
ambers    O
are    O
formed    O
from    O
resins    O
with    O
a    O
sesquiterpenoid    O
base    O
,    O
such    O
as    O
cadinene    B-Alkene114713120
.    O

Geiparvarin    B-Alkene114713120
is    O
a    O
coumarin    O
derivative    O
found    O
in    O
the    O
leaves    O
of    O
the    O
Australian    O
Willow    O
(    O
"    O
Geijera    O
parviflora    O
"    O
)    O
.    O

Skeletal    O
structure    O
of    O
calostomal    B-Alkene114713120
.    O

Hexyl    B-Alkene114713120
cinnamaldehyde    I-Alkene114713120

Pyramidal    B-Alkene114713120
alkenes    I-Alkene114713120
are    O
alkenes    O
in    O
which    O
the    O
two    O
carbon    O
atoms    O
making    O
up    O
the    O
double    O
bond    O
are    O
not    O
coplanar    O
with    O
their    O
four    O
substituents    O
.    O

elemicin    B-Alkene114713120
0.23%    O

Other    O
chemotypes    O
are    O
PK    O
(    O
perilla    O
ketone    O
)    O
,    O
EK    O
(    O
eschscholzia    O
ketone    O
)    O
,    O
PL    O
(    O
perillene    O
)    O
,    O
PP    O
(    O
phenylpropanoids    O
:    O
myristicin    B-Alkene114713120
,    O
dillapiole    B-Alkene114713120
,    O
elemicin    B-Alkene114713120
)    O
,    O
C    O
(    O
citral    O
)    O
and    O
a    O
type    O
rich    O
in    O
rosefuran    O
.    O

Elemicin    B-Alkene114713120

Other    O
ingredients    O
include    O
dicalcium    O
phosphate    O
,    O
microcrystalline    O
cellulose    O
,    O
croscarmellose    O
sodium    O
,    O
stearic    O
acid    O
,    O
film    O
coating    O
(    O
dextrin    O
)    O
,    O
titanium    O
dioxide    O
,    O
hydroxypropylmethyl    O
cellulose    O
,    O
Brilliant    B-Alkene114713120
Blue    I-Alkene114713120
FCF    I-Alkene114713120
,    O
aluminum    O
lake    O
,    O
Macrogol    O
/    O
PEG    O
8000    O
,    O
dextrose    O
monohydrate    O
,    O
lecithin    O
,    O
maltodextrin    O
,    O
Macrogol    O
/    O
PEG    O
400    O
,    O
magnesium    O
stearate    O
,    O
and    O
silica    O
.    O

Artificial    O
colors    O
(    O
Yellow    O
6    O
,    O
Blue    B-Alkene114713120
1    I-Alkene114713120
,    O
Yellow    O
5    O
and    O
Red    O
40    O
)    O

Image    O
:    O
Brilliant    O
Blue    O
Brilliant    B-Alkene114713120
Blue    I-Alkene114713120
FCF    I-Alkene114713120
,    O
a    O
common    O
food    O
colorant    O
.    O

People    O
have    O
occasionally    O
been    O
hospitalised    O
or    O
even    O
killed    O
by    O
honey    O
contaminated    O
with    O
tutin    B-Alkene114713120
.    O

Desformylflustrabromine    B-Alkene114713120

The    O
latter    O
two    O
(    O
axitinib    B-Alkene114713120
and    O
pazopanib    O
)    O
are    O
in    O
clinical    O
trials    O
.    O

Axitinib    B-Alkene114713120
,    O
a    O
drug    O
used    O
to    O
treat    O
renal    O
cell    O
carcinoma    O
,    O
has    O
been    O
shown    O
to    O
be    O
effective    O
at    O
inhibiting    O
the    O
Abl    O
kinase    O
activity    O
in    O
patients    O
with    O
BCR    O
-    O
ABL1(T315I    O
)    O
.    O

The    O
synthetic    O
analogs    O
that    O
like    O
PGF2α    O
act    O
as    O
selective    O
receptor    O
agonists    O
of    O
FP    O
viz    O
.    O
,    O
cloprostenol    O
,    O
flupostenol    O
,    O
latanoprost    O
,    O
and    O
tafluprost    O
(    O
acid    O
form    O
)    O
have    O
FP    O
binding    O
affinities    O
and    O
stimulating    O
potencies    O
similar    O
to    O
PGF2α    O
while    O
others    O
as    O
enprostil    O
,    O
sulprostone    B-Alkene114713120
,    O
U46619    O
,    O
carbacyclin    O
,    O
and    O
iloprost    B-Alkene114713120
are    O
considerably    O
weaker    O
FP    O
agonists    O
.    O

Cyanoacrylate    B-Alkene114713120
,    O
a    O
fast    O
-    O
acting    O
superglue    O

Latent    O
fingerprints    O
from    O
a    O
glass    O
were    O
enhanced    O
with    O
super    O
-    O
glue    O
fumes    O
in    O
the    O
form    O
of    O
cyanoacrylate    B-Alkene114713120
adhesive    O
and    O
photographed    O
.    O

Super    B-Alkene114713120
glue    I-Alkene114713120
,    O
which    O
can    O
also    O
be    O
used    O
to    O
suture    O
wounds    O
.    O

A.J.    O
does    O
n't    O
answer    O
it    O
;    O
his    O
face    O
is    O
Krazy    B-Alkene114713120
Glue    I-Alkene114713120
to    O
the    O
carpet    O
,    O
and    O
his    O
eyebrows    O
have    O
been    O
shaved    O
off    O
and    O
redrawn    O
with    O
a    O
permanent    O
marker    O
.    O

The    O
twins    O
seal    O
her    O
lips    O
with    O
super    B-Alkene114713120
glue    I-Alkene114713120
,    O
only    O
to    O
realize    O
that    O
she    O
is    O
unable    O
to    O
eat    O
.    O

Semi    O
-    O
permanent    O
lashes    O
,    O
also    O
known    O
as    O
individual    O
eyelash    O
extensions    O
,    O
are    O
eyelashes    O
applied    O
with    O
an    O
adhesive    O
which    O
is    O
usually    O
cyanoacrylate    B-Alkene114713120
.    O

Krazy    B-Alkene114713120
Glue    I-Alkene114713120
(    O
Tested    O
on    O
multiple    O
occasions    O
,    O
first    O
premiering    O
on    O
"    O
Consumer    O
Buyline    O
"    O
,    O
where    O
it    O
failed    O
-    O
not    O
once    O
,    O
but    O
twice    O
.    O

Nitriles    O
are    O
found    O
in    O
many    O
useful    O
compounds    O
,    O
including    O
methyl    B-Alkene114713120
cyanoacrylate    I-Alkene114713120
,    O
used    O
in    O
super    B-Alkene114713120
glue    I-Alkene114713120
,    O
and    O
nitrile    O
rubber    O
,    O
a    O
nitrile    O
-    O
containing    O
polymer    O
used    O
in    O
latex    O
-    O
free    O
laboratory    O
and    O
medical    O
gloves    O
.    O

ASA    O
can    O
be    O
glued    O
with    O
cyanoacrylate    B-Alkene114713120
;    O
uncured    O
resin    O
can    O
however    O
cause    O
stress    O
cracking    O
.    O

Chemence    O
(    O
Inc.    O
,    O
Ltd.    O
,    O
Medical    O
,    O
Graphics    O
)    O
is    O
a    O
multinational    O
conglomerate    O
which    O
manufactures    O
products    O
including    O
cyanoacrylate    B-Alkene114713120
adhesives    O
,    O
anaerobic    O
adhesives    O
,    O
impregnation    O
sealants    O
,    O
adhesive    O
activators    O
,    O
epoxy    O
resins    O
,    O
UV    O
adhesives    O
,    O
photopolymer    O
resins    O
,    O
custom    O
printer    O
ink    O
cartridges    O
,    O
Gas    O
pipe    O
sealants    O
,    O
and    O
soak    O
off    O
nail    O
polishes    O
.    O

In    O
1986    O
,    O
Chemence    O
Ltd.    O
acquired    O
the    O
assets    O
of    O
Alembic    O
Chemicals    O
,    O
a    O
cyanoacrylate    B-Alkene114713120
manufacturer    O
in    O
Dublin    O
,    O
Ireland    O
.    O

In    O
1993    O
,    O
Chemence    O
Inc.    O
relocated    O
to    O
Alpharetta    O
,    O
Georgia    O
,    O
and    O
became    O
the    O
only    O
manufacturer    O
of    O
cyanoacrylates    B-Alkene114713120
adhesives    O
and    O
sealants    O
in    O
the    O
US    O

In    O
1994    O
,    O
the    O
company    O
developed    O
and    O
patented    O
a    O
variant    O
of    O
superglue    B-Alkene114713120
used    O
to    O
repair    O
inoperable    O
aneurysms    O
in    O
the    O
brain    O
.    O

Jack    O
tries    O
to    O
clean    O
his    O
clothes    O
in    O
the    O
oven    O
to    O
be    O
presentable    O
for    O
his    O
meeting    O
with    O
Humphries    O
,    O
only    O
to    O
find    O
that    O
he    O
has    O
super-glued    B-Alkene114713120
a    O
carving    O
knife    O
to    O
his    O
hand    O
.    O

Common    O
usage    O
has    O
shown    O
the    O
glue    O
method    O
of    O
attaching    O
the    O
ball    O
to    O
be    O
troublesome    O
in    O
many    O
applications    O
as    O
some    O
commonly    O
used    O
glues    O
(    O
Super    B-Alkene114713120
Glue    I-Alkene114713120
)    O
tend    O
to    O
outgas    O
and    O
degrade    O
over    O
time    O
in    O
this    O
application    O
.    O

It    O
also    O
catalyzes    O
other    O
reactions    O
that    O
convert    O
enol    B-Alkene114713120
ether    I-Alkene114713120
,    O
dithioacetals    O
,    O
and    O
vinyl    O
sulfides    O
to    O
olefins    O
.    O

The    O
reaction    O
of    O
enolates    O
,    O
enol    B-Alkene114713120
ether    I-Alkene114713120
,    O
or    O
enol    O
acetates    O
with    O
NBS    O
is    O
the    O
preferred    O
method    O
of    O
α-bromination    O
as    O
it    O
is    O
high    O
-    O
yielding    O
with    O
few    O
side    O
-    O
products    O
.    O

An    O
aromatic    O
imine    O
reacts    O
with    O
an    O
enol    B-Alkene114713120
ether    I-Alkene114713120
to    O
a    O
quinoline    O
in    O
the    O
Povarov    O
reaction    O
.    O

3-Allylfentanyl    B-Alkene114713120

Alminoprofen    B-Alkene114713120
is    O
a    O
non    O
-    O
steroidal    O
anti    O
-    O
inflammatory    O
drug    O
.    O

The    O
intermediate    O
for    O
this    O
pathway    O
is    O
singlet    O
vinylidene    B-Alkene114713120
.    O

It    O
contains    O
subunits    O
derived    O
from    O
"    O
p    O
"-    O
coumaryl    O
alcohol    O
,    O
coniferyl    B-Alkene114713120
alcohol    I-Alkene114713120
,    O
and    O
sinapyl    O
alcohol    O
and    O
is    O
unusual    O
among    O
biomolecules    O
in    O
that    O
it    O
is    O
racemic    O
.    O

It    O
is    O
an    O
intermediate    O
in    O
the    O
biosynthesis    O
of    O
coniferyl    B-Alkene114713120
alcohol    I-Alkene114713120
,    O
the    O
conversion    O
being    O
effected    O
by    O
caffeate    O
O    O
-    O
methyltransferase    O
.    O

There    O
are    O
three    O
main    O
monolignols    O
:    O
coniferyl    B-Alkene114713120
alcohol    I-Alkene114713120
,    O
sinapyl    O
alcohol    O
and    O
paracoumaryl    O
alcohol    O
.    O

For    O
example    O
,    O
Norway    O
spruce    O
lignin    O
is    O
almost    O
entirely    O
coniferyl    B-Alkene114713120
alcohol    I-Alkene114713120
while    O
paracoumaryl    O
alcohol    O
is    O
found    O
almost    O
exclusively    O
in    O
grasses    O
.    O

Coniferyl    B-Alkene114713120
alcohol    I-Alkene114713120
is    O
an    O
organic    O
compound    O
.    O

Longifolene    B-Alkene114713120

Examples    O
include    O
longifolene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
and    O
the    O
alcohol    O
patchoulol    O
.    O

Raloxifene    B-Alkene114713120
(    O
Evista    O
)    O
,    O
which    O
has    O
a    O
reduced    O
risk    O
of    O
side    O
effects    O
,    O
is    O
used    O
as    O
an    O
alternative    O
,    O
but    O
it    O
has    O
not    O
been    O
studied    O
in    O
"    O
BRCA    O
"    O
mutation    O
carriers    O
specifically    O
.    O

Certain    O
medications    O
that    O
block    O
the    O
effect    O
of    O
estrogen    O
(    O
i.e.    O
tamoxifen    O
,    O
raloxifen    B-Alkene114713120
,    O
exemestane    B-Alkene114713120
)    O
can    O
reduce    O
the    O
risk    O
by    O
about    O
50%    O
but    O
also    O
have    O
side    O
effects    O
.    O

Daily    O
use    O
of    O
tamoxifen    O
or    O
raloxifene    B-Alkene114713120
has    O
been    O
demonstrated    O
to    O
reduce    O
the    O
risk    O
of    O
developing    O
breast    O
cancer    O
in    O
high    O
-    O
risk    O
women    O
.    O

The    O
additional    O
beneficial    O
effect    O
of    O
HRT    O
(    O
hormone    O
replacement    O
therapy    O
)    O
with    O
estrogens    O
/    O
progestins    O
or    O
raloxifene    B-Alkene114713120
in    O
postmenopausal    O
women    O
remains    O
to    O
be    O
elucidated    O
,    O
but    O
no    O
interactions    O
have    O
been    O
seen    O
.    O

On    O
May    O
4    O
,    O
2006    O
,    O
Lilly    O
was    O
ordered    O
to    O
pay    O
~$65    O
million    O
in    O
back    O
royalties    O
,    O
and    O
2.3%    O
royalties    O
on    O
future    O
sales    O
of    O
the    O
drugs    O
Evista    B-Alkene114713120
and    O
Xigris    O
which    O
inhibit    O
NF-κB    O
production    O
.    O

In    O
studies    O
of    O
breast    O
cancer    O
prevention    O
,    O
lasofoxifene    O
showed    O
a    O
79%    O
reduction    O
in    O
breast    O
cancer    O
incidence    O
and    O
an    O
83%    O
reduction    O
specific    O
incidence    O
of    O
estrogen    O
receptor    O
-    O
positive    O
breast    O
cancers    O
,    O
which    O
is    O
significantly    O
higher    O
than    O
reductions    O
found    O
with    O
the    O
related    O
SERMs    O
tamoxifen    O
and    O
raloxifene    B-Alkene114713120
.    O

CVS    O
is    O
a    O
terpene    O
cyclase    O
enzyme    O
responsible    O
for    O
the    O
biosynthesis    O
of    O
valencene    B-Alkene114713120
,    O
a    O
sesquiterpene    O
,    O
using    O
farnesyl    O
pyrophosphate    O
as    O
its    O
substrate    O
.    O

This    O
reaction    O
is    O
a    O
key    O
step    O
in    O
the    O
biosynthesis    O
of    O
sphingosine    B-Alkene114713120
which    O
is    O
a    O
precursor    O
of    O
many    O
other    O
sphingolipids    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acyl    O
-    O
CoA    O
and    O
sphingosine    B-Alkene114713120
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
N    O
-    O
acylsphingosine    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
CDP    O
-    O
choline    O
and    O
sphingosine    B-Alkene114713120
,    O
whereas    O
its    O
two    O
products    O
are    O
CMP    O
and    O
sphingosyl    O
-    O
phosphocholine    O
.    O

PAP    O
is    O
downregulated    O
by    O
sphingosine    B-Alkene114713120
and    O
dihydrosphingosine    O
.    O

The    O
lipid    O
complex    O
most    O
often    O
comprises    O
either    O
a    O
glycerol    O
or    O
a    O
sphingosine    B-Alkene114713120
backbone    O
,    O
which    O
engenders    O
glyceroglycolipids    O
and    O
sphingolipids    O
,    O
the    O
two    O
main    O
categories    O
of    O
glycolipids    O
.    O

The    O
heads    O
of    O
glycolipids    O
(    O
glyco-    O
stands    O
for    O
sugar    O
)    O
contain    O
a    O
sphingosine    B-Alkene114713120
with    O
one    O
or    O
several    O
sugar    O
units    O
attached    O
to    O
it    O
.    O

Sphingosine    B-Alkene114713120
is    O
an    O
amino    O
alcohol    O
that    O
contains    O
a    O
long    O
,    O
unsaturated    O
hydrocarbon    O
chain    O
.    O

They    O
tend    O
to    O
be    O
very    O
low    O
in    O
fruit    O
juice    O
,    O
as    O
fruit    O
juice    O
contains    O
natural    O
sugars    O
,    O
so    O
they    O
usually    O
also    O
contain    O
natural    O
or    O
artificial    O
flavourings    O
(    O
isoamyl    O
acetate    O
for    O
pear    O
or    O
banana    O
,    O
or    O
mixed    O
with    O
malic    O
acid    O
to    O
make    O
an    O
apple    O
-    O
like    O
flavour    O
,    O
ethyl    O
methylphenylglycidate    O
for    O
strawberry    O
,    O
octyl    O
acetate    O
for    O
orange    O
,    O
allyl    B-Alkene114713120
hexanoate    I-Alkene114713120
for    O
pineapple    O
etc    O
.    O
)    O
to    O
make    O
up    O
for    O
the    O
lack    O
of    O
fruit    O
juice    O
taste    O
.    O

Falcarinol    B-Alkene114713120

Ivy    O
foliage    O
contains    O
triterpenoid    O
saponins    O
and    O
falcarinol    B-Alkene114713120
.    O

Butallylonal    B-Alkene114713120
is    O
a    O
barbiturate    O
derivative    O
invented    O
in    O
the    O
1920s    O
.    O

Pulegone    B-Alkene114713120

pulegone    B-Alkene114713120

Pulegone    B-Alkene114713120
,    O
the    O
molecule    O
in    O
highest    O
concentration    O
in    O
the    O
pennyroyal    O
plant    O
,    O
causes    O
a    O
variety    O
of    O
ailments    O
in    O
those    O
who    O
ingest    O
it    O
and    O
is    O
what    O
causes    O
the    O
plant    O
to    O
have    O
its    O
peppermint    O
flavor    O
.    O

The    O
terpinenes    B-Alkene114713120
are    O
a    O
group    O
of    O
isomeric    O
hydrocarbons    O
that    O
are    O
classified    O
as    O
terpenes    O
.    O

γ-Terpinene    O
and    O
δ-terpinene    O
(    O
also    O
known    O
as    O
terpinolene    B-Alkene114713120
)    O
have    O
been    O
isolated    O
from    O
a    O
variety    O
of    O
plant    O
sources    O
.    O

The    O
process    O
starts    O
from    O
terpinene    B-Alkene114713120
which    O
reacts    O
with    O
oxygen    O
under    O
the    O
influence    O
of    O
chlorophyll    O
and    O
light    O
.    O

Sagebrush    O
essential    O
oil    O
contains    O
approximately    O
40%    O
"    O
l    O
"-    O
camphor    O
;    O
20%    O
pinene    B-Alkene114713120
;    O
7%    O
cineole    O
;    O
5%    O
methacrolein    B-Alkene114713120
;    O
and    O
12%    O
"a"-terpinene    B-Alkene114713120
,    O
"    O
d    O
"-    O
camphor    O
,    O
and    O
sesqiterpenoids    O
.    O

"    O
sinaicum    O
"    O
as    O
thymol    O
,    O
gamma-terpinene    B-Alkene114713120
and    O
p    O
-    O
cymene    O
,    O
in    O
descending    O
order    O
.    O

trans    O
"-    O
Cyclooctene    O
"    O
'    O
is    O
a    O
cycloalkene    B-Alkene114713120
with    O
an    O
eight    O
-    O
membered    O
ring    O
.    O

cis    O
"-    O
Cyclooctene    O
"    O
'    O
is    O
a    O
cycloalkene    B-Alkene114713120
with    O
the    O
formula    O
(    O
CH2)6(CH)2    O
.    O

Monocyclic    O
cycloalkene    B-Alkene114713120
are    O
cyclopropene    O
,    O
cyclobutene    O
,    O
cyclopentene    O
,    O
cyclohexene    O
,    O
cycloheptene    O
,    O
cyclooctene    O
,    O
and    O
so    O
on    O
.    O

igmesine    B-Alkene114713120
(    O
INN    O
)    O

(Hydroxyethyl)methacrylate    B-Alkene114713120
,    O
a    O
monomer    O

It    O
is    O
used    O
as    O
macroinitiator    O
to    O
initiate    O
the    O
copolymerisation    O
of    O
HEMA    B-Alkene114713120
and    O
DMAEMA    O
.    O

Vinyl    B-Alkene114713120
iodides    I-Alkene114713120
are    O
versatile    O
molecules    O
that    O
serve    O
as    O
important    O
building    O
blocks    O
and    O
precursors    O
in    O
organic    O
synthesis    O
.    O

Rivanicline    B-Alkene114713120
(    O
TC-2403    B-Alkene114713120
,    O
RJR-2403    B-Alkene114713120
,    O
(E)-metanicotine    B-Alkene114713120
)    O
is    O
a    O
drug    O
which    O
acts    O
as    O
a    O
partial    O
agonist    O
at    O
neural    O
nicotinic    O
acetylcholine    O
receptors    O
.    O

Neticonazole    B-Alkene114713120
(    O
INN    O
)    O
is    O
an    O
imidazole    O
antifungal    O
for    O
the    O
treatment    O
of    O
fungal    O
skin    O
infections    O
.    O

Neomogroside    B-Alkene114713120
is    O
a    O
cucurbitane    O
glycoside    O
isolated    O
from    O
the    O
fruit    O
of    O
"    O
Siraitia    O
grosvenorii    O
"    O
.    O

Big    O
Sagebrush    O
(    O
"    O
Artemisia    O
tridentata    O
"    O
)    O
contains    O
sesquiterpene    B-Alkene114713120
lactones    I-Alkene114713120
which    O
are    O
sesquiterpenoids    O
(    O
built    O
from    O
three    O
isoprene    B-Alkene114713120
units    O
)    O
and    O
contain    O
a    O
lactone    O
ring    O
,    O
hence    O
the    O
name    O
.    O

Artemisinins    O
are    O
sesquiterpene    B-Alkene114713120
lactone    I-Alkene114713120
isolated    O
from    O
"    O
Artemisia    O
annua    O
"    O
,    O
a    O
Chinese    O
traditional    O
medicine    O
.    O

The    O
genus    O
"    O
Crepis    O
"    O
is    O
a    O
rich    O
source    O
of    O
costus    O
lactone    O
-    O
type    O
guaianolides    O
,    O
a    O
class    O
of    O
sesquiterpene    B-Alkene114713120
lactone    I-Alkene114713120
.    O

Parthenolide    O
is    O
a    O
sesquiterpene    B-Alkene114713120
lactone    I-Alkene114713120
of    O
the    O
germacranolide    O
class    O
which    O
occurs    O
naturally    O
in    O
the    O
plant    O
feverfew    O
(    O
"    O
Tanacetum    O
parthenium    O
"    O
)    O
,    O
after    O
which    O
it    O
is    O
named    O
.    O

FOX-7    B-Alkene114713120
,    O
an    O
explosive    O

When    O
heated    O
above    O
,    O
acetic    O
acid    O
decomposes    O
to    O
produce    O
carbon    O
dioxide    O
and    O
methane    O
,    O
or    O
to    O
produce    O
ketene    B-Alkene114713120
and    O
water    O
:    O

Imines    O
react    O
,    O
thermally    O
,    O
with    O
ketenes    B-Alkene114713120
in    O
[    O
2    O
+    O
2    O
]    O
cycloadditions    O
to    O
form    O
β-lactams    O
in    O
the    O
Staudinger    O
synthesis    O
.    O

There    O
are    O
a    O
few    O
examples    O
of    O
thermal    O
cycloadditions    O
which    O
have    O
4"n    O
"    O
π    O
electrons    O
(    O
for    O
example    O
the    O
[    O
2    O
+    O
2    O
]    O
cycloaddition    O
)    O
;    O
these    O
proceed    O
in    O
a    O
suprafacial    O
-    O
antarafacial    O
sense    O
,    O
such    O
as    O
the    O
dimerisation    O
of    O
ketene    B-Alkene114713120
,    O
in    O
which    O
the    O
orthogonal    O
set    O
of    O
p    O
orbitals    O
allows    O
the    O
reaction    O
to    O
proceed    O
via    O
a    O
crossed    O
transition    O
state    O
.    O

He    O
is    O
also    O
known    O
for    O
his    O
discovery    O
of    O
ketene    B-Alkene114713120
and    O
of    O
the    O
Staudinger    O
reaction    O
.    O

It    O
was    O
here    O
that    O
he    O
discovered    O
the    O
ketene    B-Alkene114713120
,    O
a    O
family    O
of    O
molecules    O
characterized    O
by    O
the    O
general    O
form    O
depicted    O
in    O
Figure    O
1    O
.    O

The    O
Staudinger    O
Synthesis    O
,    O
also    O
called    O
the    O
Staudinger    O
Ketene    O
-    O
Imine    O
Cycloaddition    O
,    O
is    O
a    O
chemical    O
synthesis    O
in    O
which    O
an    O
imine    O
reacts    O
with    O
a    O
ketene    B-Alkene114713120
through    O
a    O
non    O
-    O
photochemical    O
2    O
+    O
2    O
cycloaddition    O
to    O
produce    O
a    O
"    O
β"-lactam    O
.    O

As    O
for    O
related    O
organic    O
cumulene    B-Alkene114713120
(    O
e.g.    O
ketene    B-Alkene114713120
)    O
,    O
C3O2    O
obeys    O
the    O
octet    O
rule    O
.    O

This    O
molecule    O
is    O
catalytically    O
synthesized    O
at    O
350    O
°C    O
from    O
ketene    B-Alkene114713120
and    O
hydrogen    O
cyanide    O
.    O

Recent    O
clinical    O
studies    O
have    O
verified    O
that    O
red    O
alder    O
contains    O
betulin    B-Alkene114713120
and    O
lupeol    B-Alkene114713120
,    O
compounds    O
shown    O
to    O
be    O
effective    O
against    O
a    O
variety    O
of    O
tumors    O
.    O

It    O
also    O
contains    O
glaucarubol    O
,    O
a    O
compound    O
characteristic    O
of    O
the    O
family    O
,    O
ellagic    O
acid    O
,    O
betulin    B-Alkene114713120
and    O
(    O
—)-syringaresinol    O
.    O

Combined    O
carbon    O
and    O
hydrogen    O
isotope    O
analysis    O
has    O
been    O
used    O
to    O
test    O
the    O
authenticity    O
of    O
(E)-methyl    B-Alkene114713120
cinnamate    I-Alkene114713120
,    O
γ-decalactone    O
and    O
δ-decalactone    O
.    O

Single    O
synthetic    O
compounds    O
are    O
commonly    O
used    O
as    O
bait    O
to    O
attract    O
and    O
collect    O
males    O
for    O
study    O
,    O
and    O
include    O
many    O
familiar    O
flavorings    O
and    O
odors    O
considered    O
appealing    O
to    O
humans    O
(    O
e.g.    O
,    O
methyl    O
salicylate    O
,    O
eugenol    B-Alkene114713120
,    O
cineole    O
,    O
benzyl    O
acetate    O
,    O
methyl    O
benzoate    O
,    O
methyl    B-Alkene114713120
cinnamate    I-Alkene114713120
)    O
,    O
and    O
others    O
which    O
are    O
not    O
(    O
e.g.    O
,    O
skatole    O
)    O
.    O

The    O
taste    O
of    O
Ecuadorian    O
cinnamon    O
is    O
thought    O
to    O
come    O
from    O
the    O
presence    O
of    O
methyl    B-Alkene114713120
cinnamate    I-Alkene114713120
and    O
trans-cinnamaldehyde    B-Alkene114713120
which    O
are    O
also    O
found    O
in    O
the    O
essential    O
oils    O
which    O
come    O
from    O
the    O
flower    O
calices    O
of    O
the    O
plant    O
.    O

Citronellol    O
is    O
used    O
as    O
a    O
raw    O
material    O
for    O
the    O
production    O
of    O
rose    B-Alkene114713120
oxide    I-Alkene114713120
.    O

First    O
,    O
1-butene    B-Alkene114713120
is    O
protonated    O
so    O
that    O
a    O
secondary    O
carbocation    O
is    O
formed    O
.    O

Examples    O
of    O
linear    O
alpha    O
-    O
olefins    O
are    O
propene    O
,    O
1-butene    B-Alkene114713120
and    O
1-decene    B-Alkene114713120
.    O

Polybutylene    O
is    O
produced    O
by    O
polymerisation    O
of    O
1-butene    B-Alkene114713120
using    O
supported    O
Ziegler    O
–    O
Natta    O
catalysts    O
.    O

Several    O
useful    O
structural    O
isomers    O
of    O
the    O
octenes    O
are    O
obtained    O
by    O
dimerization    O
of    O
isobutene    O
and    O
1-butene    B-Alkene114713120
.    O

Ethylene    B-Alkene114713120
glycol    I-Alkene114713120
dimethacrylate    I-Alkene114713120
(    O
EGDMA    O
)    O

Ethallobarbital    B-Alkene114713120

Pumiliotoxin    B-Alkene114713120

Kibayashi    O
and    O
coworkers    O
utilized    O
the    O
Negishi    O
coupling    O
in    O
the    O
total    O
synthesis    O
of    O
Pumiliotoxin    B-Alkene114713120
B.    O
Pumiliotoxin    O
B    O
is    O
one    O
of    O
the    O
major    O
toxic    O
alkaloids    O
isolated    O
from    O
Dendrobates    O
pumilio    O
,    O
a    O
Panamanian    O
poison    O
frog    O
.    O

Nalmefene    B-Alkene114713120

Nalmefene    B-Alkene114713120
is    O
similar    O
to    O
naltrexone    O
and    O
is    O
used    O
for    O
the    O
same    O
purposes    O
as    O
naltrexone    O
.    O

Nalmefene    B-Alkene114713120

Nalmefene    B-Alkene114713120

The    O
use    O
of    O
endocannabinoids    O
such    O
as    O
anandamide    B-Alkene114713120
and    O
2-arachidonoyl    B-Alkene114713120
glycerol    I-Alkene114713120
in    O
this    O
method    O
of    O
signalling    O
is    O
quite    O
logical    O
,    O
since    O
both    O
molecules    O
can    O
be    O
synthesized    O
relatively    O
easily    O
from    O
lipids    O
in    O
the    O
plasma    O
membrane    O
,    O
a    O
fundamental    O
constituent    O
of    O
all    O
cells    O
.    O

Interestingly    O
,    O
some    O
work    O
has    O
shown    O
that    O
anandamide    B-Alkene114713120
can    O
bind    O
to    O
the    O
vannilloid    O
receptor    O
VR1    O
,    O
the    O
receptor    O
responsible    O
for    O
mediating    O
the    O
effects    O
of    O
capsaicin    O
.    O

O    O
"-    O
Arachidonoyl    O
ethanolamine    O
is    O
arachidonic    O
acid    O
and    O
ethanolamine    O
joined    O
by    O
an    O
ester    O
linkage    O
,    O
the    O
opposite    O
of    O
the    O
amide    O
linkage    O
found    O
in    O
anandamide    B-Alkene114713120
.    O

Concentrations    O
of    O
virodhamine    O
in    O
the    O
human    O
hippocampus    O
are    O
similar    O
to    O
those    O
of    O
anandamide    B-Alkene114713120
,    O
but    O
they    O
are    O
2-    O
to    O
9-fold    O
higher    O
in    O
peripheral    O
tissues    O
that    O
express    O
CB2    O
.    O

Anandamide    B-Alkene114713120

It    O
displays    O
high    O
selectivity    O
for    O
MAGL    O
over    O
other    O
brain    O
serine    O
hydrolases    O
,    O
including    O
the    O
anandamide    B-Alkene114713120
-    O
degrading    O
enzyme    O
fatty    O
acid    O
amide    O
hydrolase    O
(    O
FAAH    O
)    O
,    O
thereby    O
making    O
it    O
a    O
useful    O
tool    O
for    O
studying    O
the    O
effects    O
of    O
endogenous    O
2-AG    B-Alkene114713120
signaling    O
,    O
"    O
in    O
vivo    O
"    O
.    O

AM404    O
was    O
originally    O
reported    O
to    O
be    O
an    O
endogenous    O
cannabinoid    O
reuptake    O
inhibitor    O
,    O
preventing    O
the    O
transport    O
of    O
anandamide    B-Alkene114713120
and    O
other    O
related    O
compounds    O
back    O
from    O
the    O
synaptic    O
cleft    O
,    O
much    O
in    O
the    O
same    O
way    O
that    O
common    O
selective    O
serotonin    O
reuptake    O
inhibitor    O
(    O
SSRI    O
)    O
antidepressants    O
prevent    O
the    O
reuptake    O
of    O
serotonin    O
.    O

Earlier    O
work    O
on    O
the    O
mechanism    O
of    O
AM404    O
suggested    O
that    O
the    O
inhibition    O
of    O
fatty    O
acid    O
amide    O
hydrolase    O
(    O
FAAH    O
)    O
by    O
AM404    O
was    O
responsible    O
for    O
all    O
of    O
its    O
attributed    O
reuptake    O
properties    O
,    O
since    O
intracellular    O
FAAH    O
hydrolysis    O
of    O
anandamide    B-Alkene114713120
changes    O
the    O
intra    O
/    O
extracellular    O
anandamide    O
equilibrium    O
.    O

Insulin    O
is    O
a    O
major    O
regulator    O
of    O
endocannabinoid    O
(    O
EC    O
)    O
metabolism    O
and    O
insulin    O
treatment    O
has    O
been    O
shown    O
to    O
reduce    O
intracellular    O
ECs    O
,    O
the    O
2-arachidonylglycerol    B-Alkene114713120
(    O
2-AG    O
)    O
and    O
anandamide    B-Alkene114713120
(    O
AEA    O
)    O
,    O
which    O
correspond    O
with    O
insulin    O
-    O
sensitive    O
expression    O
changes    O
in    O
enzymes    O
of    O
EC    O
metabolism    O
.    O

It    O
has    O
been    O
shown    O
that    O
the    O
actions    O
of    O
abnormal    O
cannabidiol    O
are    O
mediated    O
through    O
a    O
site    O
separate    O
from    O
the    O
CB1    O
and    O
CB2    O
receptors    O
,    O
which    O
responds    O
to    O
abnormal    O
cannabidiol    O
,    O
O-1602    O
,    O
and    O
the    O
endogenous    O
ligands    O
:    O
anandamide    B-Alkene114713120
(    O
AEA    O
)    O
,    O
N    O
-    O
arachidonoyl    O
glycine    O
(    O
NAGly    O
)    O
and    O
N    O
-    O
arachidonoyl    O
L    O
-    O
serine    O
.    O

counteracting    O
the    O
effects    O
of    O
anandamide    B-Alkene114713120
,    O
another    O
potent    O
hunger    O
promoter    O
that    O
binds    O
to    O
the    O
same    O
receptors    O
as    O
THC    O

It    O
is    O
found    O
that    O
truffles    O
contain    O
the    O
endocannabinoid    O
anandamide    B-Alkene114713120
(    O
AEA    O
)    O
and    O
the    O
major    O
metabolic    O
enzymes    O
of    O
the    O
endocannabinoid    O
system    O
ECS    O
,    O
and    O
the    O
anandamide    O
content    O
increases    O
in    O
the    O
late    O
stages    O
of    O
truffles’    O
development    O
.    O

Exercise    O
is    O
known    O
to    O
affect    O
dopamine    O
signaling    O
in    O
the    O
nucleus    O
accumbens    O
,    O
producing    O
euphoria    O
as    O
a    O
result    O
,    O
through    O
increased    O
biosynthesis    O
of    O
three    O
particular    O
neurochemicals    O
:    O
anandamide    B-Alkene114713120
(    O
an    O
endocannabinoid    O
)    O
,    O
β-endorphin    O
(    O
an    O
endogenous    O
opioid    O
)    O
,    O
and    O
phenethylamine    O
(    O
a    O
trace    O
amine    O
and    O
amphetamine    O
analog    O
)    O
.    O

Cannabinoid    O
receptor    O
1    O
agonists    O
are    O
a    O
group    O
of    O
euphoriants    O
that    O
includes    O
certain    O
plant    O
-    O
based    O
cannabinoids    O
(    O
e.g.    O
,    O
THC    O
from    O
the    O
cannabis    O
plant    O
)    O
,    O
endogenous    O
cannabinoids    O
(    O
e.g.    O
,    O
anandamide    B-Alkene114713120
)    O
,    O
and    O
synthetic    O
cannabinoids    O
.    O

The    O
endocannabinoids    O
(    O
anandamide    B-Alkene114713120
,    O
AEA    O
,    O
and    O
2-arachidonoylglycerol    B-Alkene114713120
,    O
2-AG    O
)    O
on    O
the    O
other    O
hand    O
,    O
are    O
non    O
-    O
charged    O
lipids    O
that    O
readily    O
cross    O
lipid    O
membranes    O
.    O

The    O
plant    O
contains    O
an    O
essential    O
oil    O
(    O
0.5%    O
)    O
which    O
consists    O
of    O
monoterpenoids    O
and    O
sesquiterpenoids    O
:    O
α-pinene    B-Alkene114713120
,    O
β-pinene    B-Alkene114713120
,    O
1,4-cineol    O
,    O
fenchone    O
,    O
α-humulene    B-Alkene114713120
,    O
β-caryophyllene    B-Alkene114713120
,    O
trans-β-bergamotene    O
.    O

Caryophyllene    B-Alkene114713120
,    O
or    O
(    O
−)-β-caryophyllene    O
,    O
is    O
a    O
natural    O
bicyclic    O
sesquiterpene    O
that    O
is    O
a    O
constituent    O
of    O
many    O
essential    O
oils    O
,    O
especially    O
clove    O
oil    O
,    O
the    O
oil    O
from    O
the    O
stems    O
and    O
flowers    O
of    O
"    O
Syzygium    O
aromaticum    O
"    O
(    O
cloves    O
)    O
,    O
the    O
essential    O
oil    O
of    O
"    O
Cannabis    O
sativa    O
"    O
,    O
rosemary    O
,    O
and    O
hops    O
.    O

Humulene    O
is    O
an    O
isomer    O
of    O
β-caryophyllene    B-Alkene114713120
,    O
and    O
the    O
two    O
are    O
often    O
found    O
together    O
as    O
a    O
mixture    O
in    O
many    O
aromatic    O
plants    O
.    O

Caryophyllene    B-Alkene114713120
,    O
a    O
component    O
of    O
many    O
essential    O
oils    O
such    O
as    O
clove    O
oil    O
,    O
contains    O
a    O
nine    O
-    O
membered    O
ring    O
fused    O
to    O
a    O
cyclobutane    O
ring    O
.    O

The    O
aroma    O
and    O
flavor    O
of    O
hops    O
comes    O
,    O
in    O
part    O
,    O
from    O
sesquiterpenes    O
(    O
mainly    O
alpha-humulene    B-Alkene114713120
and    O
beta-caryophyllene    B-Alkene114713120
)    O
,    O
which    O
affect    O
beer    O
quality    O
.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    B-Alkene114713120
50%    O
,    O
thujene    B-Alkene114713120
,    O
and    O
carene    B-Alkene114713120
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    B-Alkene114713120
,    O
copaene    B-Alkene114713120
,    O
α-    O
and    O
β-cubebene    O
,    O
cadinene    B-Alkene114713120
,    O
germacrene    B-Alkene114713120
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
1,8-cineole    O
and    O
the    O
alcohol    O
cubebol    O
.    O

The    O
main    O
components    O
of    O
the    O
needle    O
essential    O
oil    O
include    O
terpineol    B-Alkene114713120
(    O
30.2%    O
)    O
,    O
linalool    O
(    O
24.47%    O
)    O
,    O
limonene    O
(    O
17.01%    O
)    O
,    O
anethole    B-Alkene114713120
(    O
14.57%    O
)    O
,    O
caryophyllene    B-Alkene114713120
(    O
3.14%    O
)    O
and    O
eugenol    B-Alkene114713120
(    O
2.14%    O
)    O
.    O

JZL184    O
is    O
an    O
irreversible    O
inhibitor    O
for    O
monoacylglycerol    O
lipase    O
(    O
MAGL    O
)    O
,    O
the    O
primary    O
enzyme    O
responsible    O
for    O
degrading    O
the    O
endocannabinoid    O
2-arachidonoylglycerol    B-Alkene114713120
(    O
2-AG    O
)    O
.    O

It    O
displays    O
high    O
selectivity    O
for    O
MAGL    O
over    O
other    O
brain    O
serine    O
hydrolases    O
,    O
including    O
the    O
anandamide    B-Alkene114713120
-    O
degrading    O
enzyme    O
fatty    O
acid    O
amide    O
hydrolase    O
(    O
FAAH    O
)    O
,    O
thereby    O
making    O
it    O
a    O
useful    O
tool    O
for    O
studying    O
the    O
effects    O
of    O
endogenous    O
2-AG    B-Alkene114713120
signaling    O
,    O
"    O
in    O
vivo    O
"    O
.    O

Administration    O
of    O
JZL184    O
to    O
mice    O
was    O
reported    O
to    O
cause    O
dramatic    O
elevation    O
of    O
brain    O
2-AG    B-Alkene114713120
leading    O
to    O
several    O
cannabinoid    O
-    O
related    O
behavioral    O
effects    O
.    O

However    O
,    O
it    O
is    O
also    O
found    O
that    O
consumption    O
of    O
food    O
for    O
pleasure    O
increased    O
peripheral    O
levels    O
of    O
both    O
ghrelin    O
and    O
the    O
endocannabinoid    O
2-arachidonoyl-glycerol    B-Alkene114713120
(    O
2-AG    O
)    O
in    O
healthy    O
humans    O
,    O
and    O
this    O
hedonic    O
eating    O
influences    O
food    O
intake    O
and    O
,    O
ultimately    O
,    O
body    O
mass    O
.    O

Insulin    O
is    O
a    O
major    O
regulator    O
of    O
endocannabinoid    O
(    O
EC    O
)    O
metabolism    O
and    O
insulin    O
treatment    O
has    O
been    O
shown    O
to    O
reduce    O
intracellular    O
ECs    O
,    O
the    O
2-arachidonylglycerol    B-Alkene114713120
(    O
2-AG    O
)    O
and    O
anandamide    B-Alkene114713120
(    O
AEA    O
)    O
,    O
which    O
correspond    O
with    O
insulin    O
-    O
sensitive    O
expression    O
changes    O
in    O
enzymes    O
of    O
EC    O
metabolism    O
.    O

The    O
endocannabinoids    O
(    O
anandamide    B-Alkene114713120
,    O
AEA    O
,    O
and    O
2-arachidonoylglycerol    B-Alkene114713120
,    O
2-AG    O
)    O
on    O
the    O
other    O
hand    O
,    O
are    O
non    O
-    O
charged    O
lipids    O
that    O
readily    O
cross    O
lipid    O
membranes    O
.    O

Examples    O
of    O
linear    O
alpha    O
-    O
olefins    O
are    O
propene    O
,    O
1-butene    B-Alkene114713120
and    O
1-decene    B-Alkene114713120
.    O

Dicrotophos    B-Alkene114713120

Goitrin    B-Alkene114713120
is    O
a    O
sulfur    O
-    O
containing    O
oxazolidine    O
,    O
a    O
cyclic    O
thiocarbamate    O
,    O
that    O
reduces    O
the    O
production    O
of    O
thyroid    O
hormones    O
such    O
as    O
thyroxine    O
.    O

As    O
a    O
food    O
additive    O
,    O
it    O
has    O
E    O
number    O
E131    B-Alkene114713120
.    O

Cinepazet    B-Alkene114713120
is    O
a    O
vasodilator    O
and    O
is    O
an    O
ethyl    O
ester    O
derivative    O
of    O
cinepazic    O
acid    O
.    O

Allylnorpethidine    B-Alkene114713120

During    O
the    O
brewing    O
process    O
,    O
humulone    O
degrades    O
to    O
"    O
cis-    O
"    O
and    O
"    O
isohumulone    B-Alkene114713120
.    O

Proxibarbital    B-Alkene114713120
(    O
Ipronal    O
)    O
is    O
a    O
barbiturate    O
derivative    O
synthesized    O
in    O
1956    O
.    O

Solanidine    B-Alkene114713120
is    O
a    O
poisonous    O
steroidal    O
alkaloid    O
chemical    O
compound    O
that    O
occurs    O
in    O
plants    O
of    O
the    O
Solanaceae    O
family    O
,    O
such    O
as    O
potato    O
and    O
"    O
Solanum    O
americanum    O
"    O
.    O

1,3-Dichloropropene    B-Alkene114713120
,    O
sold    O
under    O
diverse    O
trade    O
names    O
,    O
is    O
an    O
organochlorine    O
compound    O
.    O

Apronal    B-Alkene114713120

Alimadol    B-Alkene114713120
(    O
INN    O
;    O
A-4020    B-Alkene114713120
)    O
is    O
an    O
opioid    O
analgesic    O
related    O
to    O
methadone    O
which    O
was    O
never    O
marketed    O
.    O

Viqualine    B-Alkene114713120
(    O
INN    O
)    O
(    O
developmental    O
code    O
name    O
PK-5078    B-Alkene114713120
)    O
is    O
an    O
antidepressant    O
and    O
anxiolytic    O
drug    O
that    O
was    O
never    O
marketed    O
.    O

Poly(methyl    O
vinyl    O
ether    O
)    O
,    O
a    O
polymer    O
of    O
methyl    B-Alkene114713120
vinyl    I-Alkene114713120
ether    I-Alkene114713120

It    O
produces    O
forskolin    B-Alkene114713120
,    O
an    O
extract    O
useful    O
for    O
pharmaceutical    O
preparations    O
and    O
research    O
in    O
cell    O
biology    O
.    O

Forskolin    B-Alkene114713120
,    O
which    O
derives    O
its    O
name    O
from    O
the    O
former    O
binomial    O
name    O
"    O
Coleus    O
forskohlii    O
"    O
,    O
is    O
a    O
constituent    O
of    O
"    O
Plectranthus    O
barbatus    O
"    O
.    O

Chemical    O
structure    O
of    O
forskolin    B-Alkene114713120
.    O

The    O
MONARCH    O
3    O
study    O
is    O
investigating    O
the    O
effectiveness    O
of    O
Abemaciclib    O
,    O
plus    O
either    O
anastrozole    O
or    O
letrozole    B-Alkene114713120
,    O
as    O
a    O
first    O
-    O
line    O
treatment    O
for    O
women    O
with    O
breast    O
cancer    O
.    O

File    O
:    O
Letrozole.svg|Structure    O
of    O
letrozole    B-Alkene114713120
,    O
an    O
oral    O
nonsteroidal    O
aromatase    O
inhibitor    O
for    O
the    O
treatment    O
of    O
certain    O
breast    O
cancers    O
.    O

Instead    O
of    O
in    O
vitro    O
fertilization    O
,    O
they    O
opted    O
to    O
switch    O
Danielle    O
to    O
Femara    B-Alkene114713120
and    O
attempted    O
intrauterine    O
insemination    O
again    O
,    O
ultimately    O
becoming    O
pregnant    O
with    O
Blayke    O
.    O

Letrozole    B-Alkene114713120
(    O
INN    O
,    O
trade    O
name    O
Femara    B-Alkene114713120
)    O
is    O
an    O
orally    O
active    O
nonsteroidal    O
aromatase    O
inhibitor    O
for    O
the    O
treatment    O
of    O
hormonally    O
-    O
responsive    O
breast    O
cancer    O
after    O
surgery    O
.    O

letrozole    B-Alkene114713120
(    O
aromatase    O
inhibitor    O
,    O
used    O
in    O
breast    O
cancer    O
)    O

The    O
original    O
1963    O
reaction    O
described    O
the    O
dimerization    O
of    O
the    O
ethyl    B-Alkene114713120
acrylate    I-Alkene114713120
to    O
the    O
ethyl    O
diester    O
of    O
2-methylene    O
-    O
glutaric    O
acid    O
with    O
tributylphosphine    O
in    O
acetonitrile    O
:    O

Ethyl    B-Alkene114713120
acrylate    I-Alkene114713120

Naftifine    B-Alkene114713120
,    O
an    O
allylamine    O
antifungal    O
drug    O
for    O
the    O
topical    O
treatment    O
of    O
tinea    O
pedis    O
,    O
tinea    O
cruris    O
,    O
and    O
tinea    O
corporis    O

naftifine    B-Alkene114713120

Ecdysteroids    O
are    O
insect    O
moulting    O
and    O
sex    O
hormones    O
;    O
examples    O
of    O
ecdysteroids    O
include    O
ecdysone    O
,    O
ecdysterone    B-Alkene114713120
,    O
turkesterone    O
and    O
20-hydroxyecdysone    B-Alkene114713120
.    O

The    O
skeleton    O
is    O
rich    O
in    O
histidine    O
and    O
contains    O
the    O
unusual    O
ecdysterone    B-Alkene114713120
,    O
ajugasterone    O
-    O
C.    O
The    O
growth    O
rate    O
of    O
the    O
colony    O
is    O
slow    O
and    O
carbon-14    O
dating    O
techniques    O
have    O
given    O
an    O
age    O
of    O
2,700    O
years    O
,    O
giving    O
this    O
zoanthid    O
one    O
of    O
the    O
longest    O
lifespans    O
of    O
any    O
organism    O
on    O
Earth    O
.    O

It    O
is    O
the    O
base    O
chemical    O
structure    O
of    O
various    O
alkaloids    O
in    O
the    O
"    O
Rauwolfia    O
"    O
and    O
"    O
Pausinystalia    O
"    O
plant    O
genera    O
,    O
including    O
yohimbine    O
,    O
rauwolscine    O
,    O
corynanthine    O
,    O
ajmalicine    O
,    O
reserpine    O
,    O
deserpidine    O
,    O
and    O
rescinnamine    B-Alkene114713120
,    O
among    O
others    O
.    O

Moderil    B-Alkene114713120

Pomarose    B-Alkene114713120
is    O
a    O
high    O
-    O
impact    O
captive    O
odorant    O
patented    O
by    O
Givaudan    O
.    O

The    O
boxed    O
warning    O
had    O
been    O
included    O
for    O
the    O
drugs    O
Tecfidera    B-Alkene114713120
and    O
Gilenya    O
,    O
both    O
of    O
which    O
have    O
had    O
incidences    O
of    O
PML    O
resulting    O
in    O
death    O
.    O

Non    O
-    O
biologic    O
systemic    O
treatments    O
frequently    O
used    O
for    O
psoriasis    O
include    O
methotrexate    O
,    O
ciclosporin    O
,    O
hydroxycarbamide    O
,    O
fumarates    O
such    O
as    O
dimethyl    B-Alkene114713120
fumarate    I-Alkene114713120
,    O
and    O
retinoids    O
.    O

2011    O
–    O
Dimethyl    B-Alkene114713120
fumarate    I-Alkene114713120
-    O
Dimethyl    O
fumarate    O
is    O
the    O
chemical    O
associated    O
with    O
'    O
poisoned    O
chairs    O
'    O
and    O
'    O
toxic    O
sandals    O
'    O
.    O

When    O
used    O
with    O
methyl    B-Alkene114713120
methacrylate    I-Alkene114713120
,    O
it    O
leads    O
to    O
gel    O
point    O
at    O
relatively    O
low    O
concentrations    O
because    O
of    O
the    O
nearly    O
equivalent    O
reactivities    O
of    O
all    O
the    O
double    O
bonds    O
involved    O
.    O

These    O
derivatives    O
include    O
the    O
parent    O
acid    O
(    O
CH2C(CH3)CO2H    O
)    O
,    O
salts    O
(    O
e.g.    O
,    O
CH2C(CH3)CO2−Na+    O
)    O
,    O
esters    O
(    O
e.g.    O
CH2C(CH3)CO2CH3    O
,    O
or    O
methyl    B-Alkene114713120
methacrylate    I-Alkene114713120
)    O
and    O
the    O
polymers    O
of    O
these    O
species    O
.    O

Methyl    B-Alkene114713120
methacrylate    I-Alkene114713120

Following    O
the    O
procedure    O
,    O
in    O
rare    O
cases    O
,    O
a    O
screw    O
,    O
broken    O
piece    O
of    O
trochanteric    O
wire    O
,    O
fragment    O
of    O
methyl    B-Alkene114713120
methacrylate    I-Alkene114713120
bone    O
cement    O
,    O
or    O
Burch    O
-    O
Schneider    O
metal    O
cage    O
can    O
impinge    O
on    O
the    O
nerve    O
;    O
this    O
can    O
cause    O
sciatic    O
nerve    O
palsy    O
which    O
may    O
resolve    O
after    O
the    O
fragment    O
is    O
removed    O
and    O
the    O
nerve    O
freed    O
.    O

QUINN    O
Chemicals    O
invested    O
in    O
a    O
plant    O
to    O
manufacture    O
methyl    B-Alkene114713120
methacrylate    I-Alkene114713120
(    O
MMA    O
)    O
but    O
construction    O
has    O
halted    O
as    O
of    O
January    O
2009    O
due    O
to    O
heavy    O
cost    O
overruns    O
.    O

The    O
wires    O
are    O
then    O
placed    O
on    O
the    O
shelf    O
and    O
a    O
methyl    B-Alkene114713120
methacrylate    I-Alkene114713120
gel    O
glue    O
is    O
applied    O
in    O
several    O
coats    O
,    O
with    O
care    O
taken    O
to    O
avoid    O
covering    O
the    O
conductive    O
tips    O
.    O

PTTCG    O
could    O
produce    O
in    O
collaboration    O
with    O
joint    O
-    O
venture    O
partners    O
polypropylene    O
,    O
acrylic    O
acid    O
,    O
super    O
acrylic    O
polymer    O
,    O
styrene    O
monomer    O
,    O
methyl    B-Alkene114713120
methacrylate    I-Alkene114713120
styrene    I-Alkene114713120
,    O
acrylonitrile    O
butadiene    O
styrene    O
and    O
styrene    O
-    O
acrylonitrile    O
polymers    O
,    O
solution    O
styrene    O
-    O
butadiene    O
rubber    O
,    O
thermoplastic    O
elastomers    O
,    O
polybutadiene    O
and    O
several    O
polymer    O
compounds    O
.    O

Methyl    B-Alkene114713120
methacrylate    I-Alkene114713120

Huperzine    B-Alkene114713120
A    I-Alkene114713120
while    O
promising    O
,    O
requires    O
further    O
evidence    O
before    O
its    O
use    O
can    O
be    O
recommended    O
.    O

Drugs    O
containing    O
Huperzine    B-Alkene114713120
A    I-Alkene114713120
and    O
Donepezil    O

Employing    O
intravascular    O
ultrasound    O
(    O
IVUS    O
)    O
,    O
they    O
showed    O
regression    O
of    O
the    O
atherosclerotic    O
plaques    O
in    O
response    O
to    O
a    O
high    O
dose    O
of    O
rosuvastatin    B-Alkene114713120

Also    O
,    O
co    O
-    O
administration    O
of    O
eluxadoline    O
with    O
rosuvastatin    B-Alkene114713120
may    O
increase    O
the    O
risk    O
of    O
rhabdomyolysis    O
.    O

The    O
AURORA    O
trial    O
(    O
A    O
Study    O
to    O
Evaluate    O
the    O
Use    O
of    O
Rosuvastatin    B-Alkene114713120
in    O
Subjects    O
on    O
Regular    O
Hemodialysis    O
:    O
An    O
Assessment    O
of    O
Survival    O
and    O
Cardiovascular    O
Events    O
)    O
was    O
a    O
randomized    O
,    O
double    O
-    O
blind    O
,    O
placebo    O
-    O
controlled    O
study    O
investigating    O
the    O
use    O
of    O
rosuvastatin    B-Alkene114713120
in    O
the    O
prevention    O
of    O
cardiovascular    O
disease    O
among    O
patients    O
undergoing    O
chronic    O
hemodialysis    O
.    O

The    O
trial    O
was    O
sponsored    O
,    O
in    O
part    O
,    O
by    O
AstraZeneca    O
,    O
the    O
marketer    O
of    O
Crestor    B-Alkene114713120
.    O

Dichloroethene    B-Alkene114713120

Dichloroethene    B-Alkene114713120

dichloroethylene    B-Alkene114713120
,    O
and    O
aliphatic    O
acids    O
.    O

Herapathite    B-Alkene114713120
is    O
also    O
dichroic    O
,    O
and    O
is    O
not    O
strongly    O
coloured    O
,    O
but    O
is    O
difficult    O
to    O
grow    O
in    O
large    O
crystals    O
.    O

It    O
is    O
manufactured    O
by    O
Goldshield    O
under    O
the    O
tradename    O
Rheumox    B-Alkene114713120
.    O

The    O
accident    O
was    O
caused    O
by    O
the    O
reaction    O
vessel    O
being    O
wrongly    O
filled    O
with    O
the    O
reactive    O
chemical    O
Dicyclopentadiene    B-Alkene114713120
the    O
previous    O
day    O
.    O

Nevcin    O
synthesises    O
hydrocarbon    O
resins    O
,    O
using    O
distillates    O
from    O
cracking    O
of    O
the    O
naphtha    O
fraction    O
,    O
with    O
polymerisation    O
feedstock    O
including    O
isoprene    B-Alkene114713120
,    O
piperylene    B-Alkene114713120
and    O
cyclopentadiene    O
(    O
or    O
dicyclopentadiene    B-Alkene114713120
dimer    O
)    O
as    O
well    O
as    O
styrene    O
and    O
styrene    O
-    O
type    O
products    O
including    O
vinyltoluene    O
,    O
indene    O
,    O
methylindene    O
and    O
alpha-methylstyrene    B-Alkene114713120
.    O

It    O
is    O
prepared    O
from    O
reaction    O
of    O
dihydropentalene    O
(    O
pyrolysis    O
of    O
an    O
isomer    O
of    O
dicyclopentadiene    B-Alkene114713120
)    O
with    O
"    O
n    O
"-    O
butyllithium    O
in    O
solution    O
and    O
forms    O
a    O
stable    O
salt    O
.    O

Sobrerol    B-Alkene114713120
is    O
a    O
mucolytic    O
.    O

Rhodinol    B-Alkene114713120

Oenanthotoxin    B-Alkene114713120

Antagonists    O
/    O
negative    O
allosteric    O
modulators    O
:    O
bicuculline    O
,    O
cicutoxin    B-Alkene114713120
,    O
flumazenil    O
,    O
furosemide    O
,    O
gabazine    O
,    O
oenanthotoxin    B-Alkene114713120
,    O
picrotoxin    B-Alkene114713120
,    O
Ro15    O
-    O
4513    O
,    O
thujone    O
,    O
amentoflavone    O
.    O

α-Terpinene    O
is    O
produced    O
industrially    O
by    O
acid    O
-    O
catalyzed    O
rearrangement    O
of    O
pinene    B-Alkene114713120
.    O

The    O
primary    O
chemical    O
constituents    O
of    O
the    O
seed    O
include    O
cinnamaldehyde    B-Alkene114713120
,    O
gum    O
,    O
tannins    O
,    O
mannitol    O
,    O
coumarins    O
and    O
essential    O
oils    O
(    O
aldehydes    O
,    O
eugenol    B-Alkene114713120
and    O
pinene    B-Alkene114713120
)    O
.    O

Sagebrush    O
essential    O
oil    O
contains    O
approximately    O
40%    O
"    O
l    O
"-    O
camphor    O
;    O
20%    O
pinene    B-Alkene114713120
;    O
7%    O
cineole    O
;    O
5%    O
methacrolein    B-Alkene114713120
;    O
and    O
12%    O
"a"-terpinene    B-Alkene114713120
,    O
"    O
d    O
"-    O
camphor    O
,    O
and    O
sesqiterpenoids    O
.    O

Examples    O
of    O
monoterpenes    O
and    O
monoterpenoids    O
include    O
geraniol    B-Alkene114713120
,    O
terpineol    B-Alkene114713120
(    O
present    O
in    O
lilacs    O
)    O
,    O
limonene    O
(    O
present    O
in    O
citrus    O
fruits    O
)    O
,    O
myrcene    B-Alkene114713120
(    O
present    O
in    O
hops    O
)    O
,    O
linalool    O
(    O
present    O
in    O
lavender    O
)    O
or    O
pinene    B-Alkene114713120
(    O
present    O
in    O
pine    O
trees    O
)    O
.    O

Kaffir    O
/    O
Makrut    O
lime    O
fruit    O
peel    O
contains    O
an    O
essential    O
oil    O
comparable    O
to    O
lime    O
fruit    O
peel    O
oil    O
;    O
its    O
main    O
components    O
are    O
limonene    O
and    O
β-pinene    B-Alkene114713120
.    O

The    O
secretion    O
from    O
"    O
Tenuirostritemes    O
tenuirostris    O
"    O
consists    O
of    O
a    O
mixture    O
of    O
three    O
terpenes    O
,    O
namely    O
62%    O
pinene    B-Alkene114713120
,    O
27%    O
myrcene    B-Alkene114713120
and    O
11%    O
limonene    O
.    O

Later    O
the    O
oxidation    O
and    O
reduction    O
reactions    O
of    O
chiral    O
pinene    B-Alkene114713120
lead    O
also    O
to    O
several    O
possible    O
isomers    O
of    O
carvone    B-Alkene114713120
(    O
the    O
corresponding    O
cyclohexyl    O
ketone    O
dehydrated    O
at    O
the    O
isopropyl    O
)    O
and    O
sobrerol    O
,    O
making    O
it    O
possible    O
to    O
determine    O
reaction    O
mechanism    O
and    O
the    O
structural    O
properties    O
of    O
pinene    O
and    O
of    O
other    O
terpenes    O
.    O

Tetra-"tert"-butylethylene    B-Alkene114713120

Unlike    O
other    O
D1    O
agonists    O
with    O
higher    O
efficacy    O
such    O
as    O
SKF-81,297    O
and    O
6-Br-APB    B-Alkene114713120
,    O
SKF-77,434    O
does    O
not    O
maintain    O
self    O
-    O
administration    O
in    O
animal    O
studies    O
,    O
and    O
so    O
has    O
been    O
researched    O
as    O
a    O
potential    O
treatment    O
for    O
cocaine    O
addiction    O
.    O

It    O
is    O
type    O
of    O
3-methylglutaconic    O
aciduria    O
,    O
the    O
hallmark    O
of    O
which    O
is    O
an    O
increased    O
level    O
in    O
the    O
urinary    O
concentrations    O
of    O
3-methylglutaconic    B-Alkene114713120
acid    I-Alkene114713120
and    O
3-methylglutaric    O
acid    O
;    O
this    O
can    O
allow    O
diagnosis    O
as    O
early    O
as    O
at    O
one    O
year    O
of    O
age    O
.    O

TRPA1    O
is    O
known    O
to    O
be    O
activated    O
by    O
compounds    O
capable    O
of    O
forming    O
covalent    O
chemical    O
bonds    O
with    O
the    O
protein    O
's    O
cysteins    O
like    O
isothiocyanates    O
,    O
which    O
are    O
the    O
pungent    O
chemicals    O
in    O
substances    O
such    O
as    O
mustard    O
oil    O
and    O
wasabi    O
and    O
Michael    O
acceptors    O
such    O
as    O
cinnamaldehyde    B-Alkene114713120
in    O
cinnamon    O
,    O
amongst    O
numerous    O
other    O
substances    O
.    O

Cinnamoyl    O
-    O
CoA    O
reductase    O
,    O
an    O
enzyme    O
that    O
catalyzes    O
the    O
chemical    O
reaction    O
cinnamaldehyde    B-Alkene114713120
+    O
CoA    O
+    O
NADP+    O
→    O
cinnamoyl    O
-    O
CoA    O
+    O
NADPH    O
+    O
H+    O

Cinnamaldehyde    B-Alkene114713120
,    O
an    O
essential    O
oil    O
extracted    O
from    O
"    O
C.    O
osmophloeum    O
"    O
,    O
has    O
numerous    O
commercial    O
uses    O
.    O

Tropone    O
is    O
also    O
found    O
to    O
react    O
in    O
an    O
[    O
8    O
+    O
3]annulation    O
with    O
a    O
cinnamic    B-Alkene114713120
aldehyde    I-Alkene114713120

The    O
primary    O
chemical    O
constituents    O
of    O
the    O
seed    O
include    O
cinnamaldehyde    B-Alkene114713120
,    O
gum    O
,    O
tannins    O
,    O
mannitol    O
,    O
coumarins    O
and    O
essential    O
oils    O
(    O
aldehydes    O
,    O
eugenol    B-Alkene114713120
and    O
pinene    B-Alkene114713120
)    O
.    O

The    O
taste    O
of    O
Ecuadorian    O
cinnamon    O
is    O
thought    O
to    O
come    O
from    O
the    O
presence    O
of    O
methyl    B-Alkene114713120
cinnamate    I-Alkene114713120
and    O
trans-cinnamaldehyde    B-Alkene114713120
which    O
are    O
also    O
found    O
in    O
the    O
essential    O
oils    O
which    O
come    O
from    O
the    O
flower    O
calices    O
of    O
the    O
plant    O
.    O

The    O
reaction    O
of    O
geranyl    O
pyrophosphate    O
with    O
isopentenyl    B-Alkene114713120
pyrophosphate    I-Alkene114713120
results    O
in    O
the    O
15-carbon    O
farnesyl    O
pyrophosphate    O
which    O
is    O
an    O
intermediate    O
in    O
the    O
biosynthesis    O
of    O
sesquiterpenes    O
such    O
as    O
farnesene    B-Alkene114713120
.    O

Examples    O
of    O
sesquiterpenes    O
and    O
sesquiterpenoids    O
include    O
humulene    B-Alkene114713120
,    O
farnesene    B-Alkene114713120
,    O
farnesol    B-Alkene114713120
.    O

Like    O
lapatinib    O
and    O
neratinib    B-Alkene114713120
,    O
afatinib    O
is    O
a    O
protein    O
kinase    O
inhibitor    O
that    O
also    O
irreversibly    O
inhibits    O
human    O
epidermal    O
growth    O
factor    O
receptor    O
2    O
(    O
Her2    O
)    O
and    O
epidermal    O
growth    O
factor    O
receptor    O
(    O
EGFR    O
)    O
kinases    O
.    O

This    O
half    O
-    O
sandwich    O
compound    O
is    O
prepared    O
by    O
the    O
reaction    O
of    O
ruthenium    O
trichloride    O
with    O
the    O
terpene    O
phellandrene    B-Alkene114713120
.    O

Phellandrene    B-Alkene114713120
is    O
the    O
name    O
for    O
a    O
pair    O
of    O
organic    O
compounds    O
that    O
have    O
a    O
similar    O
molecular    O
structure    O
and    O
similar    O
chemical    O
properties    O
.    O

The    O
terpinene    B-Alkene114713120
,    O
phellandrene    B-Alkene114713120
,    O
and    O
terpinolene    B-Alkene114713120
are    O
formed    O
similarly    O
.    O

Crotonaldehyde    B-Alkene114713120
,    O
or    O
2-butenal    O
,    O
an    O
unsaturated    O
aldehyde    O

At    O
one    O
time    O
,    O
it    O
was    O
produced    O
industrially    O
by    O
the    O
catalytic    O
hydrogenation    O
of    O
crotonaldehyde    B-Alkene114713120
,    O
which    O
is    O
derived    O
from    O
acetaldehyde    O
.    O

It    O
can    O
be    O
prepared    O
from    O
aniline    O
and    O
paraldehyde    O
via    O
Skraup    O
synthesis    O
or    O
from    O
aniline    O
and    O
crotonaldehyde    B-Alkene114713120
via    O
Doebner    O
-    O
von    O
Miller    O
variation    O
of    O
the    O
Skraup    O
reaction    O
.    O

For    O
instance    O
cyclobutadiene    B-Alkene114713120
is    O
a    O
very    O
unstable    O
molecule    O
but    O
with    O
both    O
olefinic    O
bonds    O
in    O
push    O
-    O
pull    O
configuration    O
(    O
two    O
ester    O
substituents    O
and    O
two    O
tertiary    O
amine    O
substituents    O
)    O
the    O
molecule    O
is    O
stable    O
indeed    O
.    O

Cyclobutadiene    B-Alkene114713120
,    O
cyclohexadiene    O
,    O
and    O
arene    O
complexes    O
have    O
all    O
been    O
observed    O
as    O
off    O
-    O
cycle    O
,    O
inactivate    O
catalyst    O
forms    O
.    O

Consider    O
the    O
molecule    O
Fe(CO)3    O
complexed    O
with    O
cyclobutadiene    B-Alkene114713120
.    O

He    O
searched    O
for    O
ways    O
of    O
obtaining    O
cyclobutadiene    B-Alkene114713120
,    O
while    O
explaining    O
the    O
chemistry    O
of    O
this    O
unstable    O
substance    O
and    O
isolating    O
its    O
dimers    O
.    O

They    O
are    O
liable    O
to    O
dimerization    O
to    O
cyclobutadiene    B-Alkene114713120
compounds    O
or    O
react    O
with    O
oxygen    O
to    O
epoxides    O
.    O


